id	sid	tid	token	lemma	pos
aji-50	1	1	_	_	PUNCT
aji-50	2	1	_	_	PUNCT
aji-50	3	1	_	_	PUNCT
aji-50	4	1	_	_	PUNCT
aji-50	5	1	_	_	PUNCT
aji-50	6	1	_	_	PUNCT
aji-50	7	1	_	_	PUNCT
aji-50	8	1	_	_	PUNCT
aji-50	9	1	_	_	PUNCT
aji-50	10	1	_	_	PUNCT
aji-50	11	1	_	_	PUNCT
aji-50	12	1	_	_	PUNCT
aji-50	13	1	_	_	PUNCT
aji-50	14	1	_	_	PUNCT
aji-50	15	1	_	_	PUNCT
aji-50	16	1	_	_	PUNCT
aji-50	17	1	_	_	PUNCT
aji-50	18	1	_	_	PUNCT
aji-50	19	1	_	_	PUNCT
aji-50	20	1	_	_	PUNCT
aji-50	21	1	_	_	PUNCT
aji-50	22	1	_	_	PUNCT
aji-50	23	1	_	_	PUNCT
aji-50	24	1	_	_	PUNCT
aji-50	25	1	_	_	PUNCT
aji-50	26	1	_	_	PUNCT
aji-50	27	1	_	_	PUNCT
aji-50	28	1	_	_	PUNCT
aji-50	29	1	_	_	PUNCT
aji-50	30	1	_	_	PUNCT
aji-50	31	1	_	_	PUNCT
aji-50	32	1	_	_	PUNCT
aji-50	33	1	_	_	PUNCT
aji-50	34	1	_	_	PUNCT
aji-50	35	1	_	_	PUNCT
aji-50	36	1	_	_	PUNCT
aji-50	37	1	_	_	PUNCT
aji-50	38	1	_	_	PUNCT
aji-50	39	1	_	_	PUNCT
aji-50	40	1	_	_	PUNCT
aji-50	41	1	_	_	PUNCT
aji-50	42	1	_	_	PUNCT
aji-50	43	1	_	_	PUNCT
aji-50	44	1	_	_	PUNCT
aji-50	45	1	_	_	PUNCT
aji-50	46	1	_	_	PUNCT
aji-50	47	1	_	_	PUNCT
aji-50	48	1	_	_	PUNCT
aji-50	49	1	_	_	PUNCT
aji-50	50	1	_	_	PUNCT
aji-50	51	1	_	_	PUNCT
aji-50	52	1	_	_	PUNCT
aji-50	53	1	_	_	PUNCT
aji-50	54	1	_	_	PUNCT
aji-50	55	1	_	_	PUNCT
aji-50	56	1	_	_	PUNCT
aji-50	57	1	_	_	PUNCT
aji-50	58	1	_	_	PUNCT
aji-50	59	1	_	_	PUNCT
aji-50	60	1	_	_	PUNCT
aji-50	61	1	_	_	PUNCT
aji-50	62	1	_	_	PUNCT
aji-50	63	1	_	_	PUNCT
aji-50	64	1	_	_	PUNCT
aji-50	65	1	_	_	PUNCT
aji-50	66	1	_	_	PUNCT
aji-50	67	1	_	_	PUNCT
aji-50	68	1	_	_	PUNCT
aji-50	69	1	_	_	PUNCT
aji-50	70	1	_	_	PUNCT
aji-50	71	1	_	_	PUNCT
aji-50	72	1	_	_	PUNCT
aji-50	73	1	_	_	PUNCT
aji-50	74	1	_	_	PUNCT
aji-50	75	1	_	_	PUNCT
aji-50	76	1	_	_	PUNCT
aji-50	77	1	_	_	PUNCT
aji-50	78	1	_	_	PUNCT
aji-50	79	1	_	_	PUNCT
aji-50	80	1	_	_	PUNCT
aji-50	81	1	_	_	PUNCT
aji-50	82	1	_	_	PUNCT
aji-50	83	1	_	_	PUNCT
aji-50	84	1	_	_	PUNCT
aji-50	85	1	_	_	PUNCT
aji-50	86	1	_	_	PUNCT
aji-50	87	1	_	_	PUNCT
aji-50	88	1	_	_	PUNCT
aji-50	89	1	_	_	PUNCT
aji-50	90	1	_	_	PUNCT
aji-50	91	1	_	_	PUNCT
aji-50	92	1	_	_	PUNCT
aji-50	93	1	_	_	PUNCT
aji-50	94	1	_	_	PUNCT
aji-50	95	1	_	_	PUNCT
aji-50	96	1	_	_	PUNCT
aji-50	97	1	_	_	PUNCT
aji-50	98	1	_	_	PUNCT
aji-50	99	1	_	_	PUNCT
aji-50	100	1	_	_	PUNCT
aji-50	101	1	_	_	PUNCT
aji-50	102	1	*	*	PUNCT
aji-50	102	2	corresponding	correspond	VERB
aji-50	102	3	author	author	NOUN
aji-50	102	4	:	:	PUNCT
aji-50	102	5	e	e	NOUN
aji-50	102	6	-	-	NOUN
aji-50	102	7	mail	mail	NOUN
aji-50	102	8	:	:	PUNCT
aji-50	102	9	drdjuraev@mail.ru	drdjuraev@mail.ru	PROPN
aji-50	102	10	;	;	PUNCT
aji-50	102	11	asian	asian	ADJ
aji-50	102	12	journal	journal	NOUN
aji-50	102	13	of	of	ADP
aji-50	102	14	immunology	immunology	NOUN
aji-50	102	15	3(1	3(1	NUM
aji-50	102	16	):	):	PUNCT
aji-50	102	17	124	124	NUM
aji-50	102	18	-	-	SYM
aji-50	102	19	130	130	NUM
aji-50	102	20	,	,	PUNCT
aji-50	102	21	2020	2020	NUM
aji-50	102	22	;	;	PUNCT
aji-50	102	23	article	article	NOUN
aji-50	102	24	no.aji.55718	no.aji.55718	PROPN
aji-50	102	25	results	result	NOUN
aji-50	102	26	of	of	ADP
aji-50	102	27	allergological	allergological	ADJ
aji-50	102	28	and	and	CCONJ
aji-50	102	29	immunological	immunological	ADJ
aji-50	102	30	research	research	NOUN
aji-50	102	31	in	in	ADP
aji-50	102	32	patients	patient	NOUN
aji-50	102	33	with	with	ADP
aji-50	102	34	polipoid	polipoid	NOUN
aji-50	102	35	rhinosinusitis	rhinosinusitis	PROPN
aji-50	102	36	j.	j.	PROPN
aji-50	102	37	a.	a.	PROPN
aji-50	102	38	djuraev1	djuraev1	PROPN
aji-50	102	39	*	*	PUNCT
aji-50	102	40	,	,	PUNCT
aji-50	102	41	u.	u.	PROPN
aji-50	102	42	s.	s.	PROPN
aji-50	102	43	khasanov1	khasanov1	PROPN
aji-50	102	44	,	,	PUNCT
aji-50	102	45	u.	u.	PROPN
aji-50	102	46	n.	n.	PROPN
aji-50	102	47	vohidov2	vohidov2	PROPN
aji-50	102	48	and	and	CCONJ
aji-50	102	49	s.	s.	PROPN
aji-50	102	50	s.	s.	PROPN
aji-50	102	51	sharipov2	sharipov2	PROPN
aji-50	102	52	1	1	NUM
aji-50	102	53	tashkent	tashkent	PROPN
aji-50	102	54	medical	medical	PROPN
aji-50	102	55	academy	academy	PROPN
aji-50	102	56	,	,	PUNCT
aji-50	102	57	uzbekistan	uzbekistan	PROPN
aji-50	102	58	.	.	PUNCT
aji-50	103	1	2	2	NUM
aji-50	103	2	tashkent	tashkent	PROPN
aji-50	103	3	state	state	NOUN
aji-50	103	4	dental	dental	PROPN
aji-50	103	5	institute	institute	PROPN
aji-50	103	6	,	,	PUNCT
aji-50	103	7	uzbekistan	uzbekistan	PROPN
aji-50	103	8	.	.	PUNCT
aji-50	104	1	authors	author	NOUN
aji-50	104	2	’	'	PUNCT
aji-50	104	3	contributions	contribution	NOUN
aji-50	104	4	this	this	DET
aji-50	104	5	work	work	NOUN
aji-50	104	6	was	be	AUX
aji-50	104	7	carried	carry	VERB
aji-50	104	8	out	out	ADP
aji-50	104	9	in	in	ADP
aji-50	104	10	collaboration	collaboration	NOUN
aji-50	104	11	among	among	ADP
aji-50	104	12	all	all	DET
aji-50	104	13	authors	author	NOUN
aji-50	104	14	.	.	PUNCT
aji-50	105	1	authors	author	NOUN
aji-50	105	2	jad	jad	PROPN
aji-50	105	3	and	and	CCONJ
aji-50	105	4	usk	usk	PROPN
aji-50	105	5	designed	design	VERB
aji-50	105	6	the	the	DET
aji-50	105	7	study	study	NOUN
aji-50	105	8	,	,	PUNCT
aji-50	105	9	performed	perform	VERB
aji-50	105	10	the	the	DET
aji-50	105	11	statistical	statistical	ADJ
aji-50	105	12	analysis	analysis	NOUN
aji-50	105	13	,	,	PUNCT
aji-50	105	14	wrote	write	VERB
aji-50	105	15	the	the	DET
aji-50	105	16	protocol	protocol	NOUN
aji-50	105	17	and	and	CCONJ
aji-50	105	18	wrote	write	VERB
aji-50	105	19	the	the	DET
aji-50	105	20	first	first	ADJ
aji-50	105	21	draft	draft	NOUN
aji-50	105	22	of	of	ADP
aji-50	105	23	the	the	DET
aji-50	105	24	manuscript	manuscript	NOUN
aji-50	105	25	.	.	PUNCT
aji-50	106	1	author	author	PROPN
aji-50	106	2	unv	unv	PROPN
aji-50	106	3	managed	manage	VERB
aji-50	106	4	the	the	DET
aji-50	106	5	analyses	analysis	NOUN
aji-50	106	6	of	of	ADP
aji-50	106	7	the	the	DET
aji-50	106	8	study	study	NOUN
aji-50	106	9	.	.	PUNCT
aji-50	107	1	author	author	NOUN
aji-50	107	2	sss	sss	PROPN
aji-50	107	3	managed	manage	VERB
aji-50	107	4	the	the	DET
aji-50	107	5	literature	literature	NOUN
aji-50	107	6	searches	search	NOUN
aji-50	107	7	.	.	PUNCT
aji-50	108	1	all	all	DET
aji-50	108	2	authors	author	NOUN
aji-50	108	3	read	read	VERB
aji-50	108	4	and	and	CCONJ
aji-50	108	5	approved	approve	VERB
aji-50	108	6	the	the	DET
aji-50	108	7	final	final	ADJ
aji-50	108	8	manuscript	manuscript	NOUN
aji-50	108	9	.	.	PUNCT
aji-50	109	1	article	article	NOUN
aji-50	109	2	information	information	PROPN
aji-50	109	3	editor(s	editor(s	PROPN
aji-50	109	4	):	):	PUNCT
aji-50	109	5	(	(	PUNCT
aji-50	109	6	1	1	X
aji-50	109	7	)	)	PUNCT
aji-50	109	8	dr	dr	PROPN
aji-50	109	9	.	.	PROPN
aji-50	109	10	wagner	wagner	PROPN
aji-50	109	11	loyola	loyola	PROPN
aji-50	109	12	,	,	PUNCT
aji-50	109	13	brazilian	brazilian	ADJ
aji-50	109	14	agricultural	agricultural	ADJ
aji-50	109	15	research	research	NOUN
aji-50	109	16	corporation	corporation	NOUN
aji-50	109	17	,	,	PUNCT
aji-50	109	18	brazil	brazil	PROPN
aji-50	109	19	.	.	PUNCT
aji-50	110	1	(	(	PUNCT
aji-50	110	2	2	2	X
aji-50	110	3	)	)	PUNCT
aji-50	110	4	dr	dr	PROPN
aji-50	110	5	.	.	PROPN
aji-50	110	6	darko	darko	PROPN
aji-50	110	7	nozic	nozic	PROPN
aji-50	110	8	,	,	PUNCT
aji-50	110	9	university	university	PROPN
aji-50	110	10	of	of	ADP
aji-50	110	11	belgrade	belgrade	PROPN
aji-50	110	12	,	,	PUNCT
aji-50	110	13	serbia	serbia	PROPN
aji-50	110	14	.	.	PUNCT
aji-50	111	1	reviewers	reviewer	NOUN
aji-50	111	2	:	:	PUNCT
aji-50	111	3	(	(	PUNCT
aji-50	111	4	1	1	X
aji-50	111	5	)	)	PUNCT
aji-50	111	6	ekaterini	ekaterini	NOUN
aji-50	111	7	goudouris	goudouris	PROPN
aji-50	111	8	,	,	PUNCT
aji-50	111	9	universidade	universidade	PROPN
aji-50	111	10	federal	federal	PROPN
aji-50	111	11	do	do	PROPN
aji-50	111	12	rio	rio	PROPN
aji-50	111	13	de	de	PROPN
aji-50	111	14	janeiro	janeiro	PROPN
aji-50	111	15	,	,	PUNCT
aji-50	111	16	brazil	brazil	PROPN
aji-50	111	17	.	.	PUNCT
aji-50	112	1	(	(	PUNCT
aji-50	112	2	2	2	X
aji-50	112	3	)	)	PUNCT
aji-50	112	4	gilbert	gilbert	PROPN
aji-50	112	5	batieka	batieka	PROPN
aji-50	112	6	bonsaana	bonsaana	PROPN
aji-50	112	7	,	,	PUNCT
aji-50	112	8	university	university	NOUN
aji-50	112	9	for	for	ADP
aji-50	112	10	development	development	NOUN
aji-50	112	11	studies	study	NOUN
aji-50	112	12	,	,	PUNCT
aji-50	112	13	ghana	ghana	PROPN
aji-50	112	14	.	.	PUNCT
aji-50	113	1	complete	complete	ADJ
aji-50	113	2	peer	peer	NOUN
aji-50	113	3	review	review	NOUN
aji-50	113	4	history	history	NOUN
aji-50	113	5	:	:	PUNCT
aji-50	113	6	http://www.sdiarticle4.com/review-history/55718	http://www.sdiarticle4.com/review-history/55718	PROPN
aji-50	113	7	received	receive	VERB
aji-50	113	8	10	10	NUM
aji-50	113	9	february	february	NOUN
aji-50	113	10	2020	2020	NUM
aji-50	113	11	accepted	accept	VERB
aji-50	113	12	16	16	NUM
aji-50	113	13	april	april	PROPN
aji-50	113	14	2020	2020	NUM
aji-50	113	15	published	publish	VERB
aji-50	113	16	22	22	NUM
aji-50	113	17	april	april	PROPN
aji-50	113	18	2020	2020	NUM
aji-50	113	19	abstract	abstract	ADV
aji-50	113	20	an	an	DET
aji-50	113	21	exceptional	exceptional	ADJ
aji-50	113	22	role	role	NOUN
aji-50	113	23	in	in	ADP
aji-50	113	24	protecting	protect	VERB
aji-50	113	25	against	against	ADP
aji-50	113	26	pathogenic	pathogenic	ADJ
aji-50	113	27	effects	effect	NOUN
aji-50	113	28	of	of	ADP
aji-50	113	29	various	various	ADJ
aji-50	113	30	pathogenic	pathogenic	ADJ
aji-50	113	31	and	and	CCONJ
aji-50	113	32	opportunistic	opportunistic	ADJ
aji-50	113	33	microorganisms	microorganism	NOUN
aji-50	113	34	is	be	AUX
aji-50	113	35	played	play	VERB
aji-50	113	36	by	by	ADP
aji-50	113	37	immunoglobulins	immunoglobulin	NOUN
aji-50	113	38	of	of	ADP
aji-50	113	39	the	the	DET
aji-50	113	40	main	main	ADJ
aji-50	113	41	classes	class	NOUN
aji-50	113	42	.	.	PUNCT
aji-50	114	1	as	as	SCONJ
aji-50	114	2	our	our	PRON
aji-50	114	3	studies	study	NOUN
aji-50	114	4	showed	show	VERB
aji-50	114	5	,	,	PUNCT
aji-50	114	6	before	before	ADP
aji-50	114	7	treatment	treatment	NOUN
aji-50	114	8	,	,	PUNCT
aji-50	114	9	the	the	DET
aji-50	114	10	igg	igg	PROPN
aji-50	114	11	content	content	NOUN
aji-50	114	12	in	in	ADP
aji-50	114	13	patients	patient	NOUN
aji-50	114	14	did	do	AUX
aji-50	114	15	not	not	PART
aji-50	114	16	differ	differ	VERB
aji-50	114	17	significantly	significantly	ADV
aji-50	114	18	from	from	ADP
aji-50	114	19	the	the	DET
aji-50	114	20	control	control	NOUN
aji-50	114	21	.	.	PUNCT
aji-50	115	1	the	the	DET
aji-50	115	2	average	average	ADJ
aji-50	115	3	iga	iga	PROPN
aji-50	115	4	level	level	NOUN
aji-50	115	5	in	in	ADP
aji-50	115	6	patients	patient	NOUN
aji-50	115	7	of	of	ADP
aji-50	115	8	both	both	DET
aji-50	115	9	groups	group	NOUN
aji-50	115	10	before	before	ADP
aji-50	115	11	surgery	surgery	NOUN
aji-50	115	12	was	be	AUX
aji-50	115	13	slightly	slightly	ADV
aji-50	115	14	reduced	reduce	VERB
aji-50	115	15	(	(	PUNCT
aji-50	115	16	p	p	X
aji-50	115	17	>	>	X
aji-50	115	18	0.05	0.05	NUM
aji-50	115	19	)	)	PUNCT
aji-50	115	20	.	.	PUNCT
aji-50	116	1	given	give	VERB
aji-50	116	2	the	the	DET
aji-50	116	3	important	important	ADJ
aji-50	116	4	role	role	NOUN
aji-50	116	5	of	of	ADP
aji-50	116	6	iga	iga	PROPN
aji-50	116	7	in	in	ADP
aji-50	116	8	protecting	protect	VERB
aji-50	116	9	the	the	DET
aji-50	116	10	body	body	NOUN
aji-50	116	11	and	and	CCONJ
aji-50	116	12	,	,	PUNCT
aji-50	116	13	above	above	ADP
aji-50	116	14	all	all	PRON
aji-50	116	15	,	,	PUNCT
aji-50	116	16	the	the	DET
aji-50	116	17	mucous	mucous	ADJ
aji-50	116	18	membranes	membrane	NOUN
aji-50	116	19	from	from	ADP
aji-50	116	20	infection	infection	NOUN
aji-50	116	21	,	,	PUNCT
aji-50	116	22	it	it	PRON
aji-50	116	23	can	can	AUX
aji-50	116	24	be	be	AUX
aji-50	116	25	concluded	conclude	VERB
aji-50	116	26	that	that	SCONJ
aji-50	116	27	such	such	DET
aji-50	116	28	a	a	DET
aji-50	116	29	disturbance	disturbance	NOUN
aji-50	116	30	of	of	ADP
aji-50	116	31	the	the	DET
aji-50	116	32	biosynthesis	biosynthesis	NOUN
aji-50	116	33	of	of	ADP
aji-50	116	34	this	this	DET
aji-50	116	35	class	class	NOUN
aji-50	116	36	of	of	ADP
aji-50	116	37	immunoglobulin	immunoglobulin	NOUN
aji-50	116	38	may	may	AUX
aji-50	116	39	be	be	AUX
aji-50	116	40	one	one	NUM
aji-50	116	41	of	of	ADP
aji-50	116	42	the	the	DET
aji-50	116	43	reasons	reason	NOUN
aji-50	116	44	for	for	ADP
aji-50	116	45	the	the	DET
aji-50	116	46	decrease	decrease	NOUN
aji-50	116	47	in	in	ADP
aji-50	116	48	immune	immune	ADJ
aji-50	116	49	reactivity	reactivity	NOUN
aji-50	116	50	and	and	CCONJ
aji-50	116	51	frequent	frequent	ADJ
aji-50	116	52	infectious	infectious	ADJ
aji-50	116	53	processes	process	NOUN
aji-50	116	54	.	.	PUNCT
aji-50	117	1	a	a	DET
aji-50	117	2	sharp	sharp	ADJ
aji-50	117	3	increase	increase	NOUN
aji-50	117	4	in	in	ADP
aji-50	117	5	serum	serum	PROPN
aji-50	117	6	ige	ige	PROPN
aji-50	117	7	levels	level	NOUN
aji-50	117	8	(	(	PUNCT
aji-50	117	9	239	239	NUM
aji-50	117	10	±	±	NUM
aji-50	117	11	19.1	19.1	NUM
aji-50	117	12	iu	iu	NOUN
aji-50	117	13	/	/	SYM
aji-50	117	14	ml	ml	VERB
aji-50	117	15	)	)	PUNCT
aji-50	117	16	was	be	AUX
aji-50	117	17	observed	observe	VERB
aji-50	117	18	in	in	ADP
aji-50	117	19	patients	patient	NOUN
aji-50	117	20	with	with	ADP
aji-50	117	21	eosinophilic	eosinophilic	ADJ
aji-50	117	22	polyposis	polyposis	NOUN
aji-50	117	23	rhinosinusitis	rhinosinusitis	NOUN
aji-50	117	24	,	,	PUNCT
aji-50	117	25	which	which	PRON
aji-50	117	26	we	we	PRON
aji-50	117	27	associate	associate	VERB
aji-50	117	28	with	with	ADP
aji-50	117	29	an	an	DET
aji-50	117	30	increase	increase	NOUN
aji-50	117	31	in	in	ADP
aji-50	117	32	il-4	il-4	NOUN
aji-50	117	33	content	content	NOUN
aji-50	117	34	and	and	CCONJ
aji-50	117	35	increased	increase	VERB
aji-50	117	36	allergization	allergization	NOUN
aji-50	117	37	of	of	ADP
aji-50	117	38	the	the	DET
aji-50	117	39	body	body	NOUN
aji-50	117	40	.	.	PUNCT
aji-50	118	1	this	this	DET
aji-50	118	2	relative	relative	ADJ
aji-50	118	3	difference	difference	NOUN
aji-50	118	4	between	between	ADP
aji-50	118	5	patients	patient	NOUN
aji-50	118	6	of	of	ADP
aji-50	118	7	the	the	DET
aji-50	118	8	two	two	NUM
aji-50	118	9	groups	group	NOUN
aji-50	118	10	proves	prove	VERB
aji-50	118	11	the	the	DET
aji-50	118	12	need	need	NOUN
aji-50	118	13	for	for	ADP
aji-50	118	14	appropriate	appropriate	ADJ
aji-50	118	15	diagnosis	diagnosis	NOUN
aji-50	118	16	and	and	CCONJ
aji-50	118	17	treatment	treatment	NOUN
aji-50	118	18	of	of	ADP
aji-50	118	19	chronic	chronic	ADJ
aji-50	118	20	polyposis	polyposis	NOUN
aji-50	118	21	of	of	ADP
aji-50	118	22	rhinosinusitis	rhinosinusitis	NOUN
aji-50	118	23	.	.	PUNCT
aji-50	119	1	the	the	DET
aji-50	119	2	aim	aim	NOUN
aji-50	119	3	of	of	ADP
aji-50	119	4	our	our	PRON
aji-50	119	5	research	research	NOUN
aji-50	119	6	work	work	NOUN
aji-50	119	7	was	be	AUX
aji-50	119	8	study	study	NOUN
aji-50	119	9	allergically	allergically	ADV
aji-50	119	10	and	and	CCONJ
aji-50	119	11	immunologically	immunologically	ADV
aji-50	119	12	results	result	VERB
aji-50	119	13	in	in	ADP
aji-50	119	14	patients	patient	NOUN
aji-50	119	15	with	with	ADP
aji-50	119	16	polipoidrhinosinusitis	polipoidrhinosinusitis	NOUN
aji-50	119	17	.	.	PUNCT
aji-50	120	1	original	original	ADJ
aji-50	120	2	research	research	NOUN
aji-50	120	3	article	article	NOUN
aji-50	120	4	djuraev	djuraev	PROPN
aji-50	120	5	et	et	PROPN
aji-50	120	6	al	al	PROPN
aji-50	120	7	.	.	PROPN
aji-50	120	8	;	;	PUNCT
aji-50	121	1	aji	aji	PROPN
aji-50	121	2	,	,	PUNCT
aji-50	121	3	3(1	3(1	NUM
aji-50	121	4	):	):	PUNCT
aji-50	121	5	124	124	NUM
aji-50	121	6	-	-	SYM
aji-50	121	7	130	130	NUM
aji-50	121	8	,	,	PUNCT
aji-50	121	9	2020	2020	NUM
aji-50	121	10	;	;	PUNCT
aji-50	121	11	article	article	NOUN
aji-50	121	12	no.aji.55718	no.aji.55718	NOUN
aji-50	121	13	125	125	NUM
aji-50	121	14	keywords	keyword	NOUN
aji-50	121	15	:	:	PUNCT
aji-50	121	16	nasal	nasal	ADJ
aji-50	121	17	polyposis	polyposis	NOUN
aji-50	121	18	;	;	PUNCT
aji-50	121	19	osteomeatal	osteomeatal	ADJ
aji-50	121	20	complex	complex	NOUN
aji-50	121	21	;	;	PUNCT
aji-50	121	22	rhinosinusitis	rhinosinusitis	NOUN
aji-50	121	23	;	;	PUNCT
aji-50	121	24	nasal	nasal	ADJ
aji-50	121	25	septum	septum	PROPN
aji-50	121	26	;	;	PUNCT
aji-50	121	27	allergen	allergen	NOUN
aji-50	121	28	;	;	PUNCT
aji-50	121	29	immune	immune	ADJ
aji-50	121	30	system	system	NOUN
aji-50	121	31	.	.	PUNCT
aji-50	122	1	1	1	X
aji-50	122	2	.	.	X
aji-50	122	3	introduction	introduction	NOUN
aji-50	122	4	the	the	DET
aji-50	122	5	second	second	ADJ
aji-50	122	6	half	half	NOUN
aji-50	122	7	of	of	ADP
aji-50	122	8	the	the	DET
aji-50	122	9	last	last	ADJ
aji-50	122	10	century	century	NOUN
aji-50	122	11	was	be	AUX
aji-50	122	12	marked	mark	VERB
aji-50	122	13	by	by	ADP
aji-50	122	14	the	the	DET
aji-50	122	15	transition	transition	NOUN
aji-50	122	16	of	of	ADP
aji-50	122	17	the	the	DET
aji-50	122	18	center	center	NOUN
aji-50	122	19	of	of	ADP
aji-50	122	20	gravity	gravity	NOUN
aji-50	122	21	from	from	ADP
aji-50	122	22	otiatrics	otiatric	NOUN
aji-50	122	23	to	to	ADP
aji-50	122	24	rhinology	rhinology	NOUN
aji-50	122	25	.	.	PUNCT
aji-50	123	1	the	the	DET
aji-50	123	2	reason	reason	NOUN
aji-50	123	3	for	for	ADP
aji-50	123	4	this	this	PRON
aji-50	123	5	is	be	AUX
aji-50	123	6	not	not	PART
aji-50	123	7	only	only	ADV
aji-50	123	8	an	an	DET
aji-50	123	9	increase	increase	NOUN
aji-50	123	10	in	in	ADP
aji-50	123	11	the	the	DET
aji-50	123	12	load	load	NOUN
aji-50	123	13	on	on	ADP
aji-50	123	14	the	the	DET
aji-50	123	15	upper	upper	ADJ
aji-50	123	16	respiratory	respiratory	ADJ
aji-50	123	17	tract	tract	NOUN
aji-50	123	18	from	from	ADP
aji-50	123	19	the	the	DET
aji-50	123	20	outside	outside	NOUN
aji-50	123	21	in	in	ADP
aji-50	123	22	the	the	DET
aji-50	123	23	human	human	ADJ
aji-50	123	24	environment	environment	NOUN
aji-50	123	25	,	,	PUNCT
aji-50	123	26	but	but	CCONJ
aji-50	123	27	also	also	ADV
aji-50	123	28	significant	significant	ADJ
aji-50	123	29	changes	change	NOUN
aji-50	123	30	in	in	ADP
aji-50	123	31	the	the	DET
aji-50	123	32	population	population	NOUN
aji-50	123	33	,	,	PUNCT
aji-50	123	34	expressed	express	VERB
aji-50	123	35	in	in	ADP
aji-50	123	36	the	the	DET
aji-50	123	37	accumulation	accumulation	NOUN
aji-50	123	38	of	of	ADP
aji-50	123	39	negative	negative	ADJ
aji-50	123	40	genetic	genetic	ADJ
aji-50	123	41	deficiency	deficiency	NOUN
aji-50	123	42	and	and	CCONJ
aji-50	123	43	,	,	PUNCT
aji-50	123	44	above	above	ADP
aji-50	123	45	all	all	PRON
aji-50	123	46	,	,	PUNCT
aji-50	123	47	in	in	ADP
aji-50	123	48	the	the	DET
aji-50	123	49	immune	immune	ADJ
aji-50	123	50	system	system	NOUN
aji-50	123	51	.	.	PUNCT
aji-50	124	1	particularly	particularly	ADV
aji-50	124	2	complex	complex	ADJ
aji-50	124	3	and	and	CCONJ
aji-50	124	4	unclear	unclear	ADJ
aji-50	124	5	are	be	AUX
aji-50	124	6	the	the	DET
aji-50	124	7	causes	cause	NOUN
aji-50	124	8	of	of	ADP
aji-50	124	9	nasal	nasal	ADJ
aji-50	124	10	polyposis	polyposis	NOUN
aji-50	125	1	[	[	X
aji-50	125	2	1,2	1,2	NUM
aji-50	125	3	]	]	PUNCT
aji-50	125	4	.	.	PUNCT
aji-50	126	1	today	today	NOUN
aji-50	126	2	,	,	PUNCT
aji-50	126	3	many	many	ADJ
aji-50	126	4	theories	theory	NOUN
aji-50	126	5	have	have	AUX
aji-50	126	6	been	be	AUX
aji-50	126	7	proposed	propose	VERB
aji-50	126	8	for	for	ADP
aji-50	126	9	the	the	DET
aji-50	126	10	etiology	etiology	NOUN
aji-50	126	11	and	and	CCONJ
aji-50	126	12	pathogenesis	pathogenesis	NOUN
aji-50	126	13	of	of	ADP
aji-50	126	14	chronic	chronic	ADJ
aji-50	126	15	polyposis	polyposis	NOUN
aji-50	126	16	rhinosinusitis	rhinosinusitis	NOUN
aji-50	126	17	(	(	PUNCT
aji-50	126	18	cid	cid	NOUN
aji-50	126	19	)	)	PUNCT
aji-50	126	20	,	,	PUNCT
aji-50	126	21	unfortunately	unfortunately	ADV
aji-50	126	22	,	,	PUNCT
aji-50	126	23	many	many	ADJ
aji-50	126	24	causative	causative	ADJ
aji-50	126	25	factors	factor	NOUN
aji-50	126	26	,	,	PUNCT
aji-50	126	27	as	as	ADV
aji-50	126	28	well	well	ADV
aji-50	126	29	as	as	ADP
aji-50	126	30	their	their	PRON
aji-50	126	31	relationship	relationship	NOUN
aji-50	126	32	and	and	CCONJ
aji-50	126	33	role	role	NOUN
aji-50	126	34	in	in	ADP
aji-50	126	35	the	the	DET
aji-50	126	36	formation	formation	NOUN
aji-50	126	37	of	of	ADP
aji-50	126	38	nasal	nasal	ADJ
aji-50	126	39	polyps	polyp	NOUN
aji-50	126	40	,	,	PUNCT
aji-50	126	41	are	be	AUX
aji-50	126	42	not	not	PART
aji-50	126	43	fully	fully	ADV
aji-50	126	44	understood	understand	VERB
aji-50	126	45	[	[	X
aji-50	126	46	3	3	NUM
aji-50	126	47	]	]	PUNCT
aji-50	126	48	.	.	PUNCT
aji-50	127	1	a	a	DET
aji-50	127	2	number	number	NOUN
aji-50	127	3	of	of	ADP
aji-50	127	4	theories	theory	NOUN
aji-50	127	5	of	of	ADP
aji-50	127	6	the	the	DET
aji-50	127	7	etiology	etiology	NOUN
aji-50	127	8	of	of	ADP
aji-50	127	9	nasal	nasal	PROPN
aji-50	127	10	polyposis	polyposis	NOUN
aji-50	127	11	are	be	AUX
aji-50	127	12	known	know	VERB
aji-50	127	13	,	,	PUNCT
aji-50	127	14	and	and	CCONJ
aji-50	127	15	they	they	PRON
aji-50	127	16	are	be	AUX
aji-50	127	17	not	not	PART
aji-50	127	18	mutually	mutually	ADV
aji-50	127	19	exclusive	exclusive	ADJ
aji-50	127	20	:	:	PUNCT
aji-50	127	21	bacterial	bacterial	ADJ
aji-50	127	22	and	and	CCONJ
aji-50	127	23	fungal	fungal	ADJ
aji-50	127	24	infections	infection	NOUN
aji-50	127	25	,	,	PUNCT
aji-50	127	26	superantigenic	superantigenic	ADJ
aji-50	127	27	stimulation	stimulation	NOUN
aji-50	127	28	of	of	ADP
aji-50	127	29	the	the	DET
aji-50	127	30	immune	immune	ADJ
aji-50	127	31	system	system	NOUN
aji-50	127	32	,	,	PUNCT
aji-50	127	33	the	the	DET
aji-50	127	34	formation	formation	NOUN
aji-50	127	35	of	of	ADP
aji-50	127	36	biofilms	biofilm	NOUN
aji-50	127	37	,	,	PUNCT
aji-50	127	38	anatomical	anatomical	ADJ
aji-50	127	39	abnormalities	abnormality	NOUN
aji-50	127	40	of	of	ADP
aji-50	127	41	the	the	DET
aji-50	127	42	osteomeatal	osteomeatal	ADJ
aji-50	127	43	complex	complex	ADJ
aji-50	127	44	,	,	PUNCT
aji-50	127	45	ciliary	ciliary	ADJ
aji-50	127	46	dysfunction	dysfunction	NOUN
aji-50	127	47	,	,	PUNCT
aji-50	127	48	allergies	allergy	NOUN
aji-50	127	49	,	,	PUNCT
aji-50	127	50	secondary	secondary	ADJ
aji-50	127	51	immunedeficiency	immunedeficiency	NOUN
aji-50	128	1	[	[	X
aji-50	128	2	4	4	NUM
aji-50	128	3	]	]	PUNCT
aji-50	128	4	.	.	PUNCT
aji-50	129	1	in	in	ADP
aji-50	129	2	this	this	DET
aji-50	129	3	regard	regard	NOUN
aji-50	129	4	,	,	PUNCT
aji-50	129	5	some	some	DET
aji-50	129	6	foreign	foreign	ADJ
aji-50	129	7	authors	author	NOUN
aji-50	129	8	,	,	PUNCT
aji-50	129	9	according	accord	VERB
aji-50	129	10	to	to	ADP
aji-50	129	11	which	which	PRON
aji-50	129	12	diseases	disease	NOUN
aji-50	129	13	accompanied	accompany	VERB
aji-50	129	14	by	by	ADP
aji-50	129	15	the	the	DET
aji-50	129	16	formation	formation	NOUN
aji-50	129	17	of	of	ADP
aji-50	129	18	nasal	nasal	ADJ
aji-50	129	19	polyps	polyp	NOUN
aji-50	129	20	are	be	AUX
aji-50	129	21	divided	divide	VERB
aji-50	129	22	into	into	ADP
aji-50	129	23	5	5	NUM
aji-50	129	24	groups	group	NOUN
aji-50	129	25	.	.	PUNCT
aji-50	130	1	the	the	DET
aji-50	130	2	first	first	ADJ
aji-50	130	3	group	group	NOUN
aji-50	130	4	consists	consist	VERB
aji-50	130	5	of	of	ADP
aji-50	130	6	systemic	systemic	ADJ
aji-50	130	7	genetically	genetically	ADV
aji-50	130	8	caused	cause	VERB
aji-50	130	9	diseases	disease	NOUN
aji-50	130	10	in	in	ADP
aji-50	130	11	the	the	DET
aji-50	130	12	form	form	NOUN
aji-50	130	13	of	of	ADP
aji-50	130	14	kartagener	kartagener	PROPN
aji-50	130	15	syndrome	syndrome	PROPN
aji-50	130	16	and	and	CCONJ
aji-50	130	17	cystic	cystic	ADJ
aji-50	130	18	fibrosis	fibrosis	NOUN
aji-50	130	19	,	,	PUNCT
aji-50	130	20	the	the	DET
aji-50	130	21	second	second	ADJ
aji-50	130	22	group	group	NOUN
aji-50	130	23	is	be	AUX
aji-50	130	24	chronic	chronic	ADJ
aji-50	130	25	polypous	polypous	ADJ
aji-50	130	26	-	-	PUNCT
aji-50	130	27	purulent	purulent	NOUN
aji-50	130	28	rhinosinusitis	rhinosinusitis	NOUN
aji-50	130	29	(	(	PUNCT
aji-50	130	30	neutrophilic	neutrophilic	ADJ
aji-50	130	31	polyps	polyp	NOUN
aji-50	130	32	)	)	PUNCT
aji-50	130	33	,	,	PUNCT
aji-50	130	34	the	the	DET
aji-50	130	35	third	third	ADJ
aji-50	130	36	group	group	NOUN
aji-50	130	37	is	be	AUX
aji-50	130	38	a	a	DET
aji-50	130	39	local	local	ADJ
aji-50	130	40	pathology	pathology	NOUN
aji-50	130	41	in	in	ADP
aji-50	130	42	the	the	DET
aji-50	130	43	osteomeatal	osteomeatal	ADJ
aji-50	130	44	complex	complex	NOUN
aji-50	130	45	with	with	ADP
aji-50	130	46	impaired	impaired	ADJ
aji-50	130	47	mucociliary	mucociliary	NOUN
aji-50	130	48	clearance	clearance	NOUN
aji-50	130	49	in	in	ADP
aji-50	130	50	the	the	DET
aji-50	130	51	paranasal	paranasal	ADJ
aji-50	130	52	sinuses	sinus	NOUN
aji-50	130	53	and	and	CCONJ
aji-50	130	54	the	the	DET
aji-50	130	55	formation	formation	NOUN
aji-50	130	56	of	of	ADP
aji-50	130	57	a	a	DET
aji-50	130	58	productive	productive	ADJ
aji-50	130	59	process	process	NOUN
aji-50	130	60	in	in	ADP
aji-50	130	61	thechoanal	thechoanal	ADJ
aji-50	130	62	polyps	polyp	NOUN
aji-50	130	63	,	,	PUNCT
aji-50	130	64	the	the	DET
aji-50	130	65	fourth	fourth	ADJ
aji-50	130	66	group	group	NOUN
aji-50	130	67	is	be	AUX
aji-50	130	68	a	a	DET
aji-50	130	69	chronic	chronic	ADJ
aji-50	130	70	infectiousallergic	infectiousallergic	ADJ
aji-50	130	71	rhinosinusitis	rhinosinusitis	NOUN
aji-50	130	72	with	with	ADP
aji-50	130	73	a	a	DET
aji-50	130	74	final	final	ADJ
aji-50	130	75	stage	stage	NOUN
aji-50	130	76	of	of	ADP
aji-50	130	77	development	development	NOUN
aji-50	130	78	in	in	ADP
aji-50	130	79	the	the	DET
aji-50	130	80	form	form	NOUN
aji-50	130	81	of	of	ADP
aji-50	130	82	a	a	DET
aji-50	130	83	chronic	chronic	ADJ
aji-50	130	84	polypous	polypous	ADJ
aji-50	130	85	allergy	allergy	NOUN
aji-50	130	86	rhinosinusitis	rhinosinusitis	NOUN
aji-50	130	87	(	(	PUNCT
aji-50	130	88	eosinophilic	eosinophilic	ADJ
aji-50	130	89	polyps	polyp	NOUN
aji-50	130	90	)	)	PUNCT
aji-50	130	91	,	,	PUNCT
aji-50	130	92	the	the	DET
aji-50	130	93	fifth	fifth	ADJ
aji-50	130	94	group	group	NOUN
aji-50	130	95	is	be	AUX
aji-50	130	96	the	the	DET
aji-50	130	97	“	"	PUNCT
aji-50	130	98	asthmatic	asthmatic	ADJ
aji-50	130	99	triad	triad	NOUN
aji-50	130	100	”	"	PUNCT
aji-50	130	101	as	as	ADP
aji-50	130	102	a	a	DET
aji-50	130	103	pseudoallergic	pseudoallergic	ADJ
aji-50	130	104	disease	disease	NOUN
aji-50	130	105	caused	cause	VERB
aji-50	130	106	by	by	ADP
aji-50	130	107	a	a	DET
aji-50	130	108	metabolic	metabolic	NOUN
aji-50	130	109	disorder	disorder	NOUN
aji-50	130	110	of	of	ADP
aji-50	130	111	arachidonic	arachidonic	ADJ
aji-50	130	112	acid	acid	NOUN
aji-50	130	113	:	:	PUNCT
aji-50	130	114	aspirin	aspirin	NOUN
aji-50	130	115	-	-	PUNCT
aji-50	130	116	induced	induce	VERB
aji-50	130	117	nasal	nasal	ADJ
aji-50	130	118	polyps	polyp	NOUN
aji-50	130	119	[	[	X
aji-50	130	120	5,6	5,6	NUM
aji-50	130	121	]	]	PUNCT
aji-50	130	122	.	.	PUNCT
aji-50	131	1	s.	s.	PROPN
aji-50	131	2	v.	v.	PROPN
aji-50	131	3	ryazantsev	ryazantsev	PROPN
aji-50	131	4	et	et	PROPN
aji-50	131	5	al	al	PROPN
aji-50	131	6	.	.	PROPN
aji-50	132	1	(	(	PUNCT
aji-50	132	2	2006	2006	NUM
aji-50	132	3	)	)	PUNCT
aji-50	132	4	consider	consider	VERB
aji-50	132	5	nasal	nasal	ADJ
aji-50	132	6	polyposis	polyposis	NOUN
aji-50	132	7	and	and	CCONJ
aji-50	132	8	snps	snps	NOUN
aji-50	132	9	as	as	ADP
aji-50	132	10	a	a	DET
aji-50	132	11	multifactorial	multifactorial	ADJ
aji-50	132	12	etiological	etiological	ADJ
aji-50	132	13	syndrome	syndrome	NOUN
aji-50	132	14	that	that	PRON
aji-50	132	15	occurs	occur	VERB
aji-50	132	16	in	in	ADP
aji-50	132	17	individuals	individual	NOUN
aji-50	132	18	predisposed	predispose	VERB
aji-50	132	19	to	to	ADP
aji-50	132	20	a	a	DET
aji-50	132	21	specific	specific	ADJ
aji-50	132	22	tissue	tissue	NOUN
aji-50	132	23	reaction	reaction	NOUN
aji-50	132	24	.	.	PUNCT
aji-50	133	1	according	accord	VERB
aji-50	133	2	to	to	ADP
aji-50	133	3	this	this	DET
aji-50	133	4	theory	theory	NOUN
aji-50	133	5	,	,	PUNCT
aji-50	133	6	the	the	DET
aji-50	133	7	formation	formation	NOUN
aji-50	133	8	of	of	ADP
aji-50	133	9	nasal	nasal	ADJ
aji-50	133	10	polyps	polyp	NOUN
aji-50	133	11	is	be	AUX
aji-50	133	12	associated	associate	VERB
aji-50	133	13	with	with	ADP
aji-50	133	14	an	an	DET
aji-50	133	15	innate	innate	ADJ
aji-50	133	16	predisposition	predisposition	NOUN
aji-50	133	17	and	and	CCONJ
aji-50	133	18	exposure	exposure	NOUN
aji-50	133	19	to	to	ADP
aji-50	133	20	environmental	environmental	ADJ
aji-50	133	21	factors	factor	NOUN
aji-50	133	22	,	,	PUNCT
aji-50	133	23	such	such	ADJ
aji-50	133	24	as	as	ADP
aji-50	133	25	mechanical	mechanical	ADJ
aji-50	133	26	,	,	PUNCT
aji-50	133	27	physical	physical	ADJ
aji-50	133	28	,	,	PUNCT
aji-50	133	29	chemical	chemical	NOUN
aji-50	133	30	,	,	PUNCT
aji-50	133	31	biological	biological	ADJ
aji-50	133	32	factors	factor	NOUN
aji-50	133	33	(	(	PUNCT
aji-50	133	34	viruses	virus	NOUN
aji-50	133	35	,	,	PUNCT
aji-50	133	36	bacteria	bacteria	NOUN
aji-50	133	37	,	,	PUNCT
aji-50	133	38	fungi	fungus	NOUN
aji-50	133	39	,	,	PUNCT
aji-50	133	40	allergens	allergen	NOUN
aji-50	133	41	)	)	PUNCT
aji-50	133	42	.	.	PUNCT
aji-50	134	1	in	in	ADP
aji-50	134	2	this	this	DET
aji-50	134	3	case	case	NOUN
aji-50	134	4	,	,	PUNCT
aji-50	134	5	a	a	DET
aji-50	134	6	disturbance	disturbance	NOUN
aji-50	134	7	of	of	ADP
aji-50	134	8	the	the	DET
aji-50	134	9	reactivity	reactivity	NOUN
aji-50	134	10	of	of	ADP
aji-50	134	11	the	the	DET
aji-50	134	12	parasympathetic	parasympathetic	ADJ
aji-50	134	13	nervous	nervous	ADJ
aji-50	134	14	system	system	NOUN
aji-50	134	15	,	,	PUNCT
aji-50	134	16	immunity	immunity	NOUN
aji-50	134	17	,	,	PUNCT
aji-50	134	18	mucociliary	mucociliary	NOUN
aji-50	134	19	transport	transport	NOUN
aji-50	134	20	,	,	PUNCT
aji-50	134	21	mucosal	mucosal	ADJ
aji-50	134	22	hypersensitivity	hypersensitivity	NOUN
aji-50	134	23	,	,	PUNCT
aji-50	134	24	defects	defect	NOUN
aji-50	134	25	in	in	ADP
aji-50	134	26	membranes	membrane	NOUN
aji-50	134	27	and	and	CCONJ
aji-50	134	28	dna	dna	NOUN
aji-50	134	29	in	in	ADP
aji-50	134	30	the	the	DET
aji-50	134	31	nuclei	nucleus	NOUN
aji-50	134	32	of	of	ADP
aji-50	134	33	cells	cell	NOUN
aji-50	134	34	areconsidered	areconsidere	VERB
aji-50	134	35	a	a	DET
aji-50	134	36	congenital	congenital	ADJ
aji-50	134	37	predisposition	predisposition	NOUN
aji-50	134	38	[	[	X
aji-50	134	39	7,8	7,8	NUM
aji-50	134	40	]	]	PUNCT
aji-50	134	41	.	.	PUNCT
aji-50	135	1	the	the	DET
aji-50	135	2	combination	combination	NOUN
aji-50	135	3	of	of	ADP
aji-50	135	4	these	these	DET
aji-50	135	5	two	two	NUM
aji-50	135	6	factors	factor	NOUN
aji-50	135	7	includes	include	VERB
aji-50	135	8	pathogenetic	pathogenetic	ADJ
aji-50	135	9	mechanisms	mechanism	NOUN
aji-50	135	10	,	,	PUNCT
aji-50	135	11	that	that	ADV
aji-50	135	12	is	is	ADV
aji-50	135	13	,	,	PUNCT
aji-50	135	14	they	they	PRON
aji-50	135	15	lead	lead	VERB
aji-50	135	16	to	to	ADP
aji-50	135	17	a	a	DET
aji-50	135	18	disturbance	disturbance	NOUN
aji-50	135	19	of	of	ADP
aji-50	135	20	neuro	neuro	NOUN
aji-50	135	21	-	-	PUNCT
aji-50	135	22	trophic	trophic	ADJ
aji-50	135	23	innervation	innervation	NOUN
aji-50	135	24	,	,	PUNCT
aji-50	135	25	mast	mast	NOUN
aji-50	135	26	cell	cell	NOUN
aji-50	135	27	degranulation	degranulation	NOUN
aji-50	135	28	,	,	PUNCT
aji-50	135	29	the	the	DET
aji-50	135	30	release	release	NOUN
aji-50	135	31	of	of	ADP
aji-50	135	32	biologically	biologically	ADV
aji-50	135	33	active	active	ADJ
aji-50	135	34	substances	substance	NOUN
aji-50	135	35	,	,	PUNCT
aji-50	135	36	which	which	PRON
aji-50	135	37	in	in	ADP
aji-50	135	38	turn	turn	NOUN
aji-50	135	39	increase	increase	VERB
aji-50	135	40	vascular	vascular	ADJ
aji-50	135	41	permeability	permeability	NOUN
aji-50	135	42	,	,	PUNCT
aji-50	135	43	followed	follow	VERB
aji-50	135	44	by	by	ADP
aji-50	135	45	tissue	tissue	NOUN
aji-50	135	46	edema	edema	NOUN
aji-50	135	47	and	and	CCONJ
aji-50	135	48	the	the	DET
aji-50	135	49	formation	formation	NOUN
aji-50	135	50	of	of	ADP
aji-50	135	51	polyps	polyp	NOUN
aji-50	135	52	.	.	PUNCT
aji-50	136	1	according	accord	VERB
aji-50	136	2	to	to	ADP
aji-50	136	3	another	another	DET
aji-50	136	4	theory	theory	NOUN
aji-50	136	5	proposed	propose	VERB
aji-50	136	6	by	by	ADP
aji-50	136	7	m.	m.	PROPN
aji-50	136	8	yu	yu	PROPN
aji-50	136	9	.	.	PROPN
aji-50	136	10	korkmazov	korkmazov	PROPN
aji-50	136	11	(	(	PUNCT
aji-50	136	12	2010	2010	NUM
aji-50	136	13	)	)	PUNCT
aji-50	136	14	,	,	PUNCT
aji-50	136	15	forpolypous	forpolypous	ADJ
aji-50	136	16	sinusitis	sinusitis	NOUN
aji-50	136	17	,	,	PUNCT
aji-50	136	18	microcirculation	microcirculation	NOUN
aji-50	136	19	in	in	ADP
aji-50	136	20	the	the	DET
aji-50	136	21	middle	middle	PROPN
aji-50	136	22	nasal	nasal	PROPN
aji-50	136	23	passage	passage	NOUN
aji-50	136	24	changes	change	NOUN
aji-50	136	25	in	in	ADP
aji-50	136	26	the	the	DET
aji-50	136	27	form	form	NOUN
aji-50	136	28	of	of	ADP
aji-50	136	29	vasomotor	vasomotor	NOUN
aji-50	136	30	reactions	reaction	NOUN
aji-50	136	31	,	,	PUNCT
aji-50	136	32	narrowing	narrow	VERB
aji-50	136	33	of	of	ADP
aji-50	136	34	the	the	DET
aji-50	136	35	arterioles	arteriole	NOUN
aji-50	136	36	and	and	CCONJ
aji-50	136	37	a	a	DET
aji-50	136	38	decrease	decrease	NOUN
aji-50	136	39	in	in	ADP
aji-50	136	40	the	the	DET
aji-50	136	41	number	number	NOUN
aji-50	136	42	of	of	ADP
aji-50	136	43	functioning	function	VERB
aji-50	136	44	capillaries	capillary	NOUN
aji-50	136	45	,	,	PUNCT
aji-50	136	46	which	which	PRON
aji-50	136	47	lead	lead	VERB
aji-50	136	48	to	to	ADP
aji-50	136	49	the	the	DET
aji-50	136	50	accumulation	accumulation	NOUN
aji-50	136	51	of	of	ADP
aji-50	136	52	metabolic	metabolic	NOUN
aji-50	136	53	products	product	NOUN
aji-50	136	54	and	and	CCONJ
aji-50	136	55	retention	retention	NOUN
aji-50	136	56	of	of	ADP
aji-50	136	57	tissue	tissue	NOUN
aji-50	136	58	fluid	fluid	NOUN
aji-50	136	59	,	,	PUNCT
aji-50	136	60	which	which	PRON
aji-50	136	61	contributes	contribute	VERB
aji-50	136	62	to	to	ADP
aji-50	136	63	the	the	DET
aji-50	136	64	development	development	NOUN
aji-50	136	65	of	of	ADP
aji-50	136	66	edema	edema	PROPN
aji-50	136	67	[	[	X
aji-50	136	68	9,10	9,10	NUM
aji-50	136	69	]	]	X
aji-50	136	70	.	.	PUNCT
aji-50	137	1	n.	n.	PROPN
aji-50	137	2	n.	n.	PROPN
aji-50	137	3	naumenko	naumenko	PROPN
aji-50	137	4	et	et	PROPN
aji-50	137	5	al	al	PROPN
aji-50	137	6	.	.	PROPN
aji-50	138	1	(	(	PUNCT
aji-50	138	2	2005	2005	NUM
aji-50	138	3	)	)	PUNCT
aji-50	138	4	suggest	suggest	VERB
aji-50	138	5	that	that	SCONJ
aji-50	138	6	forpolypousrhinosinusitis	forpolypousrhinosinusitis	PROPN
aji-50	138	7	,	,	PUNCT
aji-50	138	8	a	a	DET
aji-50	138	9	disturbance	disturbance	NOUN
aji-50	138	10	of	of	ADP
aji-50	138	11	the	the	DET
aji-50	138	12	adaptive	adaptive	ADJ
aji-50	138	13	-	-	PUNCT
aji-50	138	14	trophic	trophic	ADJ
aji-50	138	15	function	function	NOUN
aji-50	138	16	of	of	ADP
aji-50	138	17	the	the	DET
aji-50	138	18	autonomic	autonomic	ADJ
aji-50	138	19	nervous	nervous	ADJ
aji-50	138	20	system	system	NOUN
aji-50	138	21	is	be	AUX
aji-50	138	22	important	important	ADJ
aji-50	138	23	,	,	PUNCT
aji-50	138	24	and	and	CCONJ
aji-50	138	25	contributes	contribute	VERB
aji-50	138	26	to	to	ADP
aji-50	138	27	the	the	DET
aji-50	138	28	development	development	NOUN
aji-50	138	29	of	of	ADP
aji-50	138	30	neurodystrophic	neurodystrophic	ADJ
aji-50	138	31	changes	change	NOUN
aji-50	138	32	in	in	ADP
aji-50	138	33	the	the	DET
aji-50	138	34	nasal	nasal	PROPN
aji-50	138	35	mucosa	mucosa	NOUN
aji-50	138	36	,	,	PUNCT
aji-50	138	37	leading	lead	VERB
aji-50	138	38	to	to	ADP
aji-50	138	39	the	the	DET
aji-50	138	40	formation	formation	NOUN
aji-50	138	41	of	of	ADP
aji-50	138	42	polyps	polyp	NOUN
aji-50	138	43	.	.	PUNCT
aji-50	139	1	v.	v.	CCONJ
aji-50	139	2	s.	s.	PROPN
aji-50	139	3	piskunov	piskunov	PROPN
aji-50	139	4	(	(	PUNCT
aji-50	139	5	2006	2006	NUM
aji-50	139	6	)	)	PUNCT
aji-50	139	7	believes	believe	VERB
aji-50	139	8	that	that	SCONJ
aji-50	139	9	a	a	DET
aji-50	139	10	disturbance	disturbance	NOUN
aji-50	139	11	of	of	ADP
aji-50	139	12	the	the	DET
aji-50	139	13	aerodynamics	aerodynamic	NOUN
aji-50	139	14	of	of	ADP
aji-50	139	15	the	the	DET
aji-50	139	16	nose	nose	NOUN
aji-50	139	17	during	during	ADP
aji-50	139	18	deformities	deformity	NOUN
aji-50	139	19	of	of	ADP
aji-50	139	20	the	the	DET
aji-50	139	21	nasal	nasal	PROPN
aji-50	139	22	septum	septum	PROPN
aji-50	139	23	leads	lead	VERB
aji-50	139	24	to	to	ADP
aji-50	139	25	a	a	DET
aji-50	139	26	slowly	slowly	ADV
aji-50	139	27	developing	develop	VERB
aji-50	139	28	inflammatory	inflammatory	ADJ
aji-50	139	29	process	process	NOUN
aji-50	139	30	of	of	ADP
aji-50	139	31	the	the	DET
aji-50	139	32	nasal	nasal	PROPN
aji-50	139	33	mucosa	mucosa	PROPN
aji-50	139	34	,	,	PUNCT
aji-50	139	35	which	which	PRON
aji-50	139	36	manifests	manifest	VERB
aji-50	139	37	itself	itself	PRON
aji-50	139	38	as	as	ADP
aji-50	139	39	the	the	DET
aji-50	139	40	formation	formation	NOUN
aji-50	139	41	of	of	ADP
aji-50	139	42	a	a	DET
aji-50	139	43	polyp	polyp	NOUN
aji-50	139	44	in	in	ADP
aji-50	139	45	the	the	DET
aji-50	139	46	absence	absence	NOUN
aji-50	139	47	of	of	ADP
aji-50	139	48	pathological	pathological	ADJ
aji-50	139	49	changes	change	NOUN
aji-50	139	50	in	in	ADP
aji-50	139	51	the	the	DET
aji-50	139	52	paranasal	paranasal	ADJ
aji-50	139	53	sinuses	sinus	NOUN
aji-50	139	54	.	.	PUNCT
aji-50	140	1	in	in	ADP
aji-50	140	2	recent	recent	ADJ
aji-50	140	3	years	year	NOUN
aji-50	140	4	,	,	PUNCT
aji-50	140	5	the	the	DET
aji-50	140	6	role	role	NOUN
aji-50	140	7	of	of	ADP
aji-50	140	8	metabolic	metabolic	NOUN
aji-50	140	9	disorders	disorder	NOUN
aji-50	140	10	of	of	ADP
aji-50	140	11	arachidonic	arachidonic	ADJ
aji-50	140	12	acid	acid	NOUN
aji-50	140	13	,	,	PUNCT
aji-50	140	14	which	which	PRON
aji-50	140	15	leads	lead	VERB
aji-50	140	16	to	to	ADP
aji-50	140	17	"	"	PUNCT
aji-50	140	18	aspirin	aspirin	NOUN
aji-50	140	19	intolerance	intolerance	NOUN
aji-50	140	20	"	"	PUNCT
aji-50	140	21	[	[	X
aji-50	140	22	11,12	11,12	NOUN
aji-50	140	23	]	]	PUNCT
aji-50	140	24	,	,	PUNCT
aji-50	140	25	has	have	AUX
aji-50	140	26	been	be	AUX
aji-50	140	27	intensively	intensively	ADV
aji-50	140	28	studied	study	VERB
aji-50	140	29	in	in	ADP
aji-50	140	30	patients	patient	NOUN
aji-50	140	31	with	with	ADP
aji-50	140	32	cid	cid	PROPN
aji-50	140	33	.	.	PUNCT
aji-50	141	1	the	the	DET
aji-50	141	2	classical	classical	ADJ
aji-50	141	3	clinical	clinical	ADJ
aji-50	141	4	picture	picture	NOUN
aji-50	141	5	of	of	ADP
aji-50	141	6	the	the	DET
aji-50	141	7	“	"	PUNCT
aji-50	141	8	aspirin	aspirin	NOUN
aji-50	141	9	”	"	PUNCT
aji-50	141	10	triad	triad	PROPN
aji-50	141	11	implies	imply	VERB
aji-50	141	12	the	the	DET
aji-50	141	13	presence	presence	NOUN
aji-50	141	14	of	of	ADP
aji-50	141	15	bronchial	bronchial	ADJ
aji-50	141	16	asthma	asthma	NOUN
aji-50	141	17	in	in	ADP
aji-50	141	18	combination	combination	NOUN
aji-50	141	19	with	with	ADP
aji-50	141	20	eosinophilic	eosinophilic	ADJ
aji-50	141	21	rhinitis	rhinitis	NOUN
aji-50	141	22	or	or	CCONJ
aji-50	141	23	cprs	cprs	NOUN
aji-50	141	24	,	,	PUNCT
aji-50	141	25	the	the	DET
aji-50	141	26	manifestations	manifestation	NOUN
aji-50	141	27	of	of	ADP
aji-50	141	28	which	which	PRON
aji-50	141	29	sharply	sharply	ADV
aji-50	141	30	increase	increase	VERB
aji-50	141	31	after	after	ADP
aji-50	141	32	taking	take	VERB
aji-50	141	33	nonsteroidal	nonsteroidal	NOUN
aji-50	141	34	anti	anti	ADJ
aji-50	141	35	-	-	ADJ
aji-50	141	36	inflammatory	inflammatory	ADJ
aji-50	141	37	drugs	drug	NOUN
aji-50	141	38	(	(	PUNCT
aji-50	141	39	nsaids	nsaid	NOUN
aji-50	141	40	)	)	PUNCT
aji-50	142	1	[	[	X
aji-50	142	2	13	13	NUM
aji-50	142	3	]	]	PUNCT
aji-50	142	4	.	.	PUNCT
aji-50	143	1	in	in	ADP
aji-50	143	2	this	this	DET
aji-50	143	3	regard	regard	NOUN
aji-50	143	4	,	,	PUNCT
aji-50	143	5	the	the	DET
aji-50	143	6	importance	importance	NOUN
aji-50	143	7	of	of	ADP
aji-50	143	8	leukotrienes	leukotriene	NOUN
aji-50	143	9	in	in	ADP
aji-50	143	10	the	the	DET
aji-50	143	11	development	development	NOUN
aji-50	143	12	of	of	ADP
aji-50	143	13	allergic	allergic	ADJ
aji-50	143	14	inflammation	inflammation	NOUN
aji-50	143	15	is	be	AUX
aji-50	143	16	very	very	ADV
aji-50	143	17	djuraev	djuraev	NOUN
aji-50	143	18	et	et	NOUN
aji-50	143	19	al	al	PROPN
aji-50	143	20	.	.	PROPN
aji-50	143	21	;	;	PUNCT
aji-50	143	22	aji	aji	PROPN
aji-50	143	23	,	,	PUNCT
aji-50	143	24	3(1	3(1	NUM
aji-50	143	25	):	):	PUNCT
aji-50	143	26	124	124	NUM
aji-50	143	27	-	-	SYM
aji-50	143	28	130	130	NUM
aji-50	143	29	,	,	PUNCT
aji-50	143	30	2020	2020	NUM
aji-50	143	31	;	;	PUNCT
aji-50	143	32	article	article	NOUN
aji-50	143	33	no.aji.55718	no.aji.55718	VERB
aji-50	143	34	126	126	NUM
aji-50	143	35	significant	significant	ADJ
aji-50	143	36	.	.	PUNCT
aji-50	144	1	they	they	PRON
aji-50	144	2	increase	increase	VERB
aji-50	144	3	vascular	vascular	ADJ
aji-50	144	4	permeability	permeability	NOUN
aji-50	144	5	,	,	PUNCT
aji-50	144	6	promote	promote	VERB
aji-50	144	7	the	the	DET
aji-50	144	8	mobilization	mobilization	NOUN
aji-50	144	9	and	and	CCONJ
aji-50	144	10	activation	activation	NOUN
aji-50	144	11	of	of	ADP
aji-50	144	12	proinflammatory	proinflammatory	ADJ
aji-50	144	13	cells	cell	NOUN
aji-50	144	14	in	in	ADP
aji-50	144	15	the	the	DET
aji-50	144	16	airways	airway	NOUN
aji-50	144	17	,	,	PUNCT
aji-50	144	18	participate	participate	VERB
aji-50	144	19	in	in	ADP
aji-50	144	20	the	the	DET
aji-50	144	21	release	release	NOUN
aji-50	144	22	of	of	ADP
aji-50	144	23	other	other	ADJ
aji-50	144	24	pro	pro	ADJ
aji-50	144	25	-	-	ADJ
aji-50	144	26	inflammatory	inflammatory	ADJ
aji-50	144	27	agents	agent	NOUN
aji-50	144	28	,	,	PUNCT
aji-50	144	29	increase	increase	VERB
aji-50	144	30	the	the	DET
aji-50	144	31	secretory	secretory	ADJ
aji-50	144	32	activity	activity	NOUN
aji-50	144	33	of	of	ADP
aji-50	144	34	the	the	DET
aji-50	144	35	glands	gland	NOUN
aji-50	144	36	,	,	PUNCT
aji-50	144	37	can	can	AUX
aji-50	144	38	enhance	enhance	VERB
aji-50	144	39	the	the	DET
aji-50	144	40	action	action	NOUN
aji-50	144	41	of	of	ADP
aji-50	144	42	other	other	ADJ
aji-50	144	43	allergy	allergy	NOUN
aji-50	144	44	mediators	mediator	NOUN
aji-50	144	45	,	,	PUNCT
aji-50	144	46	for	for	ADP
aji-50	144	47	example	example	NOUN
aji-50	144	48	,	,	PUNCT
aji-50	144	49	histamine	histamine	NOUN
aji-50	145	1	[	[	X
aji-50	145	2	14	14	NUM
aji-50	145	3	]	]	PUNCT
aji-50	145	4	and	and	CCONJ
aji-50	145	5	as	as	ADP
aji-50	145	6	a	a	DET
aji-50	145	7	result	result	NOUN
aji-50	145	8	"	"	PUNCT
aji-50	145	9	aspirininduced	aspirininduce	VERB
aji-50	145	10	"	"	PUNCT
aji-50	145	11	polyps	polyp	NOUN
aji-50	145	12	[	[	X
aji-50	145	13	15	15	NUM
aji-50	145	14	]	]	X
aji-50	145	15	develop	develop	VERB
aji-50	145	16	.	.	PUNCT
aji-50	146	1	in	in	ADP
aji-50	146	2	addition	addition	NOUN
aji-50	146	3	,	,	PUNCT
aji-50	146	4	recently	recently	ADV
aji-50	146	5	,	,	PUNCT
aji-50	146	6	many	many	ADJ
aji-50	146	7	authors	author	NOUN
aji-50	146	8	have	have	AUX
aji-50	146	9	been	be	AUX
aji-50	146	10	paying	pay	VERB
aji-50	146	11	attention	attention	NOUN
aji-50	146	12	to	to	ADP
aji-50	146	13	the	the	DET
aji-50	146	14	role	role	NOUN
aji-50	146	15	of	of	ADP
aji-50	146	16	toll	toll	NOUN
aji-50	146	17	-	-	PUNCT
aji-50	146	18	nodreceptors	nodreceptor	NOUN
aji-50	146	19	in	in	ADP
aji-50	146	20	the	the	DET
aji-50	146	21	occurrence	occurrence	NOUN
aji-50	146	22	of	of	ADP
aji-50	146	23	nasal	nasal	ADJ
aji-50	146	24	polyps	polyp	NOUN
aji-50	146	25	and	and	CCONJ
aji-50	146	26	the	the	DET
aji-50	146	27	genetic	genetic	ADJ
aji-50	146	28	aspects	aspect	NOUN
aji-50	146	29	of	of	ADP
aji-50	146	30	the	the	DET
aji-50	146	31	development	development	NOUN
aji-50	146	32	of	of	ADP
aji-50	146	33	cprs	cprs	NOUN
aji-50	146	34	[	[	X
aji-50	146	35	16,17	16,17	NUM
aji-50	146	36	]	]	PUNCT
aji-50	146	37	.	.	PUNCT
aji-50	147	1	unfortunately	unfortunately	ADV
aji-50	147	2	,	,	PUNCT
aji-50	147	3	the	the	DET
aji-50	147	4	results	result	NOUN
aji-50	147	5	of	of	ADP
aji-50	147	6	these	these	DET
aji-50	147	7	studies	study	NOUN
aji-50	147	8	have	have	AUX
aji-50	147	9	not	not	PART
aji-50	147	10	yet	yet	ADV
aji-50	147	11	led	lead	VERB
aji-50	147	12	to	to	ADP
aji-50	147	13	a	a	DET
aji-50	147	14	complete	complete	ADJ
aji-50	147	15	disclosure	disclosure	NOUN
aji-50	147	16	of	of	ADP
aji-50	147	17	the	the	DET
aji-50	147	18	pathogenesis	pathogenesis	NOUN
aji-50	147	19	of	of	ADP
aji-50	147	20	the	the	DET
aji-50	147	21	polyposis	polyposis	NOUN
aji-50	147	22	process	process	NOUN
aji-50	147	23	.	.	PUNCT
aji-50	148	1	thus	thus	ADV
aji-50	148	2	,	,	PUNCT
aji-50	148	3	chronic	chronic	ADJ
aji-50	148	4	polypousrhinosinusitis	polypousrhinosinusitis	NOUN
aji-50	148	5	should	should	AUX
aji-50	148	6	be	be	AUX
aji-50	148	7	considered	consider	VERB
aji-50	148	8	amultiple	amultiple	ADJ
aji-50	148	9	etiologies	etiology	NOUN
aji-50	148	10	disease	disease	NOUN
aji-50	148	11	,	,	PUNCT
aji-50	148	12	in	in	ADP
aji-50	148	13	the	the	DET
aji-50	148	14	development	development	NOUN
aji-50	148	15	of	of	ADP
aji-50	148	16	which	which	PRON
aji-50	148	17	the	the	DET
aji-50	148	18	influence	influence	NOUN
aji-50	148	19	of	of	ADP
aji-50	148	20	infectious	infectious	ADJ
aji-50	148	21	factors	factor	NOUN
aji-50	148	22	and	and	CCONJ
aji-50	148	23	allergens	allergen	NOUN
aji-50	148	24	plays	play	VERB
aji-50	148	25	the	the	DET
aji-50	148	26	main	main	ADJ
aji-50	148	27	role	role	NOUN
aji-50	148	28	,	,	PUNCT
aji-50	148	29	which	which	PRON
aji-50	148	30	leads	lead	VERB
aji-50	148	31	to	to	ADP
aji-50	148	32	the	the	DET
aji-50	148	33	development	development	NOUN
aji-50	148	34	of	of	ADP
aji-50	148	35	a	a	DET
aji-50	148	36	chronic	chronic	ADJ
aji-50	148	37	inflammatory	inflammatory	ADJ
aji-50	148	38	process	process	NOUN
aji-50	148	39	and	and	CCONJ
aji-50	148	40	allergization	allergization	NOUN
aji-50	148	41	of	of	ADP
aji-50	148	42	the	the	DET
aji-50	148	43	body	body	NOUN
aji-50	148	44	,	,	PUNCT
aji-50	148	45	which	which	PRON
aji-50	148	46	affect	affect	VERB
aji-50	148	47	different	different	ADJ
aji-50	148	48	body	body	NOUN
aji-50	148	49	systems	system	NOUN
aji-50	148	50	,	,	PUNCT
aji-50	148	51	which	which	PRON
aji-50	148	52	aggravates	aggravate	VERB
aji-50	148	53	the	the	DET
aji-50	148	54	main	main	ADJ
aji-50	148	55	pathology	pathology	NOUN
aji-50	148	56	and	and	CCONJ
aji-50	148	57	leads	lead	VERB
aji-50	148	58	to	to	ADP
aji-50	148	59	a	a	DET
aji-50	148	60	decrease	decrease	NOUN
aji-50	148	61	in	in	ADP
aji-50	148	62	the	the	DET
aji-50	148	63	quality	quality	NOUN
aji-50	148	64	ofpatient	ofpatient	NOUN
aji-50	148	65	’s	’s	PART
aji-50	148	66	life	life	NOUN
aji-50	148	67	,	,	PUNCT
aji-50	148	68	therefore	therefore	ADV
aji-50	148	69	this	this	DET
aji-50	148	70	problem	problem	NOUN
aji-50	148	71	is	be	AUX
aji-50	148	72	urgent	urgent	ADJ
aji-50	148	73	,	,	PUNCT
aji-50	148	74	and	and	CCONJ
aji-50	148	75	needs	need	VERB
aji-50	148	76	a	a	DET
aji-50	148	77	solution	solution	NOUN
aji-50	148	78	which	which	PRON
aji-50	148	79	is	be	AUX
aji-50	148	80	urgent	urgent	ADJ
aji-50	148	81	.	.	PUNCT
aji-50	149	1	2	2	X
aji-50	149	2	.	.	X
aji-50	149	3	materials	material	NOUN
aji-50	149	4	and	and	CCONJ
aji-50	149	5	methods	method	NOUN
aji-50	149	6	in	in	ADP
aji-50	149	7	accordance	accordance	NOUN
aji-50	149	8	with	with	ADP
aji-50	149	9	the	the	DET
aji-50	149	10	purpose	purpose	NOUN
aji-50	149	11	of	of	ADP
aji-50	149	12	the	the	DET
aji-50	149	13	study	study	NOUN
aji-50	149	14	and	and	CCONJ
aji-50	149	15	to	to	PART
aji-50	149	16	achieve	achieve	VERB
aji-50	149	17	its	its	PRON
aji-50	149	18	objectives	objective	NOUN
aji-50	149	19	,	,	PUNCT
aji-50	149	20	clinical	clinical	ADJ
aji-50	149	21	studies	study	NOUN
aji-50	149	22	were	be	AUX
aji-50	149	23	conducted	conduct	VERB
aji-50	149	24	in	in	ADP
aji-50	149	25	150	150	NUM
aji-50	149	26	patients	patient	NOUN
aji-50	149	27	with	with	ADP
aji-50	149	28	chronic	chronic	ADJ
aji-50	149	29	kidney	kidney	NOUN
aji-50	149	30	disease	disease	NOUN
aji-50	149	31	who	who	PRON
aji-50	149	32	were	be	AUX
aji-50	149	33	examined	examine	VERB
aji-50	149	34	and	and	CCONJ
aji-50	149	35	treated	treat	VERB
aji-50	149	36	in	in	ADP
aji-50	149	37	the	the	DET
aji-50	149	38	ent	ent	PROPN
aji-50	149	39	department	department	PROPN
aji-50	149	40	of	of	ADP
aji-50	149	41	the	the	DET
aji-50	149	42	3rd	3rd	ADJ
aji-50	149	43	clinic	clinic	NOUN
aji-50	149	44	of	of	ADP
aji-50	149	45	the	the	DET
aji-50	149	46	tashkent	tashkent	PROPN
aji-50	149	47	medical	medical	PROPN
aji-50	149	48	academy	academy	NOUN
aji-50	149	49	in	in	ADP
aji-50	149	50	2018	2018	NUM
aji-50	149	51	-	-	SYM
aji-50	149	52	2019	2019	NUM
aji-50	149	53	.	.	PUNCT
aji-50	150	1	all	all	DET
aji-50	150	2	patients	patient	NOUN
aji-50	150	3	with	with	ADP
aji-50	150	4	chronic	chronic	ADJ
aji-50	150	5	kidney	kidney	NOUN
aji-50	150	6	disease	disease	NOUN
aji-50	150	7	underwent	undergo	VERB
aji-50	150	8	specific	specific	ADJ
aji-50	150	9	allergological	allergological	ADJ
aji-50	150	10	examination	examination	NOUN
aji-50	150	11	,	,	PUNCT
aji-50	150	12	which	which	PRON
aji-50	150	13	included	include	VERB
aji-50	150	14	collecting	collect	VERB
aji-50	150	15	an	an	DET
aji-50	150	16	allergic	allergic	ADJ
aji-50	150	17	history	history	NOUN
aji-50	150	18	and	and	CCONJ
aji-50	150	19	staging	stage	VERB
aji-50	150	20	skin	skin	NOUN
aji-50	150	21	tests	test	NOUN
aji-50	150	22	with	with	ADP
aji-50	150	23	allergens	allergen	NOUN
aji-50	150	24	.	.	PUNCT
aji-50	151	1	allergological	allergological	ADJ
aji-50	151	2	examination	examination	NOUN
aji-50	151	3	was	be	AUX
aji-50	151	4	carried	carry	VERB
aji-50	151	5	out	out	ADP
aji-50	151	6	according	accord	VERB
aji-50	151	7	to	to	ADP
aji-50	151	8	a	a	DET
aji-50	151	9	special	special	ADJ
aji-50	151	10	scheme	scheme	NOUN
aji-50	151	11	developed	develop	VERB
aji-50	151	12	by	by	ADP
aji-50	151	13	the	the	DET
aji-50	151	14	allergy	allergy	NOUN
aji-50	151	15	research	research	PROPN
aji-50	151	16	laboratory	laboratory	NOUN
aji-50	151	17	of	of	ADP
aji-50	151	18	the	the	DET
aji-50	151	19	2	2	NUM
aji-50	151	20	nd	nd	NOUN
aji-50	151	21	clinic	clinic	NOUN
aji-50	151	22	of	of	ADP
aji-50	151	23	the	the	DET
aji-50	151	24	tashkent	tashkent	PROPN
aji-50	151	25	medical	medical	PROPN
aji-50	151	26	academy	academy	PROPN
aji-50	151	27	.	.	PUNCT
aji-50	152	1	3	3	X
aji-50	152	2	.	.	NOUN
aji-50	152	3	results	result	NOUN
aji-50	152	4	and	and	CCONJ
aji-50	152	5	discussion	discussion	NOUN
aji-50	152	6	for	for	ADP
aji-50	152	7	skin	skin	NOUN
aji-50	152	8	tests	test	NOUN
aji-50	152	9	,	,	PUNCT
aji-50	152	10	allergens	allergen	NOUN
aji-50	152	11	from	from	ADP
aji-50	152	12	timothy	timothy	PROPN
aji-50	152	13	grass	grass	NOUN
aji-50	152	14	pollen	pollen	NOUN
aji-50	152	15	,	,	PUNCT
aji-50	152	16	team	team	NOUN
aji-50	152	17	hedgehog	hedgehog	NOUN
aji-50	152	18	,	,	PUNCT
aji-50	152	19	fescue	fescue	NOUN
aji-50	152	20	,	,	PUNCT
aji-50	152	21	ryegrass	ryegrass	NOUN
aji-50	152	22	,	,	PUNCT
aji-50	152	23	bonfire	bonfire	NOUN
aji-50	152	24	,	,	PUNCT
aji-50	152	25	birch	birch	NOUN
aji-50	152	26	,	,	PUNCT
aji-50	152	27	wormwood	wormwood	NOUN
aji-50	152	28	,	,	PUNCT
aji-50	152	29	ragweed	ragweed	NOUN
aji-50	152	30	,	,	PUNCT
aji-50	152	31	corn	corn	NOUN
aji-50	152	32	,	,	PUNCT
aji-50	152	33	sunflower	sunflower	NOUN
aji-50	152	34	,	,	PUNCT
aji-50	152	35	ash	ash	NOUN
aji-50	152	36	,	,	PUNCT
aji-50	152	37	walnut	walnut	NOUN
aji-50	152	38	,	,	PUNCT
aji-50	152	39	oak	oak	NOUN
aji-50	152	40	and	and	CCONJ
aji-50	152	41	dandelion	dandelion	NOUN
aji-50	152	42	were	be	AUX
aji-50	152	43	used	use	VERB
aji-50	152	44	(	(	PUNCT
aji-50	152	45	table	table	NOUN
aji-50	152	46	1	1	NUM
aji-50	152	47	)	)	PUNCT
aji-50	152	48	.	.	PUNCT
aji-50	153	1	table	table	NOUN
aji-50	153	2	1	1	NUM
aji-50	153	3	shows	show	VERB
aji-50	153	4	that	that	SCONJ
aji-50	153	5	the	the	DET
aji-50	153	6	reaction	reaction	NOUN
aji-50	153	7	to	to	ADP
aji-50	153	8	each	each	DET
aji-50	153	9	allergen	allergen	NOUN
aji-50	153	10	was	be	AUX
aji-50	153	11	different	different	ADJ
aji-50	153	12	.	.	PUNCT
aji-50	154	1	so	so	ADV
aji-50	154	2	,	,	PUNCT
aji-50	154	3	in	in	ADP
aji-50	154	4	92	92	NUM
aji-50	154	5	patients	patient	NOUN
aji-50	154	6	there	there	PRON
aji-50	154	7	was	be	VERB
aji-50	154	8	a	a	DET
aji-50	154	9	positive	positive	ADJ
aji-50	154	10	reaction	reaction	NOUN
aji-50	154	11	of	of	ADP
aji-50	154	12	varying	vary	VERB
aji-50	154	13	degrees	degree	NOUN
aji-50	154	14	to	to	ADP
aji-50	154	15	histamine	histamine	NOUN
aji-50	154	16	.	.	PUNCT
aji-50	155	1	however	however	ADV
aji-50	155	2	,	,	PUNCT
aji-50	155	3	no	no	DET
aji-50	155	4	reaction	reaction	NOUN
aji-50	155	5	was	be	AUX
aji-50	155	6	observed	observe	VERB
aji-50	155	7	on	on	ADP
aji-50	155	8	fescue	fescue	NOUN
aji-50	155	9	,	,	PUNCT
aji-50	155	10	ragweed	ragweed	NOUN
aji-50	155	11	,	,	PUNCT
aji-50	155	12	and	and	CCONJ
aji-50	155	13	hedgehog	hedgehog	NOUN
aji-50	155	14	.	.	PUNCT
aji-50	156	1	in	in	ADP
aji-50	156	2	addition	addition	NOUN
aji-50	156	3	,	,	PUNCT
aji-50	156	4	a	a	DET
aji-50	156	5	negative	negative	ADJ
aji-50	156	6	reaction	reaction	NOUN
aji-50	156	7	to	to	ADP
aji-50	156	8	an	an	DET
aji-50	156	9	allergen	allergen	NOUN
aji-50	156	10	was	be	AUX
aji-50	156	11	recorded	record	VERB
aji-50	156	12	in	in	ADP
aji-50	156	13	58	58	NUM
aji-50	156	14	patients	patient	NOUN
aji-50	156	15	.	.	PUNCT
aji-50	157	1	in	in	ADP
aji-50	157	2	92	92	NUM
aji-50	157	3	patients	patient	NOUN
aji-50	157	4	,	,	PUNCT
aji-50	157	5	a	a	DET
aji-50	157	6	scarification	scarification	NOUN
aji-50	157	7	test	test	NOUN
aji-50	157	8	gave	give	VERB
aji-50	157	9	a	a	DET
aji-50	157	10	positive	positive	ADJ
aji-50	157	11	result	result	NOUN
aji-50	157	12	.	.	PUNCT
aji-50	158	1	this	this	PRON
aji-50	158	2	indicates	indicate	VERB
aji-50	158	3	the	the	DET
aji-50	158	4	undoubted	undoubted	ADJ
aji-50	158	5	participation	participation	NOUN
aji-50	158	6	of	of	ADP
aji-50	158	7	the	the	DET
aji-50	158	8	allergic	allergic	ADJ
aji-50	158	9	factor	factor	NOUN
aji-50	158	10	in	in	ADP
aji-50	158	11	the	the	DET
aji-50	158	12	development	development	NOUN
aji-50	158	13	of	of	ADP
aji-50	158	14	polypousrhinosinusitis	polypousrhinosinusitis	NOUN
aji-50	158	15	.	.	PUNCT
aji-50	159	1	these	these	DET
aji-50	159	2	data	datum	NOUN
aji-50	159	3	correlated	correlate	VERB
aji-50	159	4	with	with	ADP
aji-50	159	5	blood	blood	NOUN
aji-50	159	6	test	test	NOUN
aji-50	159	7	results	result	NOUN
aji-50	159	8	.	.	PUNCT
aji-50	160	1	so	so	ADV
aji-50	160	2	,	,	PUNCT
aji-50	160	3	in	in	ADP
aji-50	160	4	a	a	DET
aji-50	160	5	blood	blood	NOUN
aji-50	160	6	test	test	NOUN
aji-50	160	7	in	in	ADP
aji-50	160	8	92	92	NUM
aji-50	160	9	(	(	PUNCT
aji-50	160	10	33.3	33.3	NUM
aji-50	160	11	%	%	NOUN
aji-50	160	12	)	)	PUNCT
aji-50	160	13	patients	patient	NOUN
aji-50	160	14	,	,	PUNCT
aji-50	160	15	eosinophilia	eosinophilia	PROPN
aji-50	160	16	was	be	AUX
aji-50	160	17	noted	note	VERB
aji-50	160	18	.	.	PUNCT
aji-50	161	1	peripheral	peripheral	ADJ
aji-50	161	2	blood	blood	NOUN
aji-50	161	3	eosinophils	eosinophil	NOUN
aji-50	161	4	were	be	AUX
aji-50	161	5	determined	determine	VERB
aji-50	161	6	in	in	ADP
aji-50	161	7	a	a	DET
aji-50	161	8	general	general	ADJ
aji-50	161	9	blood	blood	NOUN
aji-50	161	10	test	test	NOUN
aji-50	161	11	in	in	ADP
aji-50	161	12	all	all	DET
aji-50	161	13	patients	patient	NOUN
aji-50	161	14	.	.	PUNCT
aji-50	162	1	in	in	ADP
aji-50	162	2	92	92	NUM
aji-50	162	3	patients	patient	NOUN
aji-50	162	4	with	with	ADP
aji-50	162	5	chronic	chronic	ADJ
aji-50	162	6	polypousrhinosinusitis	polypousrhinosinusitis	NOUN
aji-50	162	7	,	,	PUNCT
aji-50	162	8	the	the	DET
aji-50	162	9	number	number	NOUN
aji-50	162	10	of	of	ADP
aji-50	162	11	eosinophils	eosinophil	NOUN
aji-50	162	12	was	be	AUX
aji-50	162	13	increased	increase	VERB
aji-50	162	14	.	.	PUNCT
aji-50	163	1	in	in	ADP
aji-50	163	2	particular	particular	ADJ
aji-50	163	3	,	,	PUNCT
aji-50	163	4	eosinophilia	eosinophilia	PROPN
aji-50	163	5	was	be	AUX
aji-50	163	6	observed	observe	VERB
aji-50	163	7	in	in	ADP
aji-50	163	8	88	88	NUM
aji-50	163	9	examined	examine	VERB
aji-50	163	10	with	with	ADP
aji-50	163	11	a	a	DET
aji-50	163	12	table	table	NOUN
aji-50	163	13	1	1	NUM
aji-50	163	14	.	.	PUNCT
aji-50	164	1	allergy	allergy	NOUN
aji-50	164	2	data	datum	NOUN
aji-50	164	3	in	in	ADP
aji-50	164	4	patients	patient	NOUN
aji-50	164	5	with	with	ADP
aji-50	164	6	crs	crs	PROPN
aji-50	164	7	pollenallergen	pollenallergen	NOUN
aji-50	164	8	patients	patient	NOUN
aji-50	164	9	with	with	ADP
aji-50	164	10	crs	crs	PROPN
aji-50	164	11	(	(	PUNCT
aji-50	164	12	n=150	n=150	NOUN
aji-50	164	13	)	)	PUNCT
aji-50	164	14	results	result	VERB
aji-50	164	15	+	+	X
aji-50	164	16	+	+	PUNCT
aji-50	164	17	+	+	ADJ
aji-50	164	18	+	+	ADJ
aji-50	164	19	+	+	ADJ
aji-50	164	20	+	+	ADJ
aji-50	164	21	dandelion	dandelion	NOUN
aji-50	164	22	18	18	NUM
aji-50	164	23	2	2	NUM
aji-50	164	24	2	2	NUM
aji-50	164	25	14	14	NUM
aji-50	164	26	fescue	fescue	ADJ
aji-50	164	27	sunflower	sunflower	NOUN
aji-50	164	28	16	16	NUM
aji-50	164	29	3	3	NUM
aji-50	164	30	13	13	NUM
aji-50	164	31	sagebrush	sagebrush	NOUN
aji-50	164	32	6	6	NUM
aji-50	164	33	4	4	NUM
aji-50	164	34	2	2	NUM
aji-50	164	35	ash	ash	NOUN
aji-50	164	36	8	8	NUM
aji-50	164	37	2	2	NUM
aji-50	164	38	2	2	NUM
aji-50	164	39	4	4	NUM
aji-50	164	40	bonfire	bonfire	NOUN
aji-50	164	41	10	10	NUM
aji-50	164	42	2	2	NUM
aji-50	164	43	2	2	NUM
aji-50	164	44	6	6	NUM
aji-50	164	45	birch	birch	NOUN
aji-50	164	46	2	2	NUM
aji-50	164	47	1	1	NUM
aji-50	164	48	1	1	NUM
aji-50	164	49	ragweed	ragweed	NOUN
aji-50	164	50	corn	corn	NOUN
aji-50	164	51	9	9	NUM
aji-50	164	52	3	3	NUM
aji-50	164	53	6	6	NUM
aji-50	164	54	oak	oak	NOUN
aji-50	164	55	8	8	NUM
aji-50	164	56	4	4	NUM
aji-50	164	57	4	4	NUM
aji-50	164	58	cocksfoot	cocksfoot	NOUN
aji-50	164	59	histamine	histamine	NOUN
aji-50	164	60	92	92	NUM
aji-50	164	61	38	38	NUM
aji-50	164	62	25	25	NUM
aji-50	164	63	29	29	NUM
aji-50	164	64	neg	neg	NOUN
aji-50	164	65	.	.	PUNCT
aji-50	165	1	58	58	NUM
aji-50	165	2	djuraev	djuraev	NOUN
aji-50	165	3	et	et	PROPN
aji-50	165	4	al	al	PROPN
aji-50	165	5	.	.	PROPN
aji-50	165	6	;	;	PUNCT
aji-50	165	7	aji	aji	PROPN
aji-50	165	8	,	,	PUNCT
aji-50	165	9	3(1	3(1	NUM
aji-50	165	10	):	):	PUNCT
aji-50	165	11	124	124	NUM
aji-50	165	12	-	-	SYM
aji-50	165	13	130	130	NUM
aji-50	165	14	,	,	PUNCT
aji-50	165	15	2020	2020	NUM
aji-50	165	16	;	;	PUNCT
aji-50	165	17	article	article	NOUN
aji-50	165	18	no.aji.55718	no.aji.55718	VERB
aji-50	165	19	127	127	NUM
aji-50	165	20	positive	positive	ADJ
aji-50	165	21	result	result	NOUN
aji-50	165	22	for	for	ADP
aji-50	165	23	the	the	DET
aji-50	165	24	allergen	allergen	NOUN
aji-50	165	25	,	,	PUNCT
aji-50	165	26	however	however	ADV
aji-50	165	27	,	,	PUNCT
aji-50	165	28	in	in	ADP
aji-50	165	29	the	the	DET
aji-50	165	30	remaining	remain	VERB
aji-50	165	31	62	62	NUM
aji-50	165	32	patients	patient	NOUN
aji-50	165	33	the	the	DET
aji-50	165	34	number	number	NOUN
aji-50	165	35	of	of	ADP
aji-50	165	36	eosinophils	eosinophil	NOUN
aji-50	165	37	remained	remain	VERB
aji-50	165	38	within	within	ADP
aji-50	165	39	the	the	DET
aji-50	165	40	normal	normal	ADJ
aji-50	165	41	range	range	NOUN
aji-50	165	42	(	(	PUNCT
aji-50	165	43	table	table	NOUN
aji-50	165	44	2	2	NUM
aji-50	165	45	)	)	PUNCT
aji-50	165	46	.	.	PUNCT
aji-50	166	1	peripheral	peripheral	ADJ
aji-50	166	2	blood	blood	NOUN
aji-50	166	3	eosinophilia	eosinophilia	PROPN
aji-50	166	4	indicates	indicate	VERB
aji-50	166	5	the	the	DET
aji-50	166	6	continued	continued	ADJ
aji-50	166	7	role	role	NOUN
aji-50	166	8	of	of	ADP
aji-50	166	9	allergies	allergy	NOUN
aji-50	166	10	in	in	ADP
aji-50	166	11	the	the	DET
aji-50	166	12	development	development	NOUN
aji-50	166	13	of	of	ADP
aji-50	166	14	crs	crs	PROPN
aji-50	166	15	.	.	PROPN
aji-50	167	1	allergic	allergic	ADJ
aji-50	167	2	background	background	NOUN
aji-50	167	3	was	be	AUX
aji-50	167	4	found	find	VERB
aji-50	167	5	in	in	ADP
aji-50	167	6	58.67	58.67	NUM
aji-50	167	7	%	%	NOUN
aji-50	167	8	of	of	ADP
aji-50	167	9	the	the	DET
aji-50	167	10	examined	examine	VERB
aji-50	167	11	patients	patient	NOUN
aji-50	167	12	.	.	PUNCT
aji-50	168	1	based	base	VERB
aji-50	168	2	on	on	ADP
aji-50	168	3	the	the	DET
aji-50	168	4	results	result	NOUN
aji-50	168	5	of	of	ADP
aji-50	168	6	the	the	DET
aji-50	168	7	study	study	NOUN
aji-50	168	8	,	,	PUNCT
aji-50	168	9	it	it	PRON
aji-50	168	10	should	should	AUX
aji-50	168	11	be	be	AUX
aji-50	168	12	noted	note	VERB
aji-50	168	13	that	that	SCONJ
aji-50	168	14	the	the	DET
aji-50	168	15	presence	presence	NOUN
aji-50	168	16	of	of	ADP
aji-50	168	17	a	a	DET
aji-50	168	18	positive	positive	ADJ
aji-50	168	19	allergic	allergic	ADJ
aji-50	168	20	reaction	reaction	NOUN
aji-50	168	21	in	in	ADP
aji-50	168	22	patients	patient	NOUN
aji-50	168	23	with	with	ADP
aji-50	168	24	eosinophilia	eosinophilia	PROPN
aji-50	168	25	suggests	suggest	VERB
aji-50	168	26	the	the	DET
aji-50	168	27	appointment	appointment	NOUN
aji-50	168	28	of	of	ADP
aji-50	168	29	topical	topical	ADJ
aji-50	168	30	cs	c	NOUN
aji-50	168	31	for	for	ADP
aji-50	168	32	the	the	DET
aji-50	168	33	purpose	purpose	NOUN
aji-50	168	34	of	of	ADP
aji-50	168	35	pathogenetic	pathogenetic	ADJ
aji-50	168	36	treatment	treatment	NOUN
aji-50	168	37	,	,	PUNCT
aji-50	168	38	as	as	ADV
aji-50	168	39	well	well	ADV
aji-50	168	40	as	as	ADP
aji-50	168	41	2	2	NUM
aji-50	168	42	-	-	SYM
aji-50	168	43	3	3	NUM
aji-50	168	44	generation	generation	NOUN
aji-50	168	45	antihistamines	antihistamine	NOUN
aji-50	168	46	for	for	ADP
aji-50	168	47	the	the	DET
aji-50	168	48	symptomatic	symptomatic	ADJ
aji-50	168	49	treatment	treatment	NOUN
aji-50	168	50	and	and	CCONJ
aji-50	168	51	removal	removal	NOUN
aji-50	168	52	of	of	ADP
aji-50	168	53	symptoms	symptom	NOUN
aji-50	168	54	of	of	ADP
aji-50	168	55	the	the	DET
aji-50	168	56	disease	disease	NOUN
aji-50	168	57	.	.	PUNCT
aji-50	169	1	studies	study	NOUN
aji-50	169	2	of	of	ADP
aji-50	169	3	the	the	DET
aji-50	169	4	immune	immune	ADJ
aji-50	169	5	status	status	NOUN
aji-50	169	6	in	in	ADP
aji-50	169	7	crs	crs	PROPN
aji-50	169	8	patients	patient	NOUN
aji-50	169	9	were	be	AUX
aji-50	169	10	carried	carry	VERB
aji-50	169	11	out	out	ADP
aji-50	169	12	in	in	ADP
aji-50	169	13	the	the	DET
aji-50	169	14	laboratory	laboratory	NOUN
aji-50	169	15	of	of	ADP
aji-50	169	16	immunocytokines	immunocytokine	NOUN
aji-50	169	17	of	of	ADP
aji-50	169	18	the	the	DET
aji-50	169	19	institute	institute	NOUN
aji-50	169	20	of	of	ADP
aji-50	169	21	immunology	immunology	NOUN
aji-50	169	22	of	of	ADP
aji-50	169	23	the	the	DET
aji-50	169	24	academy	academy	NOUN
aji-50	169	25	of	of	ADP
aji-50	169	26	sciences	sciences	PROPN
aji-50	169	27	of	of	ADP
aji-50	169	28	the	the	DET
aji-50	169	29	republic	republic	NOUN
aji-50	169	30	of	of	ADP
aji-50	169	31	uzbekistan	uzbekistan	PROPN
aji-50	169	32	(	(	PUNCT
aji-50	169	33	head	head	NOUN
aji-50	169	34	of	of	ADP
aji-50	169	35	laboratory	laboratory	NOUN
aji-50	169	36	,	,	PUNCT
aji-50	169	37	md	md	PROPN
aji-50	169	38	ismailova	ismailova	PROPN
aji-50	169	39	a.a	a.a	PROPN
aji-50	169	40	.	.	PROPN
aji-50	169	41	)	)	PUNCT
aji-50	169	42	.	.	PUNCT
aji-50	170	1	the	the	DET
aji-50	170	2	determination	determination	NOUN
aji-50	170	3	of	of	ADP
aji-50	170	4	cellular	cellular	ADJ
aji-50	170	5	,	,	PUNCT
aji-50	170	6	humoral	humoral	ADJ
aji-50	170	7	immunity	immunity	NOUN
aji-50	170	8	units	unit	NOUN
aji-50	170	9	was	be	AUX
aji-50	170	10	carried	carry	VERB
aji-50	170	11	out	out	ADP
aji-50	170	12	using	use	VERB
aji-50	170	13	monoclonal	monoclonal	NOUN
aji-50	170	14	antibodies	antibody	NOUN
aji-50	170	15	by	by	ADP
aji-50	170	16	the	the	DET
aji-50	170	17	method	method	NOUN
aji-50	170	18	of	of	ADP
aji-50	170	19	indirect	indirect	ADJ
aji-50	170	20	rosette	rosette	NOUN
aji-50	170	21	formation	formation	NOUN
aji-50	170	22	,	,	PUNCT
aji-50	170	23	to	to	PART
aji-50	170	24	determine	determine	VERB
aji-50	170	25	the	the	DET
aji-50	170	26	cytokines	cytokine	NOUN
aji-50	170	27	used	use	VERB
aji-50	170	28	test	test	NOUN
aji-50	170	29	systems	system	NOUN
aji-50	170	30	produced	produce	VERB
aji-50	170	31	by	by	ADP
aji-50	170	32	vector	vector	NOUN
aji-50	170	33	-	-	PUNCT
aji-50	170	34	best	good	ADJ
aji-50	170	35	of	of	ADP
aji-50	170	36	the	the	DET
aji-50	170	37	russian	russian	PROPN
aji-50	170	38	federation	federation	PROPN
aji-50	170	39	,	,	PUNCT
aji-50	170	40	based	base	VERB
aji-50	170	41	on	on	ADP
aji-50	170	42	the	the	DET
aji-50	170	43	sandwich	sandwich	NOUN
aji-50	170	44	method	method	NOUN
aji-50	170	45	of	of	ADP
aji-50	170	46	enzyme	enzyme	NOUN
aji-50	170	47	-	-	PUNCT
aji-50	170	48	linked	link	VERB
aji-50	170	49	immunosorbent	immunosorbent	NOUN
aji-50	170	50	assay	assay	NOUN
aji-50	170	51	using	use	VERB
aji-50	170	52	horseradish	horseradish	ADJ
aji-50	170	53	peroxidase	peroxidase	NOUN
aji-50	170	54	as	as	ADP
aji-50	170	55	an	an	DET
aji-50	170	56	indicator	indicator	NOUN
aji-50	170	57	enzyme	enzyme	NOUN
aji-50	170	58	.	.	PUNCT
aji-50	171	1	the	the	DET
aji-50	171	2	results	result	NOUN
aji-50	171	3	will	will	AUX
aji-50	171	4	be	be	AUX
aji-50	171	5	analyzed	analyze	VERB
aji-50	171	6	in	in	ADP
aji-50	171	7	the	the	DET
aji-50	171	8	following	follow	VERB
aji-50	171	9	subchapters	subchapter	NOUN
aji-50	171	10	.	.	PUNCT
aji-50	172	1	given	give	VERB
aji-50	172	2	the	the	DET
aji-50	172	3	important	important	ADJ
aji-50	172	4	pathogenetic	pathogenetic	ADJ
aji-50	172	5	role	role	NOUN
aji-50	172	6	of	of	ADP
aji-50	172	7	immune	immune	ADJ
aji-50	172	8	system	system	NOUN
aji-50	172	9	disorders	disorder	NOUN
aji-50	172	10	in	in	ADP
aji-50	172	11	the	the	DET
aji-50	172	12	mechanisms	mechanism	NOUN
aji-50	172	13	of	of	ADP
aji-50	172	14	crs	crs	PROPN
aji-50	172	15	development	development	NOUN
aji-50	172	16	,	,	PUNCT
aji-50	172	17	as	as	ADV
aji-50	172	18	well	well	ADV
aji-50	172	19	as	as	ADP
aji-50	172	20	unsatisfactory	unsatisfactory	ADJ
aji-50	172	21	treatment	treatment	NOUN
aji-50	172	22	results	result	NOUN
aji-50	172	23	,	,	PUNCT
aji-50	172	24	allergization	allergization	NOUN
aji-50	172	25	of	of	ADP
aji-50	172	26	the	the	DET
aji-50	172	27	body	body	NOUN
aji-50	172	28	,	,	PUNCT
aji-50	172	29	and	and	CCONJ
aji-50	172	30	the	the	DET
aji-50	172	31	possibility	possibility	NOUN
aji-50	172	32	of	of	ADP
aji-50	172	33	developing	develop	VERB
aji-50	172	34	toxic	toxic	ADJ
aji-50	172	35	and	and	CCONJ
aji-50	172	36	side	side	NOUN
aji-50	172	37	effects	effect	NOUN
aji-50	172	38	,	,	PUNCT
aji-50	172	39	we	we	PRON
aji-50	172	40	studied	study	VERB
aji-50	172	41	the	the	DET
aji-50	172	42	immune	immune	ADJ
aji-50	172	43	status	status	NOUN
aji-50	172	44	of	of	ADP
aji-50	172	45	patients	patient	NOUN
aji-50	172	46	.	.	PUNCT
aji-50	173	1	an	an	DET
aji-50	173	2	immunological	immunological	ADJ
aji-50	173	3	study	study	NOUN
aji-50	173	4	of	of	ADP
aji-50	173	5	cellular	cellular	ADJ
aji-50	173	6	and	and	CCONJ
aji-50	173	7	humoral	humoral	ADJ
aji-50	173	8	immunity	immunity	NOUN
aji-50	173	9	was	be	AUX
aji-50	173	10	performed	perform	VERB
aji-50	173	11	in	in	ADP
aji-50	173	12	79	79	NUM
aji-50	173	13	(	(	PUNCT
aji-50	173	14	52.7	52.7	NUM
aji-50	173	15	%	%	NOUN
aji-50	173	16	)	)	PUNCT
aji-50	173	17	patients	patient	NOUN
aji-50	173	18	who	who	PRON
aji-50	173	19	were	be	AUX
aji-50	173	20	hospitalized	hospitalize	VERB
aji-50	173	21	in	in	ADP
aji-50	173	22	the	the	DET
aji-50	173	23	ent	ent	PROPN
aji-50	173	24	department	department	PROPN
aji-50	173	25	of	of	ADP
aji-50	173	26	the	the	DET
aji-50	173	27	3rd	3rd	ADJ
aji-50	173	28	clinic	clinic	NOUN
aji-50	173	29	of	of	ADP
aji-50	173	30	the	the	DET
aji-50	173	31	tashkent	tashkent	PROPN
aji-50	173	32	medical	medical	PROPN
aji-50	173	33	academy	academy	PROPN
aji-50	173	34	in	in	ADP
aji-50	173	35	2012	2012	NUM
aji-50	173	36	-	-	SYM
aji-50	173	37	2013	2013	NUM
aji-50	173	38	.	.	PUNCT
aji-50	174	1	(	(	PUNCT
aji-50	174	2	table	table	NOUN
aji-50	174	3	2	2	NUM
aji-50	174	4	)	)	PUNCT
aji-50	174	5	.	.	PUNCT
aji-50	175	1	as	as	SCONJ
aji-50	175	2	can	can	AUX
aji-50	175	3	be	be	AUX
aji-50	175	4	seen	see	VERB
aji-50	175	5	from	from	ADP
aji-50	175	6	table	table	NOUN
aji-50	175	7	3	3	NUM
aji-50	175	8	,	,	PUNCT
aji-50	175	9	in	in	ADP
aji-50	175	10	patients	patient	NOUN
aji-50	175	11	there	there	PRON
aji-50	175	12	was	be	VERB
aji-50	175	13	a	a	DET
aji-50	175	14	significant	significant	ADJ
aji-50	175	15	decrease	decrease	NOUN
aji-50	175	16	in	in	ADP
aji-50	175	17	the	the	DET
aji-50	175	18	content	content	NOUN
aji-50	175	19	of	of	ADP
aji-50	175	20	tlymphocytes	tlymphocyte	NOUN
aji-50	175	21	(	(	PUNCT
aji-50	175	22	cd3	cd3	NOUN
aji-50	175	23	cells	cell	NOUN
aji-50	175	24	)	)	PUNCT
aji-50	175	25	,	,	PUNCT
aji-50	175	26	which	which	PRON
aji-50	175	27	averaged	average	VERB
aji-50	175	28	47.56	47.56	NUM
aji-50	175	29	±	±	NUM
aji-50	175	30	6.57	6.57	NUM
aji-50	175	31	and	and	CCONJ
aji-50	175	32	46.84	46.84	NUM
aji-50	175	33	±	±	NUM
aji-50	175	34	4.52	4.52	NUM
aji-50	175	35	,	,	PUNCT
aji-50	175	36	significantly	significantly	ADV
aji-50	175	37	differing	differ	VERB
aji-50	175	38	from	from	ADP
aji-50	175	39	the	the	DET
aji-50	175	40	control	control	NOUN
aji-50	175	41	data	datum	NOUN
aji-50	175	42	(	(	PUNCT
aji-50	175	43	p	p	X
aji-50	175	44	<	<	X
aji-50	175	45	0	0	NUM
aji-50	175	46	,	,	PUNCT
aji-50	175	47	05	05	NUM
aji-50	175	48	)	)	PUNCT
aji-50	175	49	.	.	PUNCT
aji-50	176	1	the	the	DET
aji-50	176	2	absolute	absolute	ADJ
aji-50	176	3	value	value	NOUN
aji-50	176	4	of	of	ADP
aji-50	176	5	cd3	cd3	PROPN
aji-50	176	6	cells	cell	NOUN
aji-50	176	7	was	be	AUX
aji-50	176	8	also	also	ADV
aji-50	176	9	below	below	ADP
aji-50	176	10	normal	normal	ADJ
aji-50	176	11	.	.	PUNCT
aji-50	177	1	the	the	DET
aji-50	177	2	level	level	NOUN
aji-50	177	3	of	of	ADP
aji-50	177	4	immunoregulatory	immunoregulatory	ADJ
aji-50	177	5	subpopulations	subpopulation	NOUN
aji-50	177	6	of	of	ADP
aji-50	177	7	t	t	PROPN
aji-50	177	8	-	-	PUNCT
aji-50	177	9	lymphocytes	lymphocyte	NOUN
aji-50	177	10	of	of	ADP
aji-50	177	11	t	t	PROPN
aji-50	177	12	-	-	PUNCT
aji-50	177	13	helper	helper	NOUN
aji-50	177	14	cells	cell	NOUN
aji-50	177	15	(	(	PUNCT
aji-50	177	16	t4	t4	PROPN
aji-50	177	17	)	)	PUNCT
aji-50	177	18	and	and	CCONJ
aji-50	177	19	tsuppressors	tsuppressor	NOUN
aji-50	177	20	/	/	SYM
aji-50	177	21	cytotoxic	cytotoxic	ADJ
aji-50	177	22	cells	cell	NOUN
aji-50	177	23	(	(	PUNCT
aji-50	177	24	t8	t8	NOUN
aji-50	177	25	)	)	PUNCT
aji-50	177	26	was	be	AUX
aji-50	177	27	lower	low	ADJ
aji-50	177	28	than	than	ADP
aji-50	177	29	the	the	DET
aji-50	177	30	control	control	NOUN
aji-50	177	31	values	value	NOUN
aji-50	177	32	.	.	PUNCT
aji-50	178	1	for	for	ADP
aji-50	178	2	t	t	NOUN
aji-50	178	3	-	-	PUNCT
aji-50	178	4	helpers	helper	NOUN
aji-50	178	5	,	,	PUNCT
aji-50	178	6	the	the	DET
aji-50	178	7	cd4	cd4	PROPN
aji-50	178	8	cell	cell	NOUN
aji-50	178	9	count	count	NOUN
aji-50	178	10	averaged	average	VERB
aji-50	178	11	26.96	26.96	NUM
aji-50	178	12	±	±	NUM
aji-50	178	13	2.58	2.58	NUM
aji-50	178	14	and	and	CCONJ
aji-50	178	15	26.19	26.19	NUM
aji-50	178	16	±	±	NUM
aji-50	178	17	2.18	2.18	NUM
aji-50	178	18	,	,	PUNCT
aji-50	178	19	which	which	PRON
aji-50	178	20	was	be	AUX
aji-50	178	21	significantly	significantly	ADV
aji-50	178	22	lower	low	ADJ
aji-50	178	23	than	than	ADP
aji-50	178	24	the	the	DET
aji-50	178	25	control	control	NOUN
aji-50	178	26	(	(	PUNCT
aji-50	178	27	p	p	X
aji-50	178	28	<	<	X
aji-50	178	29	0.05	0.05	NUM
aji-50	178	30	)	)	PUNCT
aji-50	178	31	.	.	PUNCT
aji-50	179	1	in	in	ADP
aji-50	179	2	addition	addition	NOUN
aji-50	179	3	,	,	PUNCT
aji-50	179	4	there	there	PRON
aji-50	179	5	was	be	VERB
aji-50	179	6	a	a	DET
aji-50	179	7	significant	significant	ADJ
aji-50	179	8	decrease	decrease	NOUN
aji-50	179	9	in	in	ADP
aji-50	179	10	the	the	DET
aji-50	179	11	number	number	NOUN
aji-50	179	12	of	of	ADP
aji-50	179	13	t	t	NOUN
aji-50	179	14	-	-	PUNCT
aji-50	179	15	helpers	helper	NOUN
aji-50	179	16	(	(	PUNCT
aji-50	179	17	p	p	X
aji-50	179	18	<	<	X
aji-50	179	19	0.05	0.05	NUM
aji-50	179	20	)	)	PUNCT
aji-50	179	21	.	.	PUNCT
aji-50	180	1	both	both	CCONJ
aji-50	180	2	the	the	DET
aji-50	180	3	absolute	absolute	ADJ
aji-50	180	4	and	and	CCONJ
aji-50	180	5	relative	relative	ADJ
aji-50	180	6	contents	content	NOUN
aji-50	180	7	of	of	ADP
aji-50	180	8	tsuppressors	tsuppressor	NOUN
aji-50	180	9	cytotoxic	cytotoxic	ADJ
aji-50	180	10	cells	cell	NOUN
aji-50	180	11	(	(	PUNCT
aji-50	180	12	cd8	cd8	PROPN
aji-50	180	13	)	)	PUNCT
aji-50	180	14	were	be	AUX
aji-50	180	15	also	also	ADV
aji-50	180	16	significantly	significantly	ADV
aji-50	180	17	lower	low	ADJ
aji-50	180	18	than	than	ADP
aji-50	180	19	the	the	DET
aji-50	180	20	control	control	NOUN
aji-50	180	21	(	(	PUNCT
aji-50	180	22	p	p	X
aji-50	180	23	<	<	X
aji-50	180	24	0.05	0.05	NUM
aji-50	180	25	)	)	PUNCT
aji-50	180	26	.	.	PUNCT
aji-50	181	1	an	an	DET
aji-50	181	2	equivalent	equivalent	ADJ
aji-50	181	3	decrease	decrease	NOUN
aji-50	181	4	in	in	ADP
aji-50	181	5	the	the	DET
aji-50	181	6	number	number	NOUN
aji-50	181	7	of	of	ADP
aji-50	181	8	both	both	DET
aji-50	181	9	thelpers	thelper	NOUN
aji-50	181	10	and	and	CCONJ
aji-50	181	11	t	t	PROPN
aji-50	181	12	-	-	PUNCT
aji-50	181	13	suppressors	suppressor	NOUN
aji-50	181	14	caused	cause	VERB
aji-50	181	15	significant	significant	ADJ
aji-50	181	16	changes	change	NOUN
aji-50	181	17	in	in	ADP
aji-50	181	18	the	the	DET
aji-50	181	19	immunoregulatory	immunoregulatory	ADJ
aji-50	181	20	index	index	NOUN
aji-50	181	21	.	.	PUNCT
aji-50	182	1	the	the	DET
aji-50	182	2	ratio	ratio	NOUN
aji-50	182	3	of	of	ADP
aji-50	182	4	cd4	cd4	PROPN
aji-50	182	5	/	/	SYM
aji-50	182	6	cd8	cd8	PROPN
aji-50	182	7	lymphocytes	lymphocyte	NOUN
aji-50	182	8	was	be	AUX
aji-50	182	9	below	below	ADP
aji-50	182	10	the	the	DET
aji-50	182	11	control	control	NOUN
aji-50	182	12	.	.	PUNCT
aji-50	183	1	these	these	DET
aji-50	183	2	data	datum	NOUN
aji-50	183	3	indicate	indicate	VERB
aji-50	183	4	impaired	impaired	ADJ
aji-50	183	5	immunity	immunity	NOUN
aji-50	183	6	as	as	ADP
aji-50	183	7	a	a	DET
aji-50	183	8	result	result	NOUN
aji-50	183	9	of	of	ADP
aji-50	183	10	a	a	DET
aji-50	183	11	prolonged	prolonged	ADJ
aji-50	183	12	inflammatory	inflammatory	ADJ
aji-50	183	13	process	process	NOUN
aji-50	183	14	that	that	PRON
aji-50	183	15	caused	cause	VERB
aji-50	183	16	secondary	secondary	ADJ
aji-50	183	17	immunodeficiency	immunodeficiency	NOUN
aji-50	183	18	in	in	ADP
aji-50	183	19	the	the	DET
aji-50	183	20	body	body	NOUN
aji-50	183	21	of	of	ADP
aji-50	183	22	patients	patient	NOUN
aji-50	183	23	with	with	ADP
aji-50	183	24	various	various	ADJ
aji-50	183	25	forms	form	NOUN
aji-50	183	26	of	of	ADP
aji-50	183	27	chronic	chronic	ADJ
aji-50	183	28	polypousrhinosinusitis	polypousrhinosinusitis	NOUN
aji-50	183	29	.	.	PUNCT
aji-50	184	1	thus	thus	ADV
aji-50	184	2	,	,	PUNCT
aji-50	184	3	in	in	ADP
aji-50	184	4	patients	patient	NOUN
aji-50	184	5	with	with	ADP
aji-50	184	6	crs	crs	PROPN
aji-50	184	7	,	,	PUNCT
aji-50	184	8	there	there	PRON
aji-50	184	9	were	be	VERB
aji-50	184	10	significant	significant	ADJ
aji-50	184	11	disturbances	disturbance	NOUN
aji-50	184	12	of	of	ADP
aji-50	184	13	the	the	DET
aji-50	184	14	t	t	NOUN
aji-50	184	15	-	-	PUNCT
aji-50	184	16	cell	cell	NOUN
aji-50	184	17	immunity	immunity	NOUN
aji-50	184	18	indices	index	NOUN
aji-50	184	19	,	,	PUNCT
aji-50	184	20	which	which	PRON
aji-50	184	21	is	be	AUX
aji-50	184	22	typical	typical	ADJ
aji-50	184	23	for	for	ADP
aji-50	184	24	chronic	chronic	ADJ
aji-50	184	25	respiratory	respiratory	ADJ
aji-50	184	26	diseases	disease	NOUN
aji-50	184	27	.	.	PUNCT
aji-50	185	1	indicators	indicator	NOUN
aji-50	185	2	of	of	ADP
aji-50	185	3	the	the	DET
aji-50	185	4	humoral	humoral	ADJ
aji-50	185	5	immunity	immunity	NOUN
aji-50	185	6	are	be	AUX
aji-50	185	7	presented	present	VERB
aji-50	185	8	in	in	ADP
aji-50	185	9	table	table	NOUN
aji-50	185	10	4	4	NUM
aji-50	185	11	.	.	PUNCT
aji-50	186	1	an	an	DET
aji-50	186	2	exceptional	exceptional	ADJ
aji-50	186	3	role	role	NOUN
aji-50	186	4	in	in	ADP
aji-50	186	5	protecting	protect	VERB
aji-50	186	6	against	against	ADP
aji-50	186	7	pathogenic	pathogenic	ADJ
aji-50	186	8	effects	effect	NOUN
aji-50	186	9	of	of	ADP
aji-50	186	10	various	various	ADJ
aji-50	186	11	pathogenic	pathogenic	ADJ
aji-50	186	12	and	and	CCONJ
aji-50	186	13	opportunistic	opportunistic	ADJ
aji-50	186	14	microorganisms	microorganism	NOUN
aji-50	186	15	is	be	AUX
aji-50	186	16	played	play	VERB
aji-50	186	17	by	by	ADP
aji-50	186	18	immunoglobulins	immunoglobulin	NOUN
aji-50	186	19	of	of	ADP
aji-50	186	20	the	the	DET
aji-50	186	21	main	main	ADJ
aji-50	186	22	classes	class	NOUN
aji-50	186	23	.	.	PUNCT
aji-50	187	1	as	as	SCONJ
aji-50	187	2	our	our	PRON
aji-50	187	3	studies	study	NOUN
aji-50	187	4	showed	show	VERB
aji-50	187	5	,	,	PUNCT
aji-50	187	6	before	before	ADP
aji-50	187	7	treatment	treatment	NOUN
aji-50	187	8	,	,	PUNCT
aji-50	187	9	the	the	DET
aji-50	187	10	igg	igg	PROPN
aji-50	187	11	content	content	NOUN
aji-50	187	12	in	in	ADP
aji-50	187	13	patients	patient	NOUN
aji-50	187	14	did	do	AUX
aji-50	187	15	not	not	PART
aji-50	187	16	differ	differ	VERB
aji-50	187	17	significantly	significantly	ADV
aji-50	187	18	from	from	ADP
aji-50	187	19	the	the	DET
aji-50	187	20	control	control	NOUN
aji-50	187	21	.	.	PUNCT
aji-50	188	1	the	the	DET
aji-50	188	2	average	average	ADJ
aji-50	188	3	iga	iga	PROPN
aji-50	188	4	level	level	NOUN
aji-50	188	5	in	in	ADP
aji-50	188	6	patients	patient	NOUN
aji-50	188	7	of	of	ADP
aji-50	188	8	both	both	DET
aji-50	188	9	groups	group	NOUN
aji-50	188	10	before	before	ADP
aji-50	188	11	surgery	surgery	NOUN
aji-50	188	12	was	be	AUX
aji-50	188	13	slightly	slightly	ADV
aji-50	188	14	reduced	reduce	VERB
aji-50	188	15	(	(	PUNCT
aji-50	188	16	p	p	X
aji-50	188	17	>	>	X
aji-50	188	18	0.05	0.05	NUM
aji-50	188	19	)	)	PUNCT
aji-50	188	20	.	.	PUNCT
aji-50	189	1	given	give	VERB
aji-50	189	2	the	the	DET
aji-50	189	3	important	important	ADJ
aji-50	189	4	role	role	NOUN
aji-50	189	5	of	of	ADP
aji-50	189	6	iga	iga	PROPN
aji-50	189	7	in	in	ADP
aji-50	189	8	protecting	protect	VERB
aji-50	189	9	the	the	DET
aji-50	189	10	body	body	NOUN
aji-50	189	11	and	and	CCONJ
aji-50	189	12	,	,	PUNCT
aji-50	189	13	above	above	ADP
aji-50	189	14	all	all	PRON
aji-50	189	15	,	,	PUNCT
aji-50	189	16	the	the	DET
aji-50	189	17	mucous	mucous	ADJ
aji-50	189	18	membranes	membrane	NOUN
aji-50	189	19	from	from	ADP
aji-50	189	20	infection	infection	NOUN
aji-50	189	21	,	,	PUNCT
aji-50	189	22	it	it	PRON
aji-50	189	23	can	can	AUX
aji-50	189	24	be	be	AUX
aji-50	189	25	concluded	conclude	VERB
aji-50	189	26	that	that	SCONJ
aji-50	189	27	such	such	DET
aji-50	189	28	a	a	DET
aji-50	189	29	disturbance	disturbance	NOUN
aji-50	189	30	of	of	ADP
aji-50	189	31	the	the	DET
aji-50	189	32	biosynthesis	biosynthesis	NOUN
aji-50	189	33	of	of	ADP
aji-50	189	34	this	this	DET
aji-50	189	35	class	class	NOUN
aji-50	189	36	of	of	ADP
aji-50	189	37	immunoglobulin	immunoglobulin	NOUN
aji-50	189	38	may	may	AUX
aji-50	189	39	be	be	AUX
aji-50	189	40	one	one	NUM
aji-50	189	41	of	of	ADP
aji-50	189	42	the	the	DET
aji-50	189	43	reasons	reason	NOUN
aji-50	189	44	for	for	ADP
aji-50	189	45	the	the	DET
aji-50	189	46	decrease	decrease	NOUN
aji-50	189	47	in	in	ADP
aji-50	189	48	immune	immune	ADJ
aji-50	189	49	reactivity	reactivity	NOUN
aji-50	189	50	and	and	CCONJ
aji-50	189	51	frequent	frequent	ADJ
aji-50	189	52	infectious	infectious	ADJ
aji-50	189	53	processes	process	NOUN
aji-50	189	54	.	.	PUNCT
aji-50	190	1	table	table	NOUN
aji-50	190	2	2	2	NUM
aji-50	190	3	.	.	PUNCT
aji-50	191	1	the	the	DET
aji-50	191	2	content	content	NOUN
aji-50	191	3	of	of	ADP
aji-50	191	4	eosinophils	eosinophil	NOUN
aji-50	191	5	in	in	ADP
aji-50	191	6	peripheral	peripheral	ADJ
aji-50	191	7	blood	blood	NOUN
aji-50	191	8	in	in	ADP
aji-50	191	9	patients	patient	NOUN
aji-50	191	10	with	with	ADP
aji-50	191	11	crs	crs	PROPN
aji-50	191	12	eosinophils	eosinophil	NOUN
aji-50	191	13	in	in	ADP
aji-50	191	14	the	the	DET
aji-50	191	15	peripheral	peripheral	ADJ
aji-50	191	16	blood	blood	NOUN
aji-50	191	17	patients	patient	NOUN
aji-50	191	18	with	with	ADP
aji-50	191	19	eprs	eprs	NOUN
aji-50	191	20	,	,	PUNCT
aji-50	191	21	(	(	PUNCT
aji-50	191	22	n=90),%	n=90),%	VERB
aji-50	191	23	patients	patient	NOUN
aji-50	191	24	with	with	ADP
aji-50	191	25	nprs	nprs	NOUN
aji-50	191	26	,	,	PUNCT
aji-50	191	27	(	(	PUNCT
aji-50	191	28	n=60),%	n=60),%	PROPN
aji-50	191	29	control	control	NOUN
aji-50	191	30	group	group	NOUN
aji-50	191	31	,	,	PUNCT
aji-50	191	32	(	(	PUNCT
aji-50	191	33	n=20),%	n=20),%	PROPN
aji-50	191	34	6,7±1,51	6,7±1,51	NUM
aji-50	191	35	*	*	SYM
aji-50	191	36	2,1±1,09	2,1±1,09	NUM
aji-50	191	37	2,2±1,07	2,2±1,07	NUM
aji-50	191	38	note	note	VERB
aji-50	191	39	:*	:*	PROPN
aji-50	191	40	differences	difference	NOUN
aji-50	191	41	regarding	regard	VERB
aji-50	191	42	the	the	DET
aji-50	191	43	group	group	NOUN
aji-50	191	44	up	up	ADP
aji-50	191	45	to	to	PART
aji-50	191	46	5	5	NUM
aji-50	191	47	years	year	NOUN
aji-50	191	48	are	be	AUX
aji-50	191	49	significant	significant	ADJ
aji-50	191	50	(	(	PUNCT
aji-50	191	51	*	*	NOUN
aji-50	191	52	p<0,05	p<0,05	NOUN
aji-50	191	53	)	)	PUNCT
aji-50	191	54	djuraev	djuraev	NOUN
aji-50	191	55	et	et	PROPN
aji-50	191	56	al	al	PROPN
aji-50	191	57	.	.	PROPN
aji-50	191	58	;	;	PUNCT
aji-50	191	59	aji	aji	PROPN
aji-50	191	60	,	,	PUNCT
aji-50	191	61	3(1	3(1	NUM
aji-50	191	62	):	):	PUNCT
aji-50	191	63	124	124	NUM
aji-50	191	64	-	-	SYM
aji-50	191	65	130	130	NUM
aji-50	191	66	,	,	PUNCT
aji-50	191	67	2020	2020	NUM
aji-50	191	68	;	;	PUNCT
aji-50	191	69	article	article	NOUN
aji-50	191	70	no.aji.55718	no.aji.55718	NOUN
aji-50	191	71	128	128	NUM
aji-50	191	72	table	table	NOUN
aji-50	191	73	3	3	NUM
aji-50	191	74	.	.	PUNCT
aji-50	191	75	indicators	indicator	NOUN
aji-50	191	76	of	of	ADP
aji-50	191	77	cellular	cellular	ADJ
aji-50	191	78	immunity	immunity	NOUN
aji-50	191	79	in	in	ADP
aji-50	191	80	patients	patient	NOUN
aji-50	191	81	with	with	ADP
aji-50	191	82	crs	crs	PROPN
aji-50	191	83	indicator	indicator	NOUN
aji-50	191	84	patients	patient	NOUN
aji-50	191	85	with	with	ADP
aji-50	191	86	eprs	eprs	NOUN
aji-50	191	87	,	,	PUNCT
aji-50	191	88	(	(	PUNCT
aji-50	191	89	n	n	X
aji-50	191	90	=	=	SYM
aji-50	191	91	48	48	NUM
aji-50	191	92	)	)	PUNCT
aji-50	191	93	patients	patient	NOUN
aji-50	191	94	with	with	ADP
aji-50	191	95	nprs	nprs	NOUN
aji-50	191	96	,	,	PUNCT
aji-50	191	97	(	(	PUNCT
aji-50	191	98	n=31	n=31	NOUN
aji-50	191	99	)	)	PUNCT
aji-50	191	100	control	control	NOUN
aji-50	191	101	group	group	NOUN
aji-50	191	102	,	,	PUNCT
aji-50	191	103	(	(	PUNCT
aji-50	191	104	n=20	n=20	NOUN
aji-50	191	105	)	)	PUNCT
aji-50	191	106	whitebloodcells	whitebloodcell	NOUN
aji-50	191	107	,	,	PUNCT
aji-50	191	108	μl	μl	ADP
aji-50	191	109	6187,5±943,88	6187,5±943,88	NUM
aji-50	191	110	6035,5±1759,84	6035,5±1759,84	NOUN
aji-50	191	111	6295,0±737,33	6295,0±737,33	NUM
aji-50	191	112	lymphocytes	lymphocyte	VERB
aji-50	191	113	,	,	PUNCT
aji-50	191	114	%	%	NOUN
aji-50	191	115	30,7±9,33	30,7±9,33	NUM
aji-50	191	116	29,7±4,19	29,7±4,19	NUM
aji-50	191	117	29,4±4,15	29,4±4,15	NUM
aji-50	191	118	lymphocytes	lymphocyte	NOUN
aji-50	191	119	,	,	PUNCT
aji-50	191	120	μl	μl	PROPN
aji-50	192	1	1717,0±440,38	1717,0±440,38	NUM
aji-50	192	2	1790,3±328,99	1790,3±328,99	NUM
aji-50	192	3	1945,0±225,89	1945,0±225,89	NUM
aji-50	192	4	cd3	cd3	VERB
aji-50	192	5	+	+	PROPN
aji-50	192	6	,	,	PUNCT
aji-50	192	7	%	%	INTJ
aji-50	192	8	47,2±6,05	47,2±6,05	NOUN
aji-50	192	9	47,2±5,24	47,2±5,24	NUM
aji-50	192	10	57,9±4,26	57,9±4,26	NUM
aji-50	192	11	cd3	cd3	VERB
aji-50	192	12	+	+	PROPN
aji-50	192	13	,	,	PUNCT
aji-50	192	14	μl	μl	ADV
aji-50	192	15	814,2±281,30	814,2±281,30	NUM
aji-50	192	16	758,8±135,84	758,8±135,84	NUM
aji-50	192	17	1009,1±214,33	1009,1±214,33	NUM
aji-50	193	1	cd4	cd4	PROPN
aji-50	193	2	+	+	PROPN
aji-50	193	3	,	,	PUNCT
aji-50	193	4	%	%	NOUN
aji-50	193	5	26,9±2,43	26,9±2,43	NUM
aji-50	193	6	*	*	PUNCT
aji-50	193	7	*	*	PUNCT
aji-50	193	8	26,5±2,28	26,5±2,28	PROPN
aji-50	193	9	*	*	X
aji-50	193	10	*	*	X
aji-50	193	11	36,4±1,90	36,4±1,90	NUM
aji-50	193	12	cd4	cd4	PROPN
aji-50	193	13	+	+	PROPN
aji-50	193	14	,	,	PUNCT
aji-50	193	15	μl	μl	ADP
aji-50	193	16	466,4±140,06	466,4±140,06	PROPN
aji-50	193	17	*	*	NOUN
aji-50	193	18	443,0±92,37	443,0±92,37	NOUN
aji-50	193	19	*	*	PUNCT
aji-50	193	20	*	*	PUNCT
aji-50	193	21	*	*	PUNCT
aji-50	193	22	856,7±71,23	856,7±71,23	PROPN
aji-50	194	1	cd8	cd8	PROPN
aji-50	194	2	+	+	PROPN
aji-50	194	3	,	,	PUNCT
aji-50	194	4	%	%	NOUN
aji-50	194	5	19,6±4,60	19,6±4,60	NUM
aji-50	194	6	20,4±3,30	20,4±3,30	NUM
aji-50	194	7	22,6±1,90	22,6±1,90	NUM
aji-50	195	1	cd8	cd8	PROPN
aji-50	195	2	+	+	PROPN
aji-50	195	3	,	,	PUNCT
aji-50	195	4	μl	μl	ADV
aji-50	195	5	330,4±125,28	330,4±125,28	NUM
aji-50	195	6	339,4±45,45	339,4±45,45	NOUN
aji-50	195	7	*	*	PUNCT
aji-50	195	8	498,4±60,84	498,4±60,84	ADJ
aji-50	195	9	iri	iri	NOUN
aji-50	195	10	1,44±0,21	1,44±0,21	NOUN
aji-50	195	11	1,3±0,13	1,3±0,13	NUM
aji-50	195	12	*	*	X
aji-50	195	13	*	*	NOUN
aji-50	195	14	1,75±0,10	1,75±0,10	NUM
aji-50	195	15	cd16	cd16	PROPN
aji-50	195	16	+	+	PROPN
aji-50	195	17	,	,	PUNCT
aji-50	195	18	%	%	NOUN
aji-50	195	19	19,7±3,60	19,7±3,60	NUM
aji-50	195	20	16,1±4,89	16,1±4,89	NUM
aji-50	195	21	14,2±1,84	14,2±1,84	NUM
aji-50	195	22	cd20	cd20	PROPN
aji-50	195	23	+	+	PROPN
aji-50	195	24	,	,	PUNCT
aji-50	195	25	%	%	NOUN
aji-50	195	26	22,3±2,00	22,3±2,00	NUM
aji-50	195	27	21,6±2,71	21,6±2,71	NUM
aji-50	195	28	21,9±2,02	21,9±2,02	NUM
aji-50	196	1	cd20	cd20	PROPN
aji-50	196	2	+	+	PROPN
aji-50	196	3	,	,	PUNCT
aji-50	196	4	μl	μl	PRON
aji-50	196	5	383,7±121,50	383,7±121,50	NUM
aji-50	196	6	366,0±91,66	366,0±91,66	NUM
aji-50	196	7	412,4±95,94	412,4±95,94	NOUN
aji-50	196	8	cd23	cd23	PROPN
aji-50	196	9	+	+	PROPN
aji-50	196	10	,	,	PUNCT
aji-50	196	11	%	%	NOUN
aji-50	196	12	24,2±2,25	24,2±2,25	NUM
aji-50	196	13	19,8±1,47	19,8±1,47	NUM
aji-50	196	14	20,0±1,34	20,0±1,34	NUM
aji-50	196	15	cd38	cd38	PROPN
aji-50	196	16	+	+	PROPN
aji-50	196	17	,	,	PUNCT
aji-50	196	18	%	%	NOUN
aji-50	196	19	31,6±7,02	31,6±7,02	NUM
aji-50	196	20	31,4±6,80	31,4±6,80	NUM
aji-50	196	21	20,9±5,35	20,9±5,35	NUM
aji-50	196	22	cd95	cd95	PROPN
aji-50	196	23	+	+	PROPN
aji-50	196	24	,	,	PUNCT
aji-50	196	25	%	%	NOUN
aji-50	196	26	24,0±3,15	24,0±3,15	NUM
aji-50	196	27	19,7±1,55	19,7±1,55	NUM
aji-50	196	28	19,8±1,51	19,8±1,51	NUM
aji-50	196	29	note	note	NOUN
aji-50	196	30	:	:	PUNCT
aji-50	196	31	*	*	PUNCT
aji-50	196	32	differences	difference	NOUN
aji-50	196	33	relative	relative	ADJ
aji-50	196	34	to	to	ADP
aji-50	196	35	control	control	PROPN
aji-50	196	36	group	group	NOUN
aji-50	196	37	data	datum	NOUN
aji-50	196	38	are	be	AUX
aji-50	196	39	significant	significant	ADJ
aji-50	196	40	(	(	PUNCT
aji-50	196	41	*	*	PUNCT
aji-50	196	42	*	*	PUNCT
aji-50	196	43	*	*	PUNCT
aji-50	196	44	p<0,001	p<0,001	NOUN
aji-50	196	45	)	)	PUNCT
aji-50	196	46	table	table	NOUN
aji-50	196	47	4	4	NUM
aji-50	196	48	.	.	PUNCT
aji-50	196	49	indicators	indicator	NOUN
aji-50	196	50	of	of	ADP
aji-50	196	51	cellular	cellular	ADJ
aji-50	196	52	immunity	immunity	NOUN
aji-50	196	53	in	in	ADP
aji-50	196	54	patients	patient	NOUN
aji-50	196	55	with	with	ADP
aji-50	196	56	crs	crs	PROPN
aji-50	196	57	indicator	indicator	NOUN
aji-50	196	58	patients	patient	NOUN
aji-50	196	59	with	with	ADP
aji-50	196	60	eprs	eprs	NOUN
aji-50	196	61	,	,	PUNCT
aji-50	196	62	(	(	PUNCT
aji-50	196	63	n=48	n=48	NOUN
aji-50	196	64	)	)	PUNCT
aji-50	196	65	patients	patient	NOUN
aji-50	196	66	with	with	ADP
aji-50	196	67	nprs	nprs	NOUN
aji-50	196	68	,	,	PUNCT
aji-50	196	69	(	(	PUNCT
aji-50	196	70	n=31	n=31	NOUN
aji-50	196	71	)	)	PUNCT
aji-50	196	72	control	control	NOUN
aji-50	196	73	group	group	NOUN
aji-50	196	74	,	,	PUNCT
aji-50	196	75	(	(	PUNCT
aji-50	196	76	n=20	n=20	NOUN
aji-50	196	77	)	)	PUNCT
aji-50	196	78	igg	igg	PROPN
aji-50	196	79	,	,	PUNCT
aji-50	196	80	mg%	mg%	NOUN
aji-50	196	81	1144,2±168,93	1144,2±168,93	NUM
aji-50	196	82	1184,3±99,74	1184,3±99,74	PROPN
aji-50	196	83	1176,2±99,17	1176,2±99,17	NUM
aji-50	196	84	iga	iga	PROPN
aji-50	196	85	,	,	PUNCT
aji-50	196	86	mg%	mg%	NOUN
aji-50	196	87	141,9±14,15	141,9±14,15	NUM
aji-50	196	88	167,8±17,88	167,8±17,88	NOUN
aji-50	196	89	*	*	PUNCT
aji-50	196	90	*	*	PUNCT
aji-50	196	91	*	*	PROPN
aji-50	196	92	128,4±16,94	128,4±16,94	PROPN
aji-50	196	93	igm	igm	PROPN
aji-50	196	94	,	,	PUNCT
aji-50	196	95	mg%	mg%	PROPN
aji-50	196	96	118,3±18,22	118,3±18,22	PROPN
aji-50	196	97	120,3±15,22	120,3±15,22	PROPN
aji-50	196	98	121,7±15,16	121,7±15,16	PROPN
aji-50	196	99	cic	cic	VERB
aji-50	196	100	large	large	ADJ
aji-50	196	101	,	,	PUNCT
aji-50	196	102	cu	cu	PROPN
aji-50	196	103	17,8±6,03	17,8±6,03	NUM
aji-50	196	104	19,8±5,09	19,8±5,09	NUM
aji-50	196	105	11,8±3,14	11,8±3,14	NUM
aji-50	196	106	cic	cic	VERB
aji-50	196	107	small	small	ADJ
aji-50	196	108	,	,	PUNCT
aji-50	196	109	cu	cu	PROPN
aji-50	196	110	28,1±9,17	28,1±9,17	NOUN
aji-50	196	111	*	*	PUNCT
aji-50	196	112	*	*	PUNCT
aji-50	196	113	*	*	PROPN
aji-50	196	114	22,3±8,80	22,3±8,80	NUM
aji-50	196	115	21,8±6,92	21,8±6,92	NUM
aji-50	196	116	note	note	NOUN
aji-50	196	117	:	:	PUNCT
aji-50	196	118	*	*	PUNCT
aji-50	196	119	differences	difference	NOUN
aji-50	196	120	relative	relative	ADJ
aji-50	196	121	to	to	ADP
aji-50	196	122	control	control	PROPN
aji-50	196	123	group	group	NOUN
aji-50	196	124	data	datum	NOUN
aji-50	196	125	are	be	AUX
aji-50	196	126	significant	significant	ADJ
aji-50	196	127	(	(	PUNCT
aji-50	196	128	*	*	PUNCT
aji-50	196	129	*	*	PUNCT
aji-50	196	130	*	*	PUNCT
aji-50	196	131	p<0,001	p<0,001	NOUN
aji-50	196	132	)	)	PUNCT
aji-50	196	133	the	the	DET
aji-50	196	134	igm	igm	PROPN
aji-50	196	135	content	content	NOUN
aji-50	196	136	showed	show	VERB
aji-50	196	137	a	a	DET
aji-50	196	138	tendency	tendency	NOUN
aji-50	196	139	to	to	PART
aji-50	196	140	increase	increase	VERB
aji-50	196	141	,	,	PUNCT
aji-50	196	142	but	but	CCONJ
aji-50	196	143	both	both	CCONJ
aji-50	196	144	the	the	DET
aji-50	196	145	average	average	ADJ
aji-50	196	146	values	value	NOUN
aji-50	196	147	and	and	CCONJ
aji-50	196	148	its	its	PRON
aji-50	196	149	individual	individual	ADJ
aji-50	196	150	values	value	NOUN
aji-50	196	151	did	do	AUX
aji-50	196	152	not	not	PART
aji-50	196	153	differ	differ	VERB
aji-50	196	154	significantly	significantly	ADV
aji-50	196	155	from	from	ADP
aji-50	196	156	the	the	DET
aji-50	196	157	norm	norm	NOUN
aji-50	196	158	.	.	PUNCT
aji-50	197	1	the	the	DET
aji-50	197	2	disturbances	disturbance	NOUN
aji-50	197	3	identified	identify	VERB
aji-50	197	4	by	by	ADP
aji-50	197	5	us	we	PRON
aji-50	197	6	were	be	AUX
aji-50	197	7	manifested	manifest	VERB
aji-50	197	8	:	:	PUNCT
aji-50	197	9	disturbance	disturbance	NOUN
aji-50	197	10	of	of	ADP
aji-50	197	11	the	the	DET
aji-50	197	12	cellular	cellular	ADJ
aji-50	197	13	component	component	NOUN
aji-50	197	14	of	of	ADP
aji-50	197	15	immunity	immunity	NOUN
aji-50	197	16	with	with	ADP
aji-50	197	17	insufficiency	insufficiency	NOUN
aji-50	197	18	of	of	ADP
aji-50	197	19	immunoregulatory	immunoregulatory	ADJ
aji-50	197	20	subpopulations	subpopulation	NOUN
aji-50	197	21	of	of	ADP
aji-50	197	22	thelpers	thelper	NOUN
aji-50	197	23	and	and	CCONJ
aji-50	197	24	t	t	PROPN
aji-50	197	25	-	-	PUNCT
aji-50	197	26	suppressors	suppressor	NOUN
aji-50	197	27	(	(	PUNCT
aji-50	197	28	cd4	cd4	PROPN
aji-50	197	29	and	and	CCONJ
aji-50	197	30	cd8	cd8	PROPN
aji-50	197	31	cells	cell	NOUN
aji-50	197	32	)	)	PUNCT
aji-50	197	33	;	;	PUNCT
aji-50	197	34	inhibition	inhibition	NOUN
aji-50	197	35	of	of	ADP
aji-50	197	36	humoral	humoral	ADJ
aji-50	197	37	immunity	immunity	NOUN
aji-50	197	38	(	(	PUNCT
aji-50	197	39	iga	iga	PROPN
aji-50	197	40	)	)	PUNCT
aji-50	197	41	;	;	PUNCT
aji-50	197	42	a	a	DET
aji-50	197	43	decrease	decrease	NOUN
aji-50	197	44	in	in	ADP
aji-50	197	45	natural	natural	ADJ
aji-50	197	46	cytotoxicity	cytotoxicity	NOUN
aji-50	197	47	(	(	PUNCT
aji-50	197	48	cd16	cd16	PROPN
aji-50	197	49	cells	cell	NOUN
aji-50	197	50	)	)	PUNCT
aji-50	197	51	.	.	PUNCT
aji-50	198	1	this	this	PRON
aji-50	198	2	allows	allow	VERB
aji-50	198	3	us	we	PRON
aji-50	198	4	to	to	PART
aji-50	198	5	consider	consider	VERB
aji-50	198	6	patients	patient	NOUN
aji-50	198	7	with	with	ADP
aji-50	198	8	crs	crs	PROPN
aji-50	198	9	as	as	ADP
aji-50	198	10	patients	patient	NOUN
aji-50	198	11	with	with	ADP
aji-50	198	12	prevailing	prevail	VERB
aji-50	198	13	secondary	secondary	ADJ
aji-50	198	14	immunodeficiency	immunodeficiency	NOUN
aji-50	198	15	,	,	PUNCT
aji-50	198	16	which	which	PRON
aji-50	198	17	requires	require	VERB
aji-50	198	18	appropriate	appropriate	ADJ
aji-50	198	19	treatment	treatment	NOUN
aji-50	198	20	using	use	VERB
aji-50	198	21	immunomodulators	immunomodulator	NOUN
aji-50	198	22	.	.	PUNCT
aji-50	199	1	an	an	DET
aji-50	199	2	immunological	immunological	ADJ
aji-50	199	3	study	study	NOUN
aji-50	199	4	of	of	ADP
aji-50	199	5	cytokines	cytokine	NOUN
aji-50	199	6	and	and	CCONJ
aji-50	199	7	total	total	ADJ
aji-50	199	8	ige	ige	PROPN
aji-50	199	9	in	in	ADP
aji-50	199	10	serum	serum	NOUN
aji-50	199	11	was	be	AUX
aji-50	199	12	carried	carry	VERB
aji-50	199	13	out	out	ADP
aji-50	199	14	in	in	ADP
aji-50	199	15	79	79	NUM
aji-50	199	16	(	(	PUNCT
aji-50	199	17	52.7	52.7	NUM
aji-50	199	18	%	%	NOUN
aji-50	199	19	)	)	PUNCT
aji-50	199	20	patients	patient	NOUN
aji-50	199	21	who	who	PRON
aji-50	199	22	were	be	AUX
aji-50	199	23	hospitalized	hospitalize	VERB
aji-50	199	24	in	in	ADP
aji-50	199	25	the	the	DET
aji-50	199	26	ent	ent	PROPN
aji-50	199	27	department	department	PROPN
aji-50	199	28	of	of	ADP
aji-50	199	29	the	the	DET
aji-50	199	30	3	3	NUM
aji-50	199	31	rd	rd	NOUN
aji-50	199	32	clinic	clinic	NOUN
aji-50	199	33	of	of	ADP
aji-50	199	34	the	the	DET
aji-50	199	35	tashkent	tashkent	PROPN
aji-50	199	36	medical	medical	PROPN
aji-50	199	37	academy	academy	PROPN
aji-50	199	38	in	in	ADP
aji-50	199	39	2012	2012	NUM
aji-50	199	40	-	-	SYM
aji-50	199	41	2013	2013	NUM
aji-50	199	42	(	(	PUNCT
aji-50	199	43	table	table	NOUN
aji-50	199	44	5	5	NUM
aji-50	199	45	)	)	PUNCT
aji-50	199	46	.	.	PUNCT
aji-50	200	1	as	as	SCONJ
aji-50	200	2	our	our	PRON
aji-50	200	3	study	study	NOUN
aji-50	200	4	showed	show	VERB
aji-50	200	5	,	,	PUNCT
aji-50	200	6	elevated	elevated	ADJ
aji-50	200	7	levels	level	NOUN
aji-50	200	8	of	of	ADP
aji-50	200	9	il-2	il-2	NUM
aji-50	200	10	in	in	ADP
aji-50	200	11	serum	serum	NOUN
aji-50	200	12	were	be	AUX
aji-50	200	13	observed	observe	VERB
aji-50	200	14	in	in	ADP
aji-50	200	15	patients	patient	NOUN
aji-50	200	16	of	of	ADP
aji-50	200	17	both	both	DET
aji-50	200	18	groups	group	NOUN
aji-50	200	19	,	,	PUNCT
aji-50	200	20	but	but	CCONJ
aji-50	200	21	especially	especially	ADV
aji-50	200	22	in	in	ADP
aji-50	200	23	patients	patient	NOUN
aji-50	200	24	with	with	ADP
aji-50	200	25	chronic	chronic	ADJ
aji-50	200	26	"	"	PUNCT
aji-50	200	27	neutrophilic	neutrophilic	ADJ
aji-50	200	28	"	"	PUNCT
aji-50	200	29	polypousrhinosinusitis	polypousrhinosinusitis	NOUN
aji-50	200	30	.	.	PUNCT
aji-50	201	1	such	such	DET
aji-50	201	2	an	an	DET
aji-50	201	3	increase	increase	NOUN
aji-50	201	4	in	in	ADP
aji-50	201	5	the	the	DET
aji-50	201	6	level	level	NOUN
aji-50	201	7	of	of	ADP
aji-50	201	8	cytokine	cytokine	NOUN
aji-50	201	9	indicates	indicate	VERB
aji-50	201	10	a	a	DET
aji-50	201	11	disturbance	disturbance	NOUN
aji-50	201	12	of	of	ADP
aji-50	201	13	the	the	DET
aji-50	201	14	immune	immune	ADJ
aji-50	201	15	state	state	NOUN
aji-50	201	16	of	of	ADP
aji-50	201	17	the	the	DET
aji-50	201	18	body	body	NOUN
aji-50	201	19	,	,	PUNCT
aji-50	201	20	since	since	SCONJ
aji-50	201	21	il-2	il-2	PROPN
aji-50	201	22	is	be	AUX
aji-50	201	23	responsible	responsible	ADJ
aji-50	201	24	for	for	ADP
aji-50	201	25	the	the	DET
aji-50	201	26	immune	immune	ADJ
aji-50	201	27	response	response	NOUN
aji-50	201	28	.	.	PUNCT
aji-50	202	1	at	at	ADP
aji-50	202	2	the	the	DET
aji-50	202	3	same	same	ADJ
aji-50	202	4	time	time	NOUN
aji-50	202	5	,	,	PUNCT
aji-50	202	6	the	the	DET
aji-50	202	7	content	content	NOUN
aji-50	202	8	of	of	ADP
aji-50	202	9	il-4	il-4	PROPN
aji-50	202	10	,	,	PUNCT
aji-50	202	11	which	which	PRON
aji-50	202	12	is	be	AUX
aji-50	202	13	responsible	responsible	ADJ
aji-50	202	14	for	for	ADP
aji-50	202	15	the	the	DET
aji-50	202	16	allergization	allergization	NOUN
aji-50	202	17	of	of	ADP
aji-50	202	18	the	the	DET
aji-50	202	19	body	body	NOUN
aji-50	202	20	,	,	PUNCT
aji-50	202	21	was	be	AUX
aji-50	202	22	also	also	ADV
aji-50	202	23	increased	increase	VERB
aji-50	202	24	in	in	ADP
aji-50	202	25	patients	patient	NOUN
aji-50	202	26	of	of	ADP
aji-50	202	27	both	both	DET
aji-50	202	28	groups	group	NOUN
aji-50	202	29	,	,	PUNCT
aji-50	202	30	but	but	CCONJ
aji-50	202	31	more	more	ADJ
aji-50	202	32	in	in	ADP
aji-50	202	33	patients	patient	NOUN
aji-50	202	34	with	with	ADP
aji-50	202	35	eosinophilic	eosinophilic	ADJ
aji-50	202	36	polypousrhinosinusitis	polypousrhinosinusitis	NOUN
aji-50	202	37	.	.	PUNCT
aji-50	203	1	the	the	DET
aji-50	203	2	content	content	NOUN
aji-50	203	3	of	of	ADP
aji-50	203	4	il-8	il-8	NOUN
aji-50	203	5	increased	increase	VERB
aji-50	203	6	(	(	PUNCT
aji-50	203	7	9.9	9.9	NUM
aji-50	203	8	±	±	NUM
aji-50	203	9	3.72	3.72	NUM
aji-50	203	10	pg	pg	NOUN
aji-50	203	11	/	/	SYM
aji-50	203	12	ml	ml	VERB
aji-50	203	13	)	)	PUNCT
aji-50	203	14	in	in	ADP
aji-50	203	15	patients	patient	NOUN
aji-50	203	16	with	with	ADP
aji-50	203	17	“	"	PUNCT
aji-50	203	18	neutrophilic	neutrophilic	ADJ
aji-50	203	19	”	"	PUNCT
aji-50	203	20	polyposis	polyposis	NOUN
aji-50	203	21	rhinosinusitis	rhinosinusitis	NOUN
aji-50	203	22	,	,	PUNCT
aji-50	203	23	remaining	remain	VERB
aji-50	203	24	within	within	ADP
aji-50	203	25	the	the	DET
aji-50	203	26	normal	normal	ADJ
aji-50	203	27	range	range	NOUN
aji-50	203	28	in	in	ADP
aji-50	203	29	patients	patient	NOUN
aji-50	203	30	with	with	ADP
aji-50	203	31	“	"	PUNCT
aji-50	203	32	eosinophilic	eosinophilic	ADJ
aji-50	203	33	”	"	PUNCT
aji-50	203	34	polyposis	polyposis	NOUN
aji-50	203	35	rhinosinusitis	rhinosinusitis	NOUN
aji-50	203	36	.	.	PUNCT
aji-50	204	1	djuraev	djuraev	NOUN
aji-50	204	2	et	et	PROPN
aji-50	204	3	al	al	PROPN
aji-50	204	4	.	.	PROPN
aji-50	204	5	;	;	PUNCT
aji-50	204	6	aji	aji	PROPN
aji-50	204	7	,	,	PUNCT
aji-50	204	8	3(1	3(1	NUM
aji-50	204	9	):	):	PUNCT
aji-50	204	10	124	124	NUM
aji-50	204	11	-	-	SYM
aji-50	204	12	130	130	NUM
aji-50	204	13	,	,	PUNCT
aji-50	204	14	2020	2020	NUM
aji-50	204	15	;	;	PUNCT
aji-50	204	16	article	article	NOUN
aji-50	204	17	no.aji.55718	no.aji.55718	VERB
aji-50	204	18	129	129	NUM
aji-50	204	19	table	table	NOUN
aji-50	204	20	5	5	NUM
aji-50	204	21	.	.	PUNCT
aji-50	205	1	the	the	DET
aji-50	205	2	content	content	NOUN
aji-50	205	3	of	of	ADP
aji-50	205	4	cytokines	cytokine	NOUN
aji-50	205	5	and	and	CCONJ
aji-50	205	6	their	their	PRON
aji-50	205	7	ratio	ratio	NOUN
aji-50	205	8	with	with	ADP
aji-50	205	9	total	total	ADJ
aji-50	205	10	ige	ige	NOUN
aji-50	205	11	in	in	ADP
aji-50	205	12	serum	serum	NOUN
aji-50	205	13	in	in	ADP
aji-50	205	14	patients	patient	NOUN
aji-50	205	15	with	with	ADP
aji-50	205	16	crs	crs	PROPN
aji-50	205	17	indicator	indicator	NOUN
aji-50	205	18	patients	patient	NOUN
aji-50	205	19	with	with	ADP
aji-50	205	20	eprs	eprs	NOUN
aji-50	205	21	,	,	PUNCT
aji-50	205	22	(	(	PUNCT
aji-50	205	23	n=48	n=48	NOUN
aji-50	205	24	)	)	PUNCT
aji-50	205	25	patients	patient	NOUN
aji-50	205	26	with	with	ADP
aji-50	205	27	nprs	nprs	NOUN
aji-50	205	28	,	,	PUNCT
aji-50	205	29	(	(	PUNCT
aji-50	205	30	n=31	n=31	NOUN
aji-50	205	31	)	)	PUNCT
aji-50	205	32	control	control	NOUN
aji-50	205	33	group	group	NOUN
aji-50	205	34	,	,	PUNCT
aji-50	205	35	(	(	PUNCT
aji-50	205	36	n=20	n=20	PROPN
aji-50	205	37	)	)	PUNCT
aji-50	205	38	2	2	NUM
aji-50	205	39	-	-	SYM
aji-50	205	40	2	2	NUM
aji-50	205	41	,	,	PUNCT
aji-50	205	42	pg	pg	PROPN
aji-50	205	43	/	/	SYM
aji-50	205	44	ml	ml	PROPN
aji-50	205	45	10,6±3,53	10,6±3,53	NUM
aji-50	205	46	12,5±4,81	12,5±4,81	NUM
aji-50	205	47	5,5±0,44	5,5±0,44	NUM
aji-50	205	48	2	2	NUM
aji-50	205	49	-	-	SYM
aji-50	205	50	4	4	NUM
aji-50	205	51	,	,	PUNCT
aji-50	205	52	pg	pg	VERB
aji-50	205	53	/	/	SYM
aji-50	205	54	ml	ml	ADP
aji-50	205	55	6,4±2,31	6,4±2,31	NUM
aji-50	205	56	7,3±1,13	7,3±1,13	NUM
aji-50	205	57	4,7±1,15	4,7±1,15	NUM
aji-50	205	58	2	2	NUM
aji-50	205	59	-	-	SYM
aji-50	205	60	8	8	NUM
aji-50	205	61	,	,	PUNCT
aji-50	205	62	pg	pg	PROPN
aji-50	205	63	/	/	SYM
aji-50	205	64	ml	ml	ADP
aji-50	205	65	8,3±4,58	8,3±4,58	NUM
aji-50	205	66	9,9±3,72	9,9±3,72	NUM
aji-50	205	67	5,7±0,84	5,7±0,84	NUM
aji-50	205	68	ige	ige	NOUN
aji-50	205	69	,	,	PUNCT
aji-50	205	70	iu	iu	NOUN
aji-50	205	71	/	/	SYM
aji-50	205	72	ml	ml	ADP
aji-50	205	73	239±19,1	239±19,1	NOUN
aji-50	205	74	*	*	PUNCT
aji-50	205	75	*	*	PUNCT
aji-50	205	76	*	*	PUNCT
aji-50	205	77	43,0±30,26	43,0±30,26	NUM
aji-50	205	78	14,6±8,57	14,6±8,57	NUM
aji-50	205	79	note	note	NOUN
aji-50	205	80	:	:	PUNCT
aji-50	205	81	*	*	PUNCT
aji-50	205	82	differences	difference	NOUN
aji-50	205	83	relative	relative	ADJ
aji-50	205	84	to	to	ADP
aji-50	205	85	control	control	PROPN
aji-50	205	86	group	group	NOUN
aji-50	205	87	data	datum	NOUN
aji-50	205	88	are	be	AUX
aji-50	205	89	significant	significant	ADJ
aji-50	205	90	(	(	PUNCT
aji-50	205	91	*	*	PUNCT
aji-50	205	92	p<0,05	p<0,05	NOUN
aji-50	205	93	,	,	PUNCT
aji-50	205	94	*	*	PUNCT
aji-50	205	95	*	*	PUNCT
aji-50	205	96	p<0,01	p<0,01	NOUN
aji-50	205	97	,	,	PUNCT
aji-50	205	98	*	*	PUNCT
aji-50	205	99	*	*	PUNCT
aji-50	205	100	*	*	PUNCT
aji-50	205	101	p<0,001	p<0,001	NOUN
aji-50	205	102	)	)	PUNCT
aji-50	205	103	a	a	DET
aji-50	205	104	sharp	sharp	ADJ
aji-50	205	105	increase	increase	NOUN
aji-50	205	106	in	in	ADP
aji-50	205	107	serum	serum	PROPN
aji-50	205	108	ige	ige	PROPN
aji-50	205	109	levels	level	NOUN
aji-50	205	110	(	(	PUNCT
aji-50	205	111	239	239	NUM
aji-50	205	112	±	±	NUM
aji-50	205	113	19.1	19.1	NUM
aji-50	205	114	iu	iu	NOUN
aji-50	205	115	/	/	SYM
aji-50	205	116	ml	ml	VERB
aji-50	205	117	)	)	PUNCT
aji-50	205	118	was	be	AUX
aji-50	205	119	observed	observe	VERB
aji-50	205	120	in	in	ADP
aji-50	205	121	patients	patient	NOUN
aji-50	205	122	with	with	ADP
aji-50	205	123	eosinophilic	eosinophilic	ADJ
aji-50	205	124	polyposis	polyposis	NOUN
aji-50	205	125	rhinosinusitis	rhinosinusitis	NOUN
aji-50	205	126	,	,	PUNCT
aji-50	205	127	which	which	PRON
aji-50	205	128	we	we	PRON
aji-50	205	129	associate	associate	VERB
aji-50	205	130	with	with	ADP
aji-50	205	131	an	an	DET
aji-50	205	132	increase	increase	NOUN
aji-50	205	133	in	in	ADP
aji-50	205	134	il-4	il-4	NOUN
aji-50	205	135	content	content	NOUN
aji-50	205	136	and	and	CCONJ
aji-50	205	137	increased	increase	VERB
aji-50	205	138	allergization	allergization	NOUN
aji-50	205	139	of	of	ADP
aji-50	205	140	the	the	DET
aji-50	205	141	body	body	NOUN
aji-50	205	142	.	.	PUNCT
aji-50	206	1	this	this	DET
aji-50	206	2	relative	relative	ADJ
aji-50	206	3	difference	difference	NOUN
aji-50	206	4	between	between	ADP
aji-50	206	5	patients	patient	NOUN
aji-50	206	6	in	in	ADP
aji-50	206	7	the	the	DET
aji-50	206	8	two	two	NUM
aji-50	206	9	groups	group	NOUN
aji-50	206	10	proves	prove	VERB
aji-50	206	11	the	the	DET
aji-50	206	12	need	need	NOUN
aji-50	206	13	for	for	ADP
aji-50	206	14	appropriate	appropriate	ADJ
aji-50	206	15	diagnosis	diagnosis	NOUN
aji-50	206	16	and	and	CCONJ
aji-50	206	17	treatment	treatment	NOUN
aji-50	206	18	of	of	ADP
aji-50	206	19	crs	crs	PROPN
aji-50	206	20	.	.	PROPN
aji-50	207	1	4	4	NUM
aji-50	207	2	.	.	X
aji-50	207	3	conclusions	conclusion	NOUN
aji-50	207	4	thus	thus	ADV
aji-50	207	5	,	,	PUNCT
aji-50	207	6	we	we	PRON
aji-50	207	7	did	do	AUX
aji-50	207	8	not	not	PART
aji-50	207	9	find	find	VERB
aji-50	207	10	a	a	DET
aji-50	207	11	clear	clear	ADJ
aji-50	207	12	deficit	deficit	NOUN
aji-50	207	13	in	in	ADP
aji-50	207	14	the	the	DET
aji-50	207	15	content	content	NOUN
aji-50	207	16	of	of	ADP
aji-50	207	17	igg	igg	PROPN
aji-50	207	18	and	and	CCONJ
aji-50	207	19	igm	igm	PROPN
aji-50	207	20	.	.	PUNCT
aji-50	208	1	only	only	ADV
aji-50	208	2	an	an	DET
aji-50	208	3	increase	increase	NOUN
aji-50	208	4	in	in	ADP
aji-50	208	5	the	the	DET
aji-50	208	6	level	level	NOUN
aji-50	208	7	of	of	ADP
aji-50	208	8	iga	iga	PROPN
aji-50	208	9	was	be	AUX
aji-50	208	10	observed	observe	VERB
aji-50	208	11	,	,	PUNCT
aji-50	208	12	indicating	indicate	VERB
aji-50	208	13	the	the	DET
aji-50	208	14	activation	activation	NOUN
aji-50	208	15	of	of	ADP
aji-50	208	16	the	the	DET
aji-50	208	17	body	body	NOUN
aji-50	208	18	's	's	PART
aji-50	208	19	immune	immune	ADJ
aji-50	208	20	systems	system	NOUN
aji-50	208	21	,	,	PUNCT
aji-50	208	22	which	which	PRON
aji-50	208	23	can	can	AUX
aji-50	208	24	serve	serve	VERB
aji-50	208	25	as	as	ADP
aji-50	208	26	a	a	DET
aji-50	208	27	factor	factor	NOUN
aji-50	208	28	in	in	ADP
aji-50	208	29	the	the	DET
aji-50	208	30	development	development	NOUN
aji-50	208	31	of	of	ADP
aji-50	208	32	a	a	DET
aji-50	208	33	long	long	ADJ
aji-50	208	34	inflammatory	inflammatory	ADJ
aji-50	208	35	process	process	NOUN
aji-50	208	36	,	,	PUNCT
aji-50	208	37	and	and	CCONJ
aji-50	208	38	in	in	ADP
aji-50	208	39	the	the	DET
aji-50	208	40	subsequent	subsequent	ADJ
aji-50	208	41	relapse	relapse	NOUN
aji-50	208	42	of	of	ADP
aji-50	208	43	the	the	DET
aji-50	208	44	disease	disease	NOUN
aji-50	208	45	.	.	PUNCT
aji-50	209	1	our	our	PRON
aji-50	209	2	data	datum	NOUN
aji-50	209	3	confirmed	confirm	VERB
aji-50	209	4	that	that	SCONJ
aji-50	209	5	multistep	multistep	ADJ
aji-50	209	6	surgical	surgical	ADJ
aji-50	209	7	intervention	intervention	NOUN
aji-50	209	8	and	and	CCONJ
aji-50	209	9	inadequate	inadequate	ADJ
aji-50	209	10	conservative	conservative	ADJ
aji-50	209	11	treatment	treatment	NOUN
aji-50	209	12	adversely	adversely	ADV
aji-50	209	13	affect	affect	VERB
aji-50	209	14	the	the	DET
aji-50	209	15	immunological	immunological	ADJ
aji-50	209	16	reactivity	reactivity	NOUN
aji-50	209	17	of	of	ADP
aji-50	209	18	crs	crs	NOUN
aji-50	209	19	patients	patient	NOUN
aji-50	209	20	.	.	PUNCT
aji-50	210	1	in	in	ADP
aji-50	210	2	these	these	DET
aji-50	210	3	patients	patient	NOUN
aji-50	210	4	,	,	PUNCT
aji-50	210	5	disturbances	disturbance	NOUN
aji-50	210	6	of	of	ADP
aji-50	210	7	immune	immune	ADJ
aji-50	210	8	homeostasis	homeostasis	NOUN
aji-50	210	9	and	and	CCONJ
aji-50	210	10	a	a	DET
aji-50	210	11	deficiency	deficiency	NOUN
aji-50	210	12	of	of	ADP
aji-50	210	13	cellular	cellular	ADJ
aji-50	210	14	and	and	CCONJ
aji-50	210	15	humoral	humoral	ADJ
aji-50	210	16	immunity	immunity	NOUN
aji-50	210	17	are	be	AUX
aji-50	210	18	detected	detect	VERB
aji-50	210	19	.	.	PUNCT
aji-50	211	1	a	a	DET
aji-50	211	2	study	study	NOUN
aji-50	211	3	of	of	ADP
aji-50	211	4	cellular	cellular	ADJ
aji-50	211	5	and	and	CCONJ
aji-50	211	6	humoral	humoral	ADJ
aji-50	211	7	immunity	immunity	NOUN
aji-50	211	8	revealed	reveal	VERB
aji-50	211	9	that	that	SCONJ
aji-50	211	10	“	"	PUNCT
aji-50	211	11	eosinophilic	eosinophilic	ADJ
aji-50	211	12	”	"	PUNCT
aji-50	211	13	polyposis	polyposis	NOUN
aji-50	211	14	rhinosinusitis	rhinosinusitis	NOUN
aji-50	211	15	is	be	AUX
aji-50	211	16	characterized	characterize	VERB
aji-50	211	17	by	by	ADP
aji-50	211	18	an	an	DET
aji-50	211	19	increase	increase	NOUN
aji-50	211	20	in	in	ADP
aji-50	211	21	the	the	DET
aji-50	211	22	number	number	NOUN
aji-50	211	23	of	of	ADP
aji-50	211	24	natural	natural	ADJ
aji-50	211	25	killers	killer	NOUN
aji-50	211	26	,	,	PUNCT
aji-50	211	27	allergization	allergization	NOUN
aji-50	211	28	factor	factor	NOUN
aji-50	211	29	and	and	CCONJ
aji-50	211	30	apoptosis	apoptosis	NOUN
aji-50	211	31	,	,	PUNCT
aji-50	211	32	il-2	il-2	NUM
aji-50	211	33	,	,	PUNCT
aji-50	211	34	il-4	il-4	X
aji-50	211	35	and	and	CCONJ
aji-50	211	36	ige	ige	PROPN
aji-50	211	37	,	,	PUNCT
aji-50	211	38	while	while	SCONJ
aji-50	211	39	“	"	PUNCT
aji-50	211	40	neutrophilic	neutrophilic	ADJ
aji-50	211	41	”	"	PUNCT
aji-50	211	42	polyposis	polyposis	NOUN
aji-50	211	43	rhinosinusitis	rhinosinusitis	NOUN
aji-50	211	44	indicates	indicate	VERB
aji-50	211	45	a	a	DET
aji-50	211	46	significant	significant	ADJ
aji-50	211	47	increase	increase	NOUN
aji-50	211	48	in	in	ADP
aji-50	211	49	iga	iga	PROPN
aji-50	211	50	and	and	CCONJ
aji-50	211	51	il8	il8	PROPN
aji-50	211	52	,	,	PUNCT
aji-50	211	53	which	which	PRON
aji-50	211	54	indicates	indicate	VERB
aji-50	211	55	the	the	DET
aji-50	211	56	presence	presence	NOUN
aji-50	211	57	of	of	ADP
aji-50	211	58	a	a	DET
aji-50	211	59	long	long	ADV
aji-50	211	60	-	-	PUNCT
aji-50	211	61	lasting	last	VERB
aji-50	211	62	chronic	chronic	ADJ
aji-50	211	63	inflammatory	inflammatory	ADJ
aji-50	211	64	process	process	NOUN
aji-50	211	65	.	.	PUNCT
aji-50	212	1	consent	consent	NOUN
aji-50	212	2	as	as	SCONJ
aji-50	212	3	per	per	ADP
aji-50	212	4	international	international	ADJ
aji-50	212	5	standard	standard	NOUN
aji-50	212	6	informed	inform	VERB
aji-50	212	7	and	and	CCONJ
aji-50	212	8	written	write	VERB
aji-50	212	9	participant	participant	ADJ
aji-50	212	10	consent	consent	NOUN
aji-50	212	11	has	have	AUX
aji-50	212	12	been	be	AUX
aji-50	212	13	collected	collect	VERB
aji-50	212	14	and	and	CCONJ
aji-50	212	15	preserved	preserve	VERB
aji-50	212	16	by	by	ADP
aji-50	212	17	the	the	DET
aji-50	212	18	authors	author	NOUN
aji-50	212	19	.	.	PUNCT
aji-50	213	1	ethical	ethical	ADJ
aji-50	213	2	approval	approval	NOUN
aji-50	213	3	as	as	SCONJ
aji-50	213	4	per	per	ADP
aji-50	213	5	international	international	ADJ
aji-50	213	6	standard	standard	NOUN
aji-50	213	7	written	write	VERB
aji-50	213	8	ethical	ethical	ADJ
aji-50	213	9	permission	permission	NOUN
aji-50	213	10	has	have	AUX
aji-50	213	11	been	be	AUX
aji-50	213	12	collected	collect	VERB
aji-50	213	13	and	and	CCONJ
aji-50	213	14	preserved	preserve	VERB
aji-50	213	15	by	by	ADP
aji-50	213	16	the	the	DET
aji-50	213	17	author(s	author(s	NOUN
aji-50	213	18	)	)	PUNCT
aji-50	213	19	.	.	PUNCT
aji-50	214	1	competing	compete	VERB
aji-50	214	2	interests	interest	NOUN
aji-50	214	3	authors	author	NOUN
aji-50	214	4	have	have	AUX
aji-50	214	5	declared	declare	VERB
aji-50	214	6	that	that	SCONJ
aji-50	214	7	no	no	DET
aji-50	214	8	competing	compete	VERB
aji-50	214	9	interests	interest	NOUN
aji-50	214	10	exist	exist	VERB
aji-50	214	11	.	.	PUNCT
aji-50	215	1	references	reference	NOUN
aji-50	215	2	1	1	NUM
aji-50	215	3	.	.	NUM
aji-50	215	4	voxidov	voxidov	PROPN
aji-50	215	5	un	un	PROPN
aji-50	215	6	,	,	PUNCT
aji-50	215	7	xasanov	xasanov	PROPN
aji-50	215	8	us	we	PRON
aji-50	215	9	,	,	PUNCT
aji-50	215	10	dƶuraev	dƶuraev	PROPN
aji-50	215	11	ƶa	ƶa	PROPN
aji-50	215	12	,	,	PUNCT
aji-50	215	13	sultonov	sultonov	PROPN
aji-50	215	14	dm	dm	PROPN
aji-50	215	15	,	,	PUNCT
aji-50	215	16	soʙirov	soʙirov	NOUN
aji-50	215	17	şş	şş	ADP
aji-50	215	18	.estimation	.estimation	NOUN
aji-50	215	19	of	of	ADP
aji-50	215	20	data	datum	NOUN
aji-50	215	21	of	of	ADP
aji-50	215	22	specific	specific	ADJ
aji-50	215	23	allergic	allergic	ADJ
aji-50	215	24	research	research	NOUN
aji-50	215	25	in	in	ADP
aji-50	215	26	chronic	chronic	ADJ
aji-50	215	27	polypoid	polypoid	ADJ
aji-50	215	28	-	-	PUNCT
aji-50	215	29	rhinosinusitis.2016;(9):374	rhinosinusitis.2016;(9):374	NOUN
aji-50	215	30	-	-	PUNCT
aji-50	215	31	376	376	NUM
aji-50	215	32	.	.	PUNCT
aji-50	216	1	2	2	NUM
aji-50	216	2	.	.	X
aji-50	216	3	xasanov	xasanov	PROPN
aji-50	216	4	us	we	PRON
aji-50	216	5	,	,	PUNCT
aji-50	216	6	voxidov	voxidov	PROPN
aji-50	216	7	un	un	PROPN
aji-50	216	8	,	,	PUNCT
aji-50	216	9	dƶuraev	dƶuraev	PROPN
aji-50	216	10	ƶa	ƶa	PROPN
aji-50	216	11	.	.	PUNCT
aji-50	217	1	the	the	DET
aji-50	217	2	condition	condition	NOUN
aji-50	217	3	of	of	ADP
aji-50	217	4	lumbar	lumbar	ADJ
aji-50	217	5	sinus	sinus	NOUN
aji-50	217	6	in	in	ADP
aji-50	217	7	chronic	chronic	ADJ
aji-50	217	8	inflammatory	inflammatory	ADJ
aji-50	217	9	diseases	disease	NOUN
aji-50	217	10	of	of	ADP
aji-50	217	11	the	the	DET
aji-50	217	12	nasal	nasal	NOUN
aji-50	217	13	and	and	CCONJ
aji-50	217	14	paranasal	paranasal	ADJ
aji-50	217	15	sinuses	sinus	NOUN
aji-50	217	16	in	in	ADP
aji-50	217	17	patients	patient	NOUN
aji-50	217	18	with	with	ADP
aji-50	217	19	myocarditis	myocarditis	PROPN
aji-50	217	20	.	.	PUNCT
aji-50	217	21	europeanscience	europeanscience	NOUN
aji-50	217	22	.	.	PUNCT
aji-50	218	1	2018;9(41	2018;9(41	NUM
aji-50	218	2	)	)	PUNCT
aji-50	218	3	.	.	PUNCT
aji-50	219	1	3	3	X
aji-50	219	2	.	.	X
aji-50	219	3	xasanov	xasanov	PROPN
aji-50	219	4	us	we	PRON
aji-50	219	5	,	,	PUNCT
aji-50	219	6	dƶuraev	dƶuraev	PROPN
aji-50	219	7	ƶa	ƶa	PROPN
aji-50	219	8	,	,	PUNCT
aji-50	219	9	toşpulatov	toşpulatov	PROPN
aji-50	219	10	ƶ	ƶ	PROPN
aji-50	219	11	.	.	PUNCT
aji-50	219	12	peculiarities	peculiarity	NOUN
aji-50	219	13	of	of	ADP
aji-50	219	14	diseases	disease	NOUN
aji-50	219	15	of	of	ADP
aji-50	219	16	the	the	DET
aji-50	219	17	nose	nose	NOUN
aji-50	219	18	and	and	CCONJ
aji-50	219	19	paranasal	paranasal	ADJ
aji-50	219	20	sinuses	sinus	NOUN
aji-50	219	21	in	in	ADP
aji-50	219	22	patients	patient	NOUN
aji-50	219	23	with	with	ADP
aji-50	219	24	myocarditis	myocarditis	PROPN
aji-50	219	25	.	.	PUNCT
aji-50	219	26	molodoyuchenyy	molodoyuchenyy	PROPN
aji-50	219	27	.	.	PUNCT
aji-50	220	1	2016;10	2016;10	NOUN
aji-50	220	2	:	:	PUNCT
aji-50	220	3	547	547	NUM
aji-50	220	4	-	-	SYM
aji-50	220	5	550	550	NUM
aji-50	220	6	.	.	PUNCT
aji-50	221	1	4	4	NUM
aji-50	221	2	.	.	X
aji-50	221	3	abdukhahharovich	abdukhahharovich	PROPN
aji-50	222	1	dj	dj	PROPN
aji-50	222	2	,	,	PUNCT
aji-50	222	3	saidakramovich	saidakramovich	PRON
aji-50	222	4	ku	ku	PROPN
aji-50	222	5	,	,	PUNCT
aji-50	222	6	nuridinovich	nuridinovich	PROPN
aji-50	222	7	vu	vu	PROPN
aji-50	222	8	.	.	PUNCT
aji-50	223	1	the	the	DET
aji-50	223	2	prevalence	prevalence	NOUN
aji-50	223	3	of	of	ADP
aji-50	223	4	chronic	chronic	ADJ
aji-50	223	5	inflammatory	inflammatory	ADJ
aji-50	223	6	diseases	disease	NOUN
aji-50	223	7	of	of	ADP
aji-50	223	8	the	the	DET
aji-50	223	9	nose	nose	NOUN
aji-50	223	10	and	and	CCONJ
aji-50	223	11	paranasal	paranasal	ADJ
aji-50	223	12	sinuses	sinus	NOUN
aji-50	223	13	in	in	ADP
aji-50	223	14	patients	patient	NOUN
aji-50	223	15	with	with	ADP
aji-50	223	16	myocarditis	myocarditis	PROPN
aji-50	223	17	.	.	PUNCT
aji-50	224	1	european	european	PROPN
aji-50	224	2	science	science	PROPN
aji-50	224	3	review	review	PROPN
aji-50	224	4	.	.	PUNCT
aji-50	225	1	2018;5	2018;5	NUM
aji-50	225	2	-	-	PUNCT
aji-50	225	3	6	6	NUM
aji-50	225	4	.	.	NOUN
aji-50	225	5	5	5	NUM
aji-50	225	6	.	.	X
aji-50	225	7	bellavite	bellavite	PROPN
aji-50	225	8	p	p	NOUN
aji-50	225	9	,	,	PUNCT
aji-50	225	10	marzotto	marzotto	PROPN
aji-50	225	11	m	m	PROPN
aji-50	225	12	,	,	PUNCT
aji-50	225	13	chirumbolo	chirumbolo	PROPN
aji-50	225	14	s	s	PROPN
aji-50	225	15	,	,	PUNCT
aji-50	225	16	conforti	conforti	PROPN
aji-50	225	17	a.	a.	NOUN
aji-50	225	18	advances	advance	NOUN
aji-50	225	19	in	in	ADP
aji-50	225	20	homeopathy	homeopathy	NOUN
aji-50	225	21	and	and	CCONJ
aji-50	225	22	immunology	immunology	NOUN
aji-50	225	23	:	:	PUNCT
aji-50	225	24	a	a	DET
aji-50	225	25	review	review	NOUN
aji-50	225	26	of	of	ADP
aji-50	225	27	clinical	clinical	ADJ
aji-50	225	28	research	research	NOUN
aji-50	225	29	.	.	PUNCT
aji-50	226	1	frontbiosci	frontbiosci	PROPN
aji-50	226	2	(	(	PUNCT
aji-50	226	3	scholed	scholed	ADJ
aji-50	226	4	)	)	PUNCT
aji-50	226	5	.	.	PUNCT
aji-50	227	1	2011;3	2011;3	NUM
aji-50	227	2	:	:	PUNCT
aji-50	227	3	1363	1363	NUM
aji-50	227	4	-	-	SYM
aji-50	227	5	1389	1389	NUM
aji-50	227	6	.	.	PUNCT
aji-50	228	1	6	6	NUM
aji-50	228	2	.	.	X
aji-50	228	3	bousquet	bousquet	PROPN
aji-50	228	4	j	j	PROPN
aji-50	228	5	,	,	PUNCT
aji-50	228	6	heinzerling	heinzerle	VERB
aji-50	228	7	l	l	NOUN
aji-50	228	8	,	,	PUNCT
aji-50	228	9	bachert	bachert	PROPN
aji-50	228	10	c	c	PROPN
aji-50	228	11	,	,	PUNCT
aji-50	228	12	papadopoulos	papadopoulos	PROPN
aji-50	228	13	ng	ng	PROPN
aji-50	228	14	,	,	PUNCT
aji-50	228	15	bousquet	bousquet	VERB
aji-50	228	16	pj	pj	PROPN
aji-50	228	17	,	,	PUNCT
aji-50	228	18	burney	burney	PROPN
aji-50	228	19	pg	pg	PROPN
aji-50	228	20	,	,	PUNCT
aji-50	229	1	lodrup	lodrup	NOUN
aji-50	229	2	carlsen	carlsen	PROPN
aji-50	229	3	kc	kc	PROPN
aji-50	229	4	.	.	PROPN
aji-50	230	1	practical	practical	ADJ
aji-50	230	2	guide	guide	NOUN
aji-50	230	3	to	to	ADP
aji-50	230	4	skin	skin	NOUN
aji-50	230	5	prick	prick	NOUN
aji-50	230	6	tests	test	NOUN
aji-50	230	7	in	in	ADP
aji-50	230	8	allergy	allergy	NOUN
aji-50	230	9	to	to	ADP
aji-50	230	10	aeroallergens	aeroallergens	PROPN
aji-50	230	11	.	.	PUNCT
aji-50	231	1	allergy	allergy	NOUN
aji-50	231	2	.	.	PUNCT
aji-50	232	1	2012;67(1):18	2012;67(1):18	ADV
aji-50	232	2	-	-	SYM
aji-50	232	3	24	24	NUM
aji-50	232	4	.	.	PUNCT
aji-50	233	1	7	7	X
aji-50	233	2	.	.	X
aji-50	233	3	bousquet	bousquet	PROPN
aji-50	233	4	pj	pj	PROPN
aji-50	233	5	,	,	PUNCT
aji-50	233	6	combescure	combescure	NOUN
aji-50	233	7	c	c	NOUN
aji-50	233	8	,	,	PUNCT
aji-50	233	9	neukirch	neukirch	PROPN
aji-50	233	10	f	f	NOUN
aji-50	233	11	,	,	PUNCT
aji-50	233	12	klossek	klossek	PROPN
aji-50	233	13	jm	jm	PROPN
aji-50	233	14	,	,	PUNCT
aji-50	233	15	mechin	mechin	PROPN
aji-50	233	16	h	h	PROPN
aji-50	233	17	,	,	PUNCT
aji-50	233	18	daures	daures	PROPN
aji-50	233	19	jp	jp	PROPN
aji-50	233	20	,	,	PUNCT
aji-50	233	21	bousquet	bousquet	PROPN
aji-50	233	22	j.	j.	PROPN
aji-50	233	23	visual	visual	PROPN
aji-50	233	24	analog	analog	NOUN
aji-50	233	25	scales	scale	NOUN
aji-50	233	26	can	can	AUX
aji-50	233	27	assess	assess	VERB
aji-50	233	28	the	the	DET
aji-50	233	29	severity	severity	NOUN
aji-50	233	30	of	of	ADP
aji-50	233	31	rhinitis	rhinitis	NOUN
aji-50	233	32	graded	grade	VERB
aji-50	233	33	according	accord	VERB
aji-50	233	34	to	to	ADP
aji-50	233	35	aria	aria	PROPN
aji-50	233	36	guidelines	guideline	NOUN
aji-50	233	37	.	.	PUNCT
aji-50	234	1	allergy	allergy	NOUN
aji-50	234	2	.	.	PUNCT
aji-50	235	1	2007;62(4):367	2007;62(4):367	NUM
aji-50	235	2	-	-	SYM
aji-50	235	3	372	372	NUM
aji-50	235	4	.	.	NOUN
aji-50	235	5	8	8	NUM
aji-50	235	6	.	.	PUNCT
aji-50	236	1	chen	chen	PROPN
aji-50	236	2	ys	ys	PROPN
aji-50	236	3	,	,	PUNCT
aji-50	236	4	langhammer	langhammer	PROPN
aji-50	236	5	t	t	PROPN
aji-50	236	6	,	,	PUNCT
aji-50	236	7	westhofen	westhofen	PROPN
aji-50	236	8	m	m	PROPN
aji-50	236	9	,	,	PUNCT
aji-50	236	10	lorenzen	lorenzen	PROPN
aji-50	236	11	j.	j.	PROPN
aji-50	236	12	relationship	relationship	PROPN
aji-50	236	13	between	between	ADP
aji-50	236	14	matrix	matrix	NOUN
aji-50	236	15	metalloproteinases	metalloproteinase	VERB
aji-50	236	16	mmp‐2	mmp‐2	NOUN
aji-50	236	17	,	,	PUNCT
aji-50	236	18	mmp‐9	mmp‐9	NOUN
aji-50	236	19	,	,	PUNCT
aji-50	236	20	tissue	tissue	NOUN
aji-50	236	21	inhibitor	inhibitor	NOUN
aji-50	236	22	of	of	ADP
aji-50	236	23	matrix	matrix	NOUN
aji-50	236	24	metalloproteinases	metalloproteinase	VERB
aji-50	236	25	‐1	‐1	NUM
aji-50	236	26	and	and	CCONJ
aji-50	236	27	il‐5	il‐5	PROPN
aji-50	236	28	,	,	PUNCT
aji-50	236	29	il‐8	il‐8	PROPN
aji-50	236	30	in	in	ADP
aji-50	236	31	nasal	nasal	PROPN
aji-50	236	32	polyps	polyp	NOUN
aji-50	236	33	.	.	PUNCT
aji-50	237	1	allergy	allergy	NOUN
aji-50	237	2	.	.	PUNCT
aji-50	238	1	2007;62(1):66	2007;62(1):66	NUM
aji-50	238	2	-	-	SYM
aji-50	238	3	72	72	NUM
aji-50	238	4	.	.	NOUN
aji-50	239	1	9	9	NUM
aji-50	239	2	.	.	X
aji-50	239	3	compalati	compalati	PROPN
aji-50	239	4	e	e	PROPN
aji-50	239	5	,	,	PUNCT
aji-50	239	6	passalacqua	passalacqua	PROPN
aji-50	239	7	g	g	PROPN
aji-50	239	8	,	,	PUNCT
aji-50	239	9	bonini	bonini	PROPN
aji-50	239	10	m	m	PROPN
aji-50	239	11	,	,	PUNCT
aji-50	239	12	canonica	canonica	PROPN
aji-50	239	13	gw	gw	PROPN
aji-50	239	14	.	.	PUNCT
aji-50	240	1	the	the	DET
aji-50	240	2	efficacy	efficacy	NOUN
aji-50	240	3	of	of	ADP
aji-50	240	4	sublingual	sublingual	ADJ
aji-50	240	5	immunotherapy	immunotherapy	NOUN
aji-50	240	6	for	for	ADP
aji-50	240	7	house	house	NOUN
aji-50	240	8	dust	dust	NOUN
aji-50	240	9	mites	mite	VERB
aji-50	240	10	djuraev	djuraev	NOUN
aji-50	240	11	et	et	NOUN
aji-50	240	12	al	al	PROPN
aji-50	240	13	.	.	PROPN
aji-50	240	14	;	;	PUNCT
aji-50	240	15	aji	aji	PROPN
aji-50	240	16	,	,	PUNCT
aji-50	240	17	3(1	3(1	NUM
aji-50	240	18	):	):	PUNCT
aji-50	240	19	124	124	NUM
aji-50	240	20	-	-	SYM
aji-50	240	21	130	130	NUM
aji-50	240	22	,	,	PUNCT
aji-50	240	23	2020	2020	NUM
aji-50	240	24	;	;	PUNCT
aji-50	240	25	article	article	NOUN
aji-50	240	26	no.aji.55718	no.aji.55718	VERB
aji-50	240	27	130	130	NUM
aji-50	240	28	respiratory	respiratory	ADJ
aji-50	240	29	allergy	allergy	NOUN
aji-50	240	30	:	:	PUNCT
aji-50	240	31	results	result	NOUN
aji-50	240	32	of	of	ADP
aji-50	240	33	a	a	DET
aji-50	240	34	ga²len	ga²len	NOUN
aji-50	240	35	meta‐analysis	meta‐analysis	NOUN
aji-50	240	36	.	.	PUNCT
aji-50	241	1	allergy.2009;64(11):15701579	allergy.2009;64(11):15701579	NOUN
aji-50	241	2	.	.	PUNCT
aji-50	242	1	10	10	NUM
aji-50	242	2	.	.	PUNCT
aji-50	243	1	dutta	dutta	PROPN
aji-50	243	2	r	r	PROPN
aji-50	243	3	,	,	PUNCT
aji-50	243	4	dubal	dubal	ADJ
aji-50	243	5	pm	pm	PROPN
aji-50	243	6	,	,	PUNCT
aji-50	243	7	eloy	eloy	PROPN
aji-50	243	8	ja	ja	PROPN
aji-50	243	9	.	.	PUNCT
aji-50	244	1	the	the	DET
aji-50	244	2	connection	connection	NOUN
aji-50	244	3	between	between	ADP
aji-50	244	4	seasonal	seasonal	ADJ
aji-50	244	5	allergies	allergy	NOUN
aji-50	244	6	,	,	PUNCT
aji-50	244	7	food	food	NOUN
aji-50	244	8	allergies	allergy	NOUN
aji-50	244	9	,	,	PUNCT
aji-50	244	10	and	and	CCONJ
aji-50	244	11	rhinosinusitis	rhinosinusitis	NOUN
aji-50	244	12	:	:	PUNCT
aji-50	244	13	what	what	PRON
aji-50	244	14	is	be	AUX
aji-50	244	15	the	the	DET
aji-50	244	16	evidence	evidence	NOUN
aji-50	244	17	?	?	PUNCT
aji-50	244	18	.	.	PUNCT
aji-50	245	1	current	current	ADJ
aji-50	245	2	opinion	opinion	NOUN
aji-50	245	3	in	in	ADP
aji-50	245	4	otolaryngology	otolaryngology	NOUN
aji-50	245	5	&	&	CCONJ
aji-50	245	6	head	head	PROPN
aji-50	245	7	and	and	CCONJ
aji-50	245	8	neck	neck	NOUN
aji-50	245	9	surgery	surgery	NOUN
aji-50	245	10	.	.	PUNCT
aji-50	246	1	2015;23(1):2	2015;23(1):2	NUM
aji-50	246	2	-	-	SYM
aji-50	246	3	7	7	NUM
aji-50	246	4	.	.	NOUN
aji-50	246	5	11	11	NUM
aji-50	246	6	.	.	PUNCT
aji-50	247	1	jutel	jutel	PROPN
aji-50	247	2	m	m	PROPN
aji-50	247	3	,	,	PUNCT
aji-50	247	4	akdis	akdis	PROPN
aji-50	247	5	ca	ca	NOUN
aji-50	247	6	.	.	PUNCT
aji-50	248	1	immunological	immunological	ADJ
aji-50	248	2	mechanisms	mechanism	NOUN
aji-50	248	3	of	of	ADP
aji-50	248	4	allergen‐specific	allergen‐specific	ADJ
aji-50	248	5	immunotherapy	immunotherapy	NOUN
aji-50	248	6	.	.	PUNCT
aji-50	249	1	allergy	allergy	NOUN
aji-50	249	2	.	.	PUNCT
aji-50	250	1	2011;66(6):725732	2011;66(6):725732	NUM
aji-50	250	2	.	.	PROPN
aji-50	251	1	12	12	NUM
aji-50	251	2	.	.	PUNCT
aji-50	252	1	kouzaki	kouzaki	PROPN
aji-50	252	2	h	h	PROPN
aji-50	252	3	,	,	PUNCT
aji-50	252	4	matsumoto	matsumoto	PROPN
aji-50	252	5	k	k	PROPN
aji-50	252	6	,	,	PUNCT
aji-50	252	7	kato	kato	PROPN
aji-50	252	8	t	t	PROPN
aji-50	252	9	,	,	PUNCT
aji-50	252	10	tojima	tojima	PROPN
aji-50	252	11	i	i	PRON
aji-50	252	12	,	,	PUNCT
aji-50	252	13	shimizu	shimizu	PROPN
aji-50	252	14	s	s	PROPN
aji-50	252	15	,	,	PUNCT
aji-50	252	16	shimizu	shimizu	PROPN
aji-50	252	17	t.	t.	PROPN
aji-50	252	18	epithelial	epithelial	PROPN
aji-50	252	19	cellderived	cellderive	VERB
aji-50	252	20	cytokines	cytokine	NOUN
aji-50	252	21	contribute	contribute	VERB
aji-50	252	22	to	to	ADP
aji-50	252	23	the	the	DET
aji-50	252	24	pathophysiology	pathophysiology	NOUN
aji-50	252	25	of	of	ADP
aji-50	252	26	eosinophilic	eosinophilic	ADJ
aji-50	252	27	chronic	chronic	NOUN
aji-50	252	28	rhinosinusitis	rhinosinusitis	PROPN
aji-50	252	29	.	.	PUNCT
aji-50	253	1	journal	journal	PROPN
aji-50	253	2	of	of	ADP
aji-50	253	3	interfer	interfer	VERB
aji-50	253	4	on	on	ADP
aji-50	253	5	&	&	CCONJ
aji-50	253	6	cytokine	cytokine	VERB
aji-50	253	7	research	research	NOUN
aji-50	253	8	.	.	PUNCT
aji-50	254	1	2016;36(3):169	2016;36(3):169	NUM
aji-50	254	2	179	179	NUM
aji-50	254	3	.	.	PUNCT
aji-50	254	4	13	13	NUM
aji-50	254	5	.	.	PUNCT
aji-50	255	1	radulovic	radulovic	PROPN
aji-50	255	2	s	s	PROPN
aji-50	255	3	,	,	PUNCT
aji-50	255	4	wilson	wilson	PROPN
aji-50	255	5	d	d	PROPN
aji-50	255	6	,	,	PUNCT
aji-50	255	7	calderon	calderon	PROPN
aji-50	255	8	m	m	PROPN
aji-50	255	9	,	,	PUNCT
aji-50	256	1	durham	durham	PROPN
aji-50	256	2	s.	s.	PROPN
aji-50	256	3	systematic	systematic	PROPN
aji-50	256	4	reviews	review	NOUN
aji-50	256	5	of	of	ADP
aji-50	256	6	sublingual	sublingual	ADJ
aji-50	256	7	immunotherapy	immunotherapy	NOUN
aji-50	256	8	(	(	PUNCT
aji-50	256	9	slit	slit	NOUN
aji-50	256	10	)	)	PUNCT
aji-50	256	11	.	.	PUNCT
aji-50	257	1	allergy	allergy	NOUN
aji-50	257	2	.	.	PUNCT
aji-50	258	1	2011;66(6):740	2011;66(6):740	NUM
aji-50	258	2	-	-	SYM
aji-50	258	3	752	752	NUM
aji-50	258	4	.	.	PUNCT
aji-50	259	1	14	14	NUM
aji-50	259	2	.	.	PUNCT
aji-50	260	1	vokhidov	vokhidov	PROPN
aji-50	260	2	un	un	PROPN
aji-50	260	3	,	,	PUNCT
aji-50	260	4	khasanov	khasanov	VERB
aji-50	260	5	us	we	PRON
aji-50	260	6	,	,	PUNCT
aji-50	260	7	vokhidov	vokhidov	PROPN
aji-50	260	8	nk	nk	PROPN
aji-50	260	9	.	.	PUNCT
aji-50	261	1	the	the	DET
aji-50	261	2	effectiveness	effectiveness	NOUN
aji-50	261	3	of	of	ADP
aji-50	261	4	use	use	NOUN
aji-50	261	5	macrolides	macrolide	NOUN
aji-50	261	6	in	in	ADP
aji-50	261	7	the	the	DET
aji-50	261	8	treatment	treatment	NOUN
aji-50	261	9	of	of	ADP
aji-50	261	10	chronic"neutrophil	chronic"neutrophil	NOUN
aji-50	261	11	"	"	PUNCT
aji-50	261	12	polypoidrhinosinusitis	polypoidrhinosinusitis	PROPN
aji-50	261	13	.	.	PUNCT
aji-50	262	1	folia	folia	PROPN
aji-50	262	2	otorhinolaryngologiae	otorhinolaryngologiae	PROPN
aji-50	262	3	et	et	PROPN
aji-50	262	4	pathologiae	pathologiae	VERB
aji-50	262	5	respiratoriae	respiratoriae	NOUN
aji-50	262	6	.	.	PUNCT
aji-50	263	1	2014;20	2014;20	NUM
aji-50	263	2	(	(	PUNCT
aji-50	263	3	2):79	2):79	NUM
aji-50	263	4	-	-	SYM
aji-50	263	5	79	79	NUM
aji-50	263	6	.	.	PUNCT
aji-50	264	1	15	15	NUM
aji-50	264	2	.	.	PUNCT
aji-50	265	1	yamamoto	yamamoto	PROPN
aji-50	265	2	m	m	PROPN
aji-50	265	3	,	,	PUNCT
aji-50	265	4	okano	okano	PROPN
aji-50	265	5	m	m	PROPN
aji-50	265	6	,	,	PUNCT
aji-50	265	7	fujiwara	fujiwara	PROPN
aji-50	265	8	t	t	PROPN
aji-50	265	9	,	,	PUNCT
aji-50	265	10	kariya	kariya	PROPN
aji-50	265	11	s	s	PROPN
aji-50	265	12	,	,	PUNCT
aji-50	265	13	higaki	higaki	PROPN
aji-50	265	14	t	t	PROPN
aji-50	265	15	,	,	PUNCT
aji-50	265	16	nagatsuka	nagatsuka	ADV
aji-50	265	17	h	h	NOUN
aji-50	265	18	,	,	PUNCT
aji-50	265	19	nishizaki	nishizaki	ADJ
aji-50	265	20	k.	k.	NOUN
aji-50	265	21	expression	expression	NOUN
aji-50	265	22	and	and	CCONJ
aji-50	265	23	characterization	characterization	NOUN
aji-50	265	24	of	of	ADP
aji-50	265	25	pgd2	pgd2	ADJ
aji-50	265	26	receptors	receptor	NOUN
aji-50	265	27	in	in	ADP
aji-50	265	28	chronic	chronic	ADJ
aji-50	265	29	rhinosinusitis	rhinosinusitis	NOUN
aji-50	265	30	:	:	PUNCT
aji-50	265	31	modulation	modulation	NOUN
aji-50	265	32	of	of	ADP
aji-50	265	33	dp	dp	NOUN
aji-50	265	34	and	and	CCONJ
aji-50	265	35	crth2	crth2	NOUN
aji-50	265	36	by	by	ADP
aji-50	265	37	pgd2	pgd2	PROPN
aji-50	265	38	.	.	PUNCT
aji-50	266	1	international	international	ADJ
aji-50	266	2	archive	archive	NOUN
aji-50	266	3	sofallergy	sofallergy	NOUN
aji-50	266	4	and	and	CCONJ
aji-50	266	5	immunology	immunology	NOUN
aji-50	266	6	.	.	PUNCT
aji-50	267	1	2009;148(2):127	2009;148(2):127	NUM
aji-50	267	2	-	-	SYM
aji-50	267	3	136	136	NUM
aji-50	267	4	.	.	PUNCT
aji-50	268	1	16	16	NUM
aji-50	268	2	.	.	PUNCT
aji-50	269	1	yao	yao	PROPN
aji-50	269	2	t	t	PROPN
aji-50	269	3	,	,	PUNCT
aji-50	269	4	kojima	kojima	PROPN
aji-50	269	5	y	y	PROPN
aji-50	269	6	,	,	PUNCT
aji-50	269	7	koyanagi	koyanagi	PROPN
aji-50	269	8	a	a	PROPN
aji-50	269	9	,	,	PUNCT
aji-50	269	10	yokoi	yokoi	PROPN
aji-50	269	11	h	h	NOUN
aji-50	269	12	,	,	PUNCT
aji-50	269	13	saitoh	saitoh	PROPN
aji-50	269	14	t	t	PROPN
aji-50	269	15	,	,	PUNCT
aji-50	269	16	kawano	kawano	PROPN
aji-50	269	17	k	k	PROPN
aji-50	269	18	,	,	PUNCT
aji-50	269	19	kusunoki	kusunoki	PROPN
aji-50	269	20	t.	t.	PROPN
aji-50	269	21	eotaxin1,-2	eotaxin1,-2	PROPN
aji-50	269	22	,	,	PUNCT
aji-50	269	23	and-3	and-3	ADV
aji-50	269	24	immunoreactivity	immunoreactivity	NOUN
aji-50	269	25	and	and	CCONJ
aji-50	269	26	protein	protein	NOUN
aji-50	269	27	concentration	concentration	NOUN
aji-50	269	28	in	in	ADP
aji-50	269	29	the	the	DET
aji-50	269	30	nasal	nasal	ADJ
aji-50	269	31	polyps	polyp	NOUN
aji-50	269	32	of	of	ADP
aji-50	269	33	eosinophilic	eosinophilic	ADJ
aji-50	269	34	chronic	chronic	ADJ
aji-50	269	35	rhinosinusitis	rhinosinusitis	NOUN
aji-50	269	36	patients	patient	NOUN
aji-50	269	37	.	.	PUNCT
aji-50	270	1	actaclinica	actaclinica	PROPN
aji-50	270	2	croatica	croatica	PROPN
aji-50	270	3	.	.	PUNCT
aji-50	271	1	2009;48(1	2009;48(1	NOUN
aji-50	271	2	):	):	PUNCT
aji-50	271	3	96	96	NUM
aji-50	271	4	-	-	SYM
aji-50	271	5	96	96	NUM
aji-50	271	6	.	.	PUNCT
aji-50	272	1	17	17	NUM
aji-50	272	2	.	.	X
aji-50	273	1	yonamine	yonamine	PROPN
aji-50	273	2	gh	gh	PROPN
aji-50	273	3	,	,	PUNCT
aji-50	273	4	contim	contim	PROPN
aji-50	273	5	d	d	NOUN
aji-50	273	6	,	,	PUNCT
aji-50	273	7	moschione	moschione	PROPN
aji-50	273	8	apb	apb	PROPN
aji-50	273	9	,	,	PUNCT
aji-50	273	10	castro	castro	PROPN
aji-50	273	11	md	md	PROPN
aji-50	273	12	,	,	PUNCT
aji-50	273	13	jacob	jacob	PROPN
aji-50	273	14	cma	cma	PROPN
aji-50	273	15	,	,	PUNCT
aji-50	273	16	carlos	carlos	PROPN
aji-50	273	17	a.	a.	PROPN
aji-50	273	18	olfactory	olfactory	PROPN
aji-50	273	19	disfunctions	disfunction	NOUN
aji-50	273	20	in	in	ADP
aji-50	273	21	patients	patient	NOUN
aji-50	273	22	with	with	ADP
aji-50	273	23	chronic	chronic	ADJ
aji-50	273	24	rhinosinusitis	rhinosinusitis	NOUN
aji-50	273	25	;	;	PUNCT
aji-50	273	26	2012	2012	NUM
aji-50	273	27	.	.	PUNCT
aji-50	274	1	_	_	PUNCT
aji-50	275	1	_	_	PUNCT
aji-50	276	1	_	_	PUNCT
aji-50	277	1	_	_	PUNCT
aji-50	278	1	_	_	PUNCT
aji-50	279	1	_	_	PUNCT
aji-50	280	1	_	_	PUNCT
aji-50	281	1	_	_	PUNCT
aji-50	282	1	_	_	PUNCT
aji-50	283	1	_	_	PUNCT
aji-50	284	1	_	_	PUNCT
aji-50	285	1	_	_	PUNCT
aji-50	286	1	_	_	PUNCT
aji-50	287	1	_	_	PUNCT
aji-50	288	1	_	_	PUNCT
aji-50	289	1	_	_	PUNCT
aji-50	290	1	_	_	PUNCT
aji-50	291	1	_	_	PUNCT
aji-50	292	1	_	_	PUNCT
aji-50	293	1	_	_	PUNCT
aji-50	294	1	_	_	PUNCT
aji-50	295	1	_	_	PUNCT
aji-50	296	1	_	_	PUNCT
aji-50	297	1	_	_	PUNCT
aji-50	298	1	_	_	PUNCT
aji-50	299	1	_	_	PUNCT
aji-50	300	1	_	_	PUNCT
aji-50	301	1	_	_	PUNCT
aji-50	302	1	_	_	PUNCT
aji-50	303	1	_	_	PUNCT
aji-50	304	1	_	_	PUNCT
aji-50	305	1	_	_	PUNCT
aji-50	306	1	_	_	PUNCT
aji-50	307	1	_	_	PUNCT
aji-50	308	1	_	_	PUNCT
aji-50	309	1	_	_	PUNCT
aji-50	310	1	_	_	PUNCT
aji-50	311	1	_	_	PUNCT
aji-50	312	1	_	_	PUNCT
aji-50	313	1	_	_	PUNCT
aji-50	314	1	_	_	PUNCT
aji-50	315	1	_	_	PUNCT
aji-50	316	1	_	_	PUNCT
aji-50	317	1	_	_	PUNCT
aji-50	318	1	_	_	PUNCT
aji-50	319	1	_	_	PUNCT
aji-50	320	1	_	_	PUNCT
aji-50	321	1	_	_	PUNCT
aji-50	322	1	_	_	PUNCT
aji-50	323	1	_	_	PUNCT
aji-50	324	1	_	_	PUNCT
aji-50	325	1	_	_	PUNCT
aji-50	326	1	_	_	PUNCT
aji-50	327	1	_	_	PUNCT
aji-50	328	1	_	_	PUNCT
aji-50	329	1	_	_	PUNCT
aji-50	330	1	_	_	PUNCT
aji-50	331	1	_	_	PUNCT
aji-50	332	1	_	_	PUNCT
aji-50	333	1	_	_	PUNCT
aji-50	334	1	_	_	PUNCT
aji-50	335	1	_	_	PUNCT
aji-50	336	1	_	_	PUNCT
aji-50	337	1	_	_	PUNCT
aji-50	338	1	_	_	PUNCT
aji-50	339	1	_	_	PUNCT
aji-50	340	1	_	_	PUNCT
aji-50	341	1	_	_	PUNCT
aji-50	342	1	_	_	PUNCT
aji-50	343	1	_	_	PUNCT
aji-50	344	1	_	_	PUNCT
aji-50	345	1	_	_	PUNCT
aji-50	346	1	_	_	PUNCT
aji-50	347	1	_	_	PUNCT
aji-50	348	1	_	_	PUNCT
aji-50	349	1	_	_	PUNCT
aji-50	350	1	_	_	PUNCT
aji-50	351	1	_	_	PUNCT
aji-50	352	1	_	_	PUNCT
aji-50	353	1	_	_	PUNCT
aji-50	354	1	_	_	PUNCT
aji-50	355	1	©	©	ADP
aji-50	355	2	2020	2020	NUM
aji-50	355	3	djuraev	djuraev	X
aji-50	355	4	et	et	PROPN
aji-50	355	5	al	al	PROPN
aji-50	355	6	.	.	PROPN
aji-50	355	7	;	;	PUNCT
aji-50	355	8	this	this	PRON
aji-50	355	9	is	be	AUX
aji-50	355	10	an	an	DET
aji-50	355	11	open	open	ADJ
aji-50	355	12	access	access	NOUN
aji-50	355	13	article	article	NOUN
aji-50	355	14	distributed	distribute	VERB
aji-50	355	15	under	under	ADP
aji-50	355	16	the	the	DET
aji-50	355	17	terms	term	NOUN
aji-50	355	18	of	of	ADP
aji-50	355	19	the	the	DET
aji-50	355	20	creative	creative	ADJ
aji-50	355	21	commons	common	NOUN
aji-50	355	22	attribution	attribution	NOUN
aji-50	355	23	license	license	NOUN
aji-50	355	24	(	(	PUNCT
aji-50	355	25	http://creativecommons.org/licenses/by/4.0	http://creativecommons.org/licenses/by/4.0	NOUN
aji-50	355	26	)	)	PUNCT
aji-50	355	27	,	,	PUNCT
aji-50	355	28	which	which	PRON
aji-50	355	29	permits	permit	VERB
aji-50	355	30	unrestricted	unrestricted	ADJ
aji-50	355	31	use	use	NOUN
aji-50	355	32	,	,	PUNCT
aji-50	355	33	distribution	distribution	NOUN
aji-50	355	34	,	,	PUNCT
aji-50	355	35	and	and	CCONJ
aji-50	355	36	reproduction	reproduction	NOUN
aji-50	355	37	in	in	ADP
aji-50	355	38	any	any	DET
aji-50	355	39	medium	medium	NOUN
aji-50	355	40	,	,	PUNCT
aji-50	355	41	provided	provide	VERB
aji-50	355	42	the	the	DET
aji-50	355	43	original	original	ADJ
aji-50	355	44	work	work	NOUN
aji-50	355	45	is	be	AUX
aji-50	355	46	properly	properly	ADV
aji-50	355	47	cited	cite	VERB
aji-50	355	48	.	.	PUNCT
aji-50	356	1	peer	peer	NOUN
aji-50	356	2	-	-	PUNCT
aji-50	356	3	review	review	NOUN
aji-50	356	4	history	history	NOUN
aji-50	356	5	:	:	PUNCT
aji-50	356	6	the	the	DET
aji-50	356	7	peer	peer	NOUN
aji-50	356	8	review	review	NOUN
aji-50	356	9	history	history	NOUN
aji-50	356	10	for	for	ADP
aji-50	356	11	this	this	DET
aji-50	356	12	paper	paper	NOUN
aji-50	356	13	can	can	AUX
aji-50	356	14	be	be	AUX
aji-50	356	15	accessed	access	VERB
aji-50	356	16	here	here	ADV
aji-50	356	17	:	:	PUNCT
aji-50	356	18	http://www.sdiarticle4.com/review-history/55718	http://www.sdiarticle4.com/review-history/55718	PROPN
aji-50	356	19	http://creativecommons.org/licenses/by/4.0	http://creativecommons.org/licenses/by/4.0	X